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Clinical background 
Our mental health care system is going through a transition1. For years, researchers have 
invested in the development of extensive classification systems to gain grip on mental 
suffering. However, frustrations in clinical practice remain2. Clinicians and patients alike often 
find that a categorical diagnostic explanation has marginal relevance for the alleviation of 
mental suffering3. In itself, this is no problem because the ultimate goal is to feel better no 
matter the cause. Selecting optimal interventions remains relevant, but our knowledge base 
for treatment choices are organized on those classification systems. It is important to try to 
bring assessments closer to clinical relevance2,3.  
Knowing why suffering occurs can help to make a treatment choice and provide clues for an 
adequate solution. In the past years, researchers have spent a tremendous amount of time 
and resources to find out what causes depression, anxiety or schizophrenia. Although 
several causes have been identified, no satisfactory explanation to date exists4,5. Without a 
clear etiology, a single treatment target is unrealistic and not enough. The development and 
revisions of classification systems such as the Diagnostic and Statistical Manual of Mental 
Disorders is motivated by the assumption that a better delineation will improve etiological 
research6. However, multiple categorical diagnoses with precise definitions and complex 
decision rules have led to a frustrating reference tool with only limited relevance for 
research4,7. 
The system was originally meant as a guideline for clinicians to inform treatment choices8. 
One of the problems is that the focus of a categorical system lies on susceptibility for mental 
health complaints or in other words, vulnerabilities9. According to the etiological explanation 
of the stress-vulnerability model, early life factors such as genetics, stress, and childhood 
experiences lead to the development of vulnerabilities10,11. These vulnerabilities are part of 
humanity, and human variety is as broad and diverse as all the terms in a mental health 
spectrum. The majority of people will fit at least one criterion and most do not fit perfectly 
within a single classification5. Knowing that multiple factors cause mental suffering has not 
led to better health care by definition. Vulnerabilities represent stable components in a 
specific period of someone’s life, but their expression can wax and wane in reaction to the 
environment11,12. Someone can have a (stable) vulnerability for psychosis, but psychotic 
symptoms can increase after experiencing a stressful event. The deviation from the norm 
during residual phases is the vulnerability13. It is this deviation or variability in vulnerability 
expressions that can create possibilities for interventions, not the vulnerability itself.  
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In order to provide appropriate evidence-based treatment and distribute finances, 
classification is a prerequisite for care in the Netherlands3. However, classification is not 
related to needs and therefore only marginally relevant for prioritizing resources, a concern 
in a fast growing sector. This results in long waiting lists and specialized care programs that 
select outpatients but disregard comorbidity, an important factor in severity. The recognition 
of an inefficient health care system has led to the realization that a transition is needed3,5. 
The time is right to try a different approach, one that shifts the focus from a vulnerability 
perspective to a health perspective14. With the goal to explore what is going on, instead of 
answering the why question.   
Positive health  
What is health and what is illness? Historically, health was defined as the lack of illness15. In 
1948, the World Health Organization (WHO) defined health as “a state of complete physical, 
mental and social wellbeing and not merely the absence of disease or infirmity”16. However, many 
people feel healthy, while still being treated for health complaints. Curing the disease proved 
too stringent a criterion and this definition still receives criticism17. The WHO defined mental 
health as “a state of well-being in which the individual realizes his or her own abilities, can cope 
with the normal stresses of life, can work productively and fruitfully, and is able to make a 
contribution to his or her community”18. According to this definition, mental health or well-
being is a dynamic concept with a societal impact19.  
Recently, Machteld Huber introduced positive health as “the ability to adapt and to self-
manage, in the face of social, physical and emotional challenges”17. This definition better 
matches the way we actually think about mental health care. A more holistic view is taken, 
with a central role for the individual. People suffer from symptoms, but are not defined by 
those symptoms. The focus shifts to aspects of well-being and resilience17. What is the 
strength of a person? When does someone feel better and when is someone able to 
participate in meaningful activities and interactions? Positive health warrants a different 
approach in clinical practice. Often, treatment sessions start with vulnerabilities and 
assessment instruments focus on defining and monitoring psychological complaints. The 
new definition invites us to focus on the positive experiences first. The same holds for 
assessment instruments; they need to have a holistic approach.  
The new definition of health changed the role of patients during treatment. Patients are 
required to play an active role in their own recovery5. Mental health treatment often requires 
a continuous effort from patients; an enduring behavioral change takes time. In these long 
trajectories, empowerment is especially crucial. Empowerment is the process in which 
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individuals gain influence on decisions and actions that are related to their personal health20. 
As a psychological concept, it describes the sense of control over one’s own health and the 
feeling of being responsible21. In order to be empowered, the role of a health care 
professional needs to change as well3,22. Instead of providing complicated and often 
mystifying answers from an expert perspective, the professional needs to listen and ask 
questions. Answers are created together, by thinking along together in a collaborative effort. 
This is important because it helps to motivate patients to take control of their own situation. 
Being motivated and feeling empowered will result in enduring health changes.  
Recovery 
The mental health recovery movement has a long tradition and current views parallel the 
new health perspective1,14. Clinical recovery that is reached by decreasing symptomatic 
complaints, has only limited impact on well-being and life satisfaction14. Other aspects such 
as societal recovery and personal recovery are equally important. Societal recovery is 
reached when someone is able to function in the community and personal recovery when 
someone experiences his or her life as meaningful14. The Institute for Positive Health has 
tried to quantify the different health domains involved23. The domains related to recovery 
include bodily functions (e.g., energy level and physical complaints), mental well-being (e.g., 
emotional state and cognitive functioning), meaningfulness (e.g., acceptance and future 
prospects), quality of life (e.g., happiness and balance), social-societal participation (e.g., work 
and communication skills), and daily functioning (e.g., ability to work and participate). In 
clinical practice, all domains and aspects are relevant3.  
Recovery is a very personal process; everyone has his or her own tempo and phases24,25. 
Care needs to be tailored to these personal recovery phases and both the client and 
caregivers need to be aware of this14. Recovery as a comprehensive process is reached 
through different strategies and is not limited to professional care5,14. Receiving advice from 
neighbors or friends, following a restful yoga class, or finding a meaningful job can all improve 
resilience and life satisfaction.  
Daily life functioning 
Functioning in daily life is an important outcome measure for recovery. Irrational thoughts 
about social situations can easily be addressed in the therapy office, but are more 
challenging in everyday life. Vulnerabilities as well as resilient moments occur in context and 
this context is missing in the office. Optimal care should therefore have a 24/7 impact. Well-
dosed medication has this effect, but interventions such as psychotherapy rely on the 
generalization of skills. This is often difficult. Detecting automatic depressive thoughts or 
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relaxing muscle tension for example, are not self-evident when navigating in a busy 
environment or doing household shores. To increase skill generalization, we need to create 
a daily life impact and find innovative ways to strengthen the current care system.   
eHealth or mHealth 
One such innovation is electronic Health or eHealth: a broad term that encompasses the use 
of internet-related technologies to deliver or enhance health services. A common factor in 
varying definitions of eHealth is that it increases care efficiency due to improved logistics 
provided by technology26. A computerized blood pressure monitor that can be taken home 
to collect data and provide automated feedback to the user is an example of eHealth 
technology. No special skills are required for its use. More specific, but related is mobile 
Health or mHealth: the use of wireless information and communication technology such as 
smartphones, tablets, or smartwatches to improve health, and to support and improve the 
health care system27. The crucial element here is that the technology is available to people 
in different situations. Mobile health can be used in the flow of daily living. It helps to monitor, 
to remind, or to change health care behavior in different contexts or environments. 
Advantages are the independency from professionals, fostering active engagement and 
autonomy and creating empowerment. Furthermore, technology use can be a cost-effective 
way of distributing resources in mental health care28. 
The above-mentioned benefits have led different stakeholders to invest in health technology, 
and the government and funding agencies to encourage the development of mHealth 
tools28,29. As a result, the number of mHealth applications has risen exponentially in the last 
years. However, many tools are developed without a sound scientific background and, while 
improving care logistics, no fundamental changes are made to care provision28. MHealth 
tools for mental health care need to provide accurate insight into daily life functioning, mood, 
and cognition in a holistic manner that is relevant to the individual’s recovery process30.  
Experience sampling method 
The Experience Sampling method (ESM) – or Ecological Momentary Assessment is an 
empirically validated diary method for repeated assessments in daily life31-33. Numerous 
research studies in the mental health field have used the technology to look into mental 
states and symptom dynamics, and examine psychopathology at the micro-level. This offered 
valuable insight on how the expression of vulnerability evolves in the daily context34-36. 
Previously, the logistics of the method were cumbersome, but technology improved and the 
assessment strategy is now available on a smartphone.  
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ESM can be used as an mHealth tool in clinical practice37,38. Short, repeated assessments on 
an app allow the collection of information on current mood, behavior, and cognition in 
different situations. Questions that relate to the current activity, location, and company 
complement the assessments and contextualize mental state reports. By doing so, 
information is gathered across relevant recovery domains37. When sufficient data is available, 
the mental state reports and context information can be combined to provide insight in 
someone’s own functioning. This can be done using an online feedback module, as is 
possible with the PsyMate™ application. In clinical practice, a patient can start to monitor 
their own functioning and decide to share the results with a clinician. Seeing how mood 
fluctuates in the personal situation can form the starting point of a treatment session and 
facilitating shared-decision making9.  
After a while, ESM on a smartphone can function as a therapist in the pocket, increasing 
autonomy. In order to do so, technology needs to be intuitive, embedded in the flow of daily 
life with limited burden, and easy to use. Patients and clinicians alike need to be able to 
understand their data and learn from it39. Now, graphs and figures are used to show dynamic 
patterns between mood states. These data visualizations are not always intuitive and often 
require some explanation. Although very promising, steps need to be taken in order to make 
ESM as an mHealth tool widely available and useful for a broad public. An assessment tool is 
needed that takes into account both vulnerabilities and strengths, and provides an answer 
to what is going on. In a transdiagnostic world of mental health that is embedded in good 
clinical practice.  
Aims and outline of this thesis 
The work in this thesis explores the use of ESM in clinical practice and broadening its scope 
within mental health care. Attention is payed to the power of individual landscapes: the 
picture that unfolds after a period of data collection and the lessons we can learn from this 
picture. Along with the journey of patients exploring their landscapes and engaging in the 
adventure that can lead to empowerment and recovery. The thesis consists of three parts.  
Part I illustrates the usefulness of ESM in clinical practice, approached from different 
perspectives. Chapter 2 provides an overview of the use of the experience sampling method 
in the context of clinical trials. Advantages are highlighted and disadvantages discussed. 
Guidelines and recommendations are presented for setting up an ESM protocol, analyzing 
its data, and implementing it in clinical trials. Furthermore, its promise to improve clinical 
decision-making is considered. In chapter 3, data examples are used to illustrate the 
advantages that ESM provides for routine clinical practice. This chapter gives a 
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comprehensive overview on applications of the methodology to strengthen individual health 
care. Chapter 4 argues that ESM, as a generic transdiagnostic tool, is a reliable instrument 
for meaningful routine outcome monitoring. ESM is implemented in a general hospital 
setting and it as psychometric properties are examined. Chapter 5 illustrates the clinical 
relevance of self-monitoring during recovery from a first-person perspective. Monitoring for 
more than two years is possible and yields valuable lessons, showing its strength in providing 
meaning during darker times in life.  
Part II builds on clinical relevance by leveraging the methodological power of ESM data. 
Providing feedback on an individual basis is very relevant but risky. The feedback needs to 
reflect the personal situation in a correct way. Now, insufficient knowledge exists to 
understand when enough data is gathered for a stable interpretation of the results. In 
chapter 6, a first attempt is made to answer this question. In this proof of concept study, a 
momentary reward-related quality of life statistic is operationalized and tested with Monte 
Carlo experiments. ESM data from patients suffering from serious mental illness served as 
seeds for the data simulations.  
Part III extents ESM with objective cognitive measures in daily life. Chapter 7 is a first pilot 
study in patients suffering from bipolar disorder. A neurocognitive task and a social cognitive 
task are tested within an ESM paradigm. Initial feasibility is examined and the relation 
between momentary cognition outcomes and other relevant ESM measures is explored. In 
Chapter 8, the momentary digit-symbol substitution task is translated to a mobile ESM 
application and tested in the general population. Next to initial feasibility, attention is payed 
to the assessment of cognitive patterns in daily life. Chapter 9 is an extension of the research 
in chapter 8, complementing the digit-symbol substitution task with a visuospatial working 
memory task. Both tasks are tested in a single ESM questionnaire using a broad general 
population sample. Special attention is payed to task evaluation, contextualization, and 
lessons-learned.  
In chapter 10, the main findings of this thesis are summarized and discussed. This is done in 
the light of its clinical implications and from personal experience. The thesis will conclude 
with directions for future ESM use: towards new horizons in clinical care.   
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Abstract 
Objective: The experience sampling method (ESM) is a structured diary technique to appraise 
subjective experiences in daily life. It is applied in psychiatric patients, as well as in patients 
with somatic illness. Despite the potential of ESM assessment, the improved logistics and its 
increased administration in research, its use in clinical trials remains limited. This paper 
introduces ESM for clinical trials in psychiatry and beyond.  
Method: ESM is an ecologically valid method that yields a comprehensive view of an 
individual’s daily life. It allows the assessment of various constructs (e.g., quality of life, 
psychopathology) and psychological mechanisms (e.g., stress-sensitivity, coping). These 
constructs are difficult to assess using cross-sectional questionnaires. ESM can be applied in 
treatment monitoring, as an ecological momentary intervention, in clinical trials, or in single 
case clinical trials. Technological advances (e.g., smartphone applications) make its 
implementation easier.  
Results: Advantages of ESM are highlighted and disadvantages are discussed. Furthermore, 
the ecological nature of ESM data and its consequences are explored, including the potential 
pitfalls of ambiguously formulated research questions and the specificities of ESM in 
statistical analyses. The last section focuses on ESM in relation to clinical trials and discusses 
its future use in optimizing clinical decision-making.  
Conclusion: ESM can be a valuable asset in clinical trial research and should be used more 
often to study the benefits of treatment in psychiatry and somatic health. 
ESM in clinical trials 
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Introduction 
In clinical trials, the effectiveness of a psychiatric intervention is often assessed 
retrospectively, by asking patients to complete self-report questionnaires or by administering 
clinical interviews over the past days or weeks1. These methods lack detailed insight into 
momentary processes and context sensitivity relevant to assess stress-reactivity, a notion 
central to psychopathology. Therefore, the use of momentary assessment techniques is 
proposed in mental health research to tap into daily life symptom experiences2,3. Momentary 
assessment techniques, such as the Experience Sampling Method (ESM), have a long 
tradition4-6. This paper aims to demonstrate the usefulness of these methods in clinical trial 
research, in the field of psychiatry and beyond.  
What is ESM? 
ESM is an umbrella term for a family of momentary assessment techniques that use signals 
to trigger data collection in daily life5. Alternative terms are ecological momentary 
assessment6, ambulatory assessment7, event sampling8, beeper studies9, the structured 
diary method10, intensive longitudinal assessment11, and real-time data capture studies12.  
ESM assesses sampled experiences and behaviours as well as moment-to-moment changes 
in mental states, embedded in (normal) daily life. It is an empirically validated structured diary 
technique. Typically, participants are asked to repeatedly complete short questionnaires 
(lasting no more than 2 min) in response to beep prompts. The questionnaires cover current 
mood, cognitions, perceptions, behaviours and descriptors of the momentary context (e.g., 
location, company, activity)4-6. ESM is useful in psychiatry, as well as in patients with somatic 
illness. The method focusses on symptoms (ill health), as well as on adaptive functioning 
(well-being), aiming to map (normal) daily psychological functioning13. 
Originally, paper diaries were used in combination with pagers or electronic wristwatches4. 
As technology became more advanced, data collection logistics and reliability was improved 
by the use of personal digital assistants13 and smartphone applications14 (e.g., the PsyMate, 
ExperienceSampler or apps by Invivo, lifeData). Typically, assessments are collected using an 
unpredictable (random) time sampling protocol. Assessments can also be triggered by an 
event (event sampling)8. Questionnaires are designed for quick and easy data collection and 
use open-ended questions, visual analogue scales, check lists or self-report Likert scales4,13. 
A typical ESM data form 
ESM assessments usually comprise a morning questionnaire, a beep questionnaire assessed 
repeatedly within a day and an evening questionnaire. The content of the items is subject to 
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the assessment theme. Questions are short and can be rated quickly. An example of such 
an assessment form is included in table 1.  
 
Table 1 
Beep-level assessment sheet from the Psymate standard assessment protocol 
(http://www.psymate.eu) 
I feel cheerful 1=not at all … 7=very 
I feel insecure 1=not at all … 7=very 
I feel relaxed 1=not at all … 7=very 
I feel annoyed 1=not at all … 7=very 
I feel satisfied 1=not at all … 7=very 
I feel lonely 1=not at all … 7=very 
I feel anxious 1=not at all … 7=very 
I feel down 1=not at all … 7=very 
I feel guilty 1=not at all … 7=very 
(optional additional personal question) 1=not at all … 7=very 
What am I doing? 
Select: resting, work or study, household, hygiene, 
eating/drinking, leisure, other, nothing 
I would rather do something else 1=not at all … 7=very 
Where am I? 
Select: at home, at family or friend's place, at work 
or school, public place, transport, somewhere else 
Who am I with? 
Select: partner, family resident, family non-resident, 
friends, colleagues, acquaintances, strangers or 
others, nobody 
I am hungry 1=not at all … 7=very 
I am tired 1=not at all … 7=very 
I am in pain 1=not at all … 7=very 
(automatic recording) Day and time tag 
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Why is ESM used in research? 
ESM typically has a number of advantages, but its implementation varies.  
 ESM has high ecological validity because assessments are made in the natural flow of 
real life13,15. 
 ESM reduces memory strains and avoids aggregation because only the actual moment 
is assessed repeatedly over time. This increases accuracy and is comparatively easier15.  
 The repeated assessments are collected in different situations (contextualized), which 
allows researchers to disentangle and understand the variability in mental states and 
psychological constructs16.  
 ESM yields a rich data set covering information on mental state, quality of life, mobility, 
social network and more, which reduces the need to use separate questionnaires 
measuring different constructs13.  
 Assessment error is reduced by repeated measures over time. This improves the 
validity, reliability, and transparency of individual pattern assessments, which is helpful 
in clinical practice12. 
 Sensitivity to detect change increases due to the collection of data at multiple time 
points11.  
 ESM makes it easier for patients during feedback sessions to acknowledge and 
translate the findings to daily life practice, because they have rated the items (e.g., 
anxiety) repeatedly. This avoids mystification. Involvement and collaboration in care are 
improved and feelings of empowerment in the treatment process are heightened17. 
A possible drawback of ESM is that the method is perceived as time-consuming and 
demanding16. Ideally, assessments are kept as brief as possible, preferably <1 min, with a 
maximum of 2 min4. A study protocol of 10 assessments for 6 consecutive days results in a 
cumulative time investment of < 120 min. The set of questionnaires needed in cross-
sectional studies easily exceeds this time investment. Selection bias is a second concern. Not 
all patients are willing to participate or comply with the protocol, and this subgroup possibly 
functions better than the non-responders3. However, previous research has shown that the 
method is feasible in a wide variety of patients, including those suffering from severe mental 
illness2,4. Most studies have reported good compliance18. On the other hand, patients are 
inclined to miss assessments as a response to their current mood, which could also lead to 
selection bias. However, extensive analysis of missed responses demonstrate that beeps are 
predominantly missed at logical moments, such as the morning and evening (when 
participants are most likely sleeping), and lag analysis found no mood-related dropped 
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responses19. Third, ESM can induce reactivity16. For instance, participants report increased 
awareness during ESM data collection18. Monitoring is also used as a behavioural 
intervention, for instance, to reduce cigarette smoking. In this case, behavioural change is 
maximised by single target assessment of unwanted (automatic) behaviours. ESM, in 
contrast, is an open exploration of daily life using multiple targets. This open exploration 
reduces reactivity. Furthermore, repeated (exclusive) assessments of negative mood states 
can be confrontational and induce negative feelings. To avoid this, a careful and balanced 
construction of the questionnaire is needed; for example, changing the order of questions 
so that positive and negative momentary mood items are mixed. Finally, the complexity of 
ESM data analyses could form a drawback for both researchers and clinicians11. Normal 
statistical methods, such as linear regression analysis and analysis of variance, cannot be 
used20. Aggregation of data per participant removes the multilevel structure, allowing simple 
analyses. In addition, most statistical packages now have easily accessible multilevel 
regression tools. The present paper provides guidelines how to analyse the data properly, 
allowing a reliable assessment of the richness of the ESM data (see below)20. 
 
Method and statistics 
ESM has advantages over classical assessment methods in clinical trials. However, ESM is a 
complex assessment method and considerations should be taken into account when using 
this innovative approach. 
The nature of ESM data 
The nature of ESM data is appealing but its complexity often challenges researchers and 
clinicians. The data collection parameters (the actual design) that define the nature of the 
data can be more important than statistical techniques. Aspects to consider are item 
selection, item order, the timeframe (e.g., number of days), the intensity (e.g., number of 
beeps per day; number of questions within a beep), the need for additional information (e.g., 
sleep quality assessed in a morning questionnaire), the signalling algorithm (e.g., random, 
fixed, beep-free periods, anticipation), the addition of event recording (e.g., of stressors or 
panic attacks), application type and data storage.  
Items from cross-sectional questionnaires are often unsuitable for repeated assessment in 
daily life. In one-time questionnaires, a reliable assessment of a construct is achieved by 
redundancy (multiple items in a sum score). Repeated (up to 10 times a day) answering of 
similar items is frustrating. Often, metaphors are used, but these lack variation within the 
day21. ESM information, such as current mood, activity and company, is assessed with single 
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items, which can be combined to improve reliability: different aspects at one moment or the 
same items over time. ESM data is ecologically valid but correlational in nature22. The current 
activity can be a cause as well as an effect of momentary mood states. Furthermore, different 
mental states have different natural flows. Anxiety, for example, fluctuates and is more 
contextually reactive than depression. With an ESM sampling frequency of 10 times a day, 
highly variable states will not be adequately represented. In that case, the process is under-
sampled. Other slow changing states are often over-sampled. The actual ESM protocol is 
usually a compromise.  
Event monitoring is often added to ESM protocols. For example, participants are asked to 
complete a questionnaire when a certain stressor is present, or when the participant has a 
panic attack. This requires continual prospective monitoring and results in a high workload 
for participants. The recorded event initiates a questionnaire. Events should be discrete 
(have a clear beginning and end) and often require coding instructions (what is a panic attack 
or a social interaction?). There is no correction for rating misinterpretation. Feasibility limits 
the number of (different) events that can be reported. Having to respond to additional 
questions after reporting an event can act as a ‘punishment’ and results in an extinction of 
the report (not the actual event) under some (stressful) circumstances. The same ‘learning 
curve’ can occur in branching when different answers lead to different workloads. Often, time 
sampling is preferred because it is less burdensome, more reliable, allows the (non-
exhaustive) assessment of a larger set of events and reports events as well as non-events 
(e.g., when a participant smokes, as well as when a participant does not smoke). 
When beeps are programmed at fixed times, predictability increases reactivity and this may 
induce behavioural changes (e.g., postpone shopping or showering). More generally, when 
beep-free periods can be anticipated (e.g., no beep expected within an hour after a beep), 
reactivity increases. Random sampling avoids this reactivity. Unexpectedly, true random 
schedules (e.g., 3 beeps on 1 day and 15 on another) are not ideal, because long periods 
with no beeps can result in some participants staying at home (not to miss a beep). This 
behaviour disrupts normal daily life. Therefore, a stratified random schedule with restricted 
intervals is advised4. This list of design modalities is not exhaustive and the actual choices 
depend on the research question and study population.  
Statistical analyses of ESM data 
ESM samples daily life and can be used to compute time budgets, for example, the 
proportion of time spent alone or doing sports. Similarly, the average anxiety level (or anxiety 
while alone) can be computed, resulting in one statistic per participant as the input for 
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standard statistical analyses. However, in most situations, statisticians prefer to use all 
available data. In that case, analyses have to account for the fact that in ESM, multiple 
participants answer a set of questions multiple times, resulting in a multilevel data set. Hence, 
ESM observations are not independent and standard linear and logistic regression analysis 
techniques cannot be used20. Multilevel linear and logistic regression is indicated and is now 
available in most statistical analysis packages (e.g., Stata, R, SPSS). Since observations are 
nested in participants, the most simple multilevel regression models for ESM data include a 
random intercept that allows appropriate control for the between participant variability20. 
These models therefore include a second error term at the participant level, in addition to 
the regular error term (at the assessment level) used in unilevel regression. Even when 
trends over time are not the primary interest, it is advisable to remove the potentially 
confounding effects of time in ESM data by adding a time variable (detrending23). This is 
effective when values increase or decrease linearly over the time of the study. Furthermore, 
since adjacent assessments tend to be more similar to each other than to other assessments 
further apart in time (autocorrelation), ESM analyses also need more sophisticated 
adjustment methods11. For example, autocorrelation can be taken into account by using 
appropriate correlational structures for the residuals (e.g., AR, MA, ARMA)11. Care must be 
exercised when using such models, since observations are not evenly spaced due to 
randomization and data collection usually proceeds over multiple days, resulting in a huge 
time lag for observations on consecutive days. Therefore, continuous-time structures are 
usually preferable, although their availability across different software packages differs. It is 
also highly recommended to allow random slopes in the model where applicable20. This 
yields more realistic estimates of SEs, which otherwise might be underestimated. A random 
slope means that the regression coefficient is not fixed, but is allowed to vary between 
participants. This variation is realised by adding an extra error term for each predictor. In 
these models a simple variance-covariance matrix of the random effects (e.g., which assumes 
that all covariances are zero: the default in some statistical software packages) is not realistic. 
Therefore, an unstructured variance-covariance matrix, where all variances and covariances 
are allowed to be different, is preferable. However, this can lead to rather complex and time-
consuming models. Sometimes, the statistical program may even fail to provide output. 
Alternatively, one can consider only using random slopes for the main independent 
variable(s). If the analysis includes multiple main independent variables, or if the analysis still 
does not yield valid results after reducing the number of random slopes, it may be necessary 
to remove essential random slopes. In that case, resampling methods (e.g., permutation 
tests, bootstrapping) can be used to obtain valid tests and CIs24. 
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Clarifying ESM questions 
ESM allows the study of a broad range of research questions. The epidemiological finding 
that the mental health of people in urban environments is poor25 (a between subject 
question), can be explored by assessing whether people in crowded environments feel worse 
(a within subject question). ESM allows the exploration or ‘unpacking’ of relevant factors26. 
The multilevel data structure of ESM can confuse researchers. Consider, for example, a study 
that explores the relation between depression and loneliness. What should be studied? Are 
depressive persons often alone, do lonely people become depressed, does depression make 
people lonely, are people in general more depressed when alone, and does this relation hold 
for depressed people? ESM data analyses require more specific research questions. The 
pitfall lies in the convergence of person-related questions and situation-related questions, 
both of which are represented in ESM data and can lead to divergent conclusions22. In 
addition, results from ESM studies are easily misinterpreted. The conclusion that 
agoraphobia is a bogus diagnosis because ESM data shows that people with this diagnosis 
feel worse when at home (and better when out), disregards the fact that people may select 
going out on days they feel best. In correlational relations, causal attributions should be 
avoided.  
 
Discussion 
ESM was developed to sample moments from daily life. Since then, the method has yielded 
valuable results to better understand mental illness16. ESM yields a comprehensive view of 
the participant’s daily life. This comprehensive view is valuable in clinical trials because the 
same instrument can measure various constructs, such as quality of life, psychopathology, 
social networks or productive activities. This broad measurement is done with high sensitivity 
to change11. Even more, ESM allows assessment of mechanisms that are difficult to assess 
with cross-sectional questionnaires, such as stress-sensitivity, coping, reward-sensitivity and 
resilience16. ESM has the potential to replace a larger body of instruments and sensitively 
assesses new and relevant parameters. It is, however, not yet the gold standard in clinical 
trials. This fact is mainly due to the heterogeneity in ESM applications27. Nevertheless, it has 
the potential to become the de facto gold standard.  
ESM monitoring in clinical trials 
ESM data is ideal to inform and optimize personalized treatment in mental health. Feedback 
modules have been developed that translate ESM data into understandable graphs and 
figures that help promote patient engagement in treatment. Kramer et al28 assessed the 
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benefits of an ESM feedback-intervention in a randomized control clinical trial. An ESM 
feedback-intervention was studied in addition to treatment as usual in patients diagnosed 
with depression. They demonstrated that ESM with weekly feedback moments reduced 
depression more than treatment as usual. ESM monitoring without feedback had a similar 
association, but this reduction did not last. The majority of ESM studies have short 
assessment periods, ranging from several days to a few weeks12. In clinical practice, it is 
important to follow a patient for months or years. To reduce the burden, clinicians 
experiment with interrupted periodic ESM assessments. Psychiatrists and patients can 
mutually agree to customize ESM to monitor the effectiveness of treatment and update 
interventions accordingly. There is growing insight in what might be relevant to individual 
patients. For example, a patient who used ESM for a year had increased associations 
between symptoms in periods of exacerbation (personal communication, Dr. M. Bak). The 
patient’s subjective feeling of relapse coincided with changes in ESM towards higher severity. 
Monitoring patients this way provides both the clinician and the patient with additional 
information that can improve a personalized treatment process. 
Ecological momentary intervention (EMI) has been cued as an umbrella term for mobile 
interventions in the daily living environment of participants. Unlike ESM, EMI aims not to 
observe, but to intervene. Only recently has mobile technology allows to bridge the gap 
between the therapist’s office and situations in daily life, where acquired skills should 
generalize and be autonomously applied. Several studies have demonstrated that EMI is 
feasible, acceptable, and can be successful in mental health treatment29. 
Single case clinical trials 
The translation of evidence from clinical trials assumes that patients are a homogeneous 
group. This is often not true. A large variability exists in treatment responses between 
subject. Single case designs can be used to customize treatment to individual needs and 
accommodate to strengths. Since treatment effect (or outcome optimization) can be difficult 
to detect, single case trials can add (experimental) control to clinical decision making30-31. 
This control requires that the timing of conditions is allocated randomly (independent from 
the clinical effect). Guidelines are available for the randomization of single case trials32, and 
statistical software packages33 facilitate the analyses. An interesting innovation is a user-
initiated program, which implements ESM to monitor the effects of gradual dose-reductions 
in the user’s antidepressant medication34. Over the course of a year, the user collected over 
a thousand ESM observations. Meanwhile, his clinician teamed up with a pharmacist to 
blindly implement a dose-reduction (tapering) schedule. From the data, early warning signs 
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were detected for mood changes that predicted relapse. They could relate the mood change 
patterns to the medication reduction and were able to find the optimal, safe medication 
dosage34. The use of ESM in classical clinical trials is less challenging because only aggregated 
group findings are pursued. Global constructs can be used to comprehensively describe the 
mental state of groups of individuals. In single-case studies, the data is highly individual and 
can benefit from the individual selection of items that maximally reflects the user’s variability. 
Future of ESM in clinical trials 
The advantages of single case trials to optimize treatment are increasingly recognized31. In 
addition, there is increasing recognition of how mobile phones can be used as medical 
instruments in the treatment of mental illness35. The benefits of combining mobile 
technologies with single case designs are also recognized36. Dissemination in regular practice 
requires freely available user-friendly technology and software that reduces the logistical 
burden and need for statistical skills. By making this technology available, treatment 
efficiency can be improved. Most participants are already used to carry mobile phones, so 
the threshold for using them to collect ESM data via an app is greatly reduced. ESM 
progresses in parallel with evolutions in mobile technology. Data collection logistics are 
reduced by innovations in tools and programs, as well as cultural changes related to the use 
of mobile devices. Furthermore, innovation in mobile tools facilitates the general acceptance 
of momentary assessment. For broader clinical dissemination, great investments are needed 
in software that allows on-the-fly comprehensive feedback. More research should focus on 
the way data become information. This knowledge is important for academically trained 
professionals, as well as for clinicians who are more reluctant to use and less able to 
understand statistical analyses. In addition, the patients themselves should be able to 
comprehend the data. Ideally, treatment planning, implementation, and evaluation should 
be a collaborative process. ESM can prove its utility both in large-scale studies and at the 
level of clinical practice. The latter is especially important, as ESM can be used to optimize 
individual treatment and to help in decision-making. In the future, assessment strategies that 
are more sensitive in detecting change could be used in all prescriptions of pain or 
psychotropic medication. Medication should be continued only when efficacy is determined 
in a specific patient. Sensitive assessment strategies can also be used in the domain of 
optimal dose finding. Furthermore, recovery oriented care in psychiatry is not restricted to ill 
health and symptoms, but extends to well-being. Daily life assessment strategies can inform 
patients and clinicians how to improve resilience by maximizing strengths in patients.  
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Abstract 
Background: The experience sampling method (ESM) builds an intensive time series of 
experiences and contexts in the flow of daily life, typically consisting of around 70 reports, 
collected at 8–10 random time points per day over a period of up to 10 days. 
Method: With the advent of widespread smartphone use, ESM can be used in routine clinical 
practice. Multiple examples of ESM data collections across different patient groups and 
settings are shown and discussed, varying from an ESM evaluation of a 6-week randomized 
trial of mindfulness, to a twin study on emotion dynamics in daily life.  
Results: Research shows that ESM-based self-monitoring and feedback can enhance 
resilience by strengthening the capacity to use natural rewards. Personalized trajectories of 
starting or stopping medication can be more easily initiated and predicted if sensitive 
feedback data are available in real time. In addition, personalized trajectories of symptoms, 
cognitive abilities, symptoms impacting on other symptoms, the capacity of the dynamic 
system of mental health to “bounce back” from disturbance, and patterns of environmental 
reactivity yield uniquely personal data to support shared decision-making and prediction in 
clinical practice. Finally, ESM makes it possible to develop insight into previous implicit 
patterns of thought, experience, and behavior, particularly if rapid personalized feedback is 
available.  
Conclusion: ESM enhances clinical practice and research. It is empowering, providing 
coownership of the process of diagnosis, treatment evaluation, and routine outcome 
measurement. Blended care, based on a mix of face-to-face and ESM-based outside-the-
office treatment, may reduce costs and improve outcomes. 
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Introduction 
The practice of mental health is changing rapidly, requiring new tools to involve patients in 
the process of diagnosis and treatment, and to provide perspectives of acceptance and 
sense of purpose. Two factors are particularly important. First, treatment models propose a 
more active and empowered role of patients, with active self-management and shared 
decision making as core elements1. Self-monitoring is a main component of self-
management, providing an opportunity for collaborative diagnosis and treatment evaluation, 
and forming the starting point for self-insight and initiation of change in patterns of 
experience and behavior. Second, the process of assessment and treatment in mental health 
care is becoming more personalized. Traditional diagnostic and guideline-based practice for 
the “average” patient is being complemented with more dynamic, personalized formulations 
of psychopathology as a within-person series of mental states that evolve over time, under 
the influence of daily life environments and the impact of mental states on each other, 
requiring personalized solutions. The fit of selected intervention strategies can be assessed, 
and personalized formulations reevaluated in an iterative monitoring process toward shared 
decision making. 
In this article, we will discuss how the collection of intensive contextual mental state data, 
known as the experience sampling method (ESM) or ecological momentary assessment 
(EMA2), in the form of an mHealth smartphone application, has the potential to become a 
mainstream instrument to support self-monitoring, personalized health care and the 
development of self-insight and avenues for personal change and acceptance of disabilities 
in clinical practice. Although ESM was initially used as a research tool in social psychology 
and the study of psychopathology, it was also found to have value in the management of 
(severe) mental illness3-8. Smartphones and customized apps have dramatically simplified 
the user experience and reduced the logistic burden of data collection and analysis. ESM is 
now available as a free mHealth smartphone app in Apple App Store and Android Store (e.g., 
PsyMate, xSample, movisensXS, BeepMe, RealLife). Free availability makes it possible to use 
ESM in regular clinical practice. Although the multilevel analysis of ESM research data can be 
complex, even simple graphical feedback of ESM data can represent a source of substantial 
enrichment of clinical practice. By making use of the data at the personal and the descriptive 
level, testing n = 1 clinical hypotheses about diagnosis, treatment, change, and acceptance 
becomes possible4,9. 
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The practice of ESM  
ESM is a structured data collection technique in which participants respond to randomly 
timed repeated assessments (up to around 10 times per day) over the course of time (up to 
around 10 days—with extensions of up to 1 year) while functioning within their natural 
setting2,4 (Figure 1). The sampling is signal-contingent, meaning that individuals respond to 
semirandom signals ("beeps"—typically one random beep per 90-min slot). Data collection 
focusses on (i) emotions—items that reflect the broad dimensions of positive affect (PA; e.g., 
cheerful, relaxed, satisfied, happy) and negative affect (e.g., down, lonely, anxious, insecure); 
(ii) contexts—where, with whom, events; (iii) activities—doing what, (iv) food, alcohol, drugs, 
medication; (v) aspects of psychopathology –psychotic phenomena, suicidality, craving, self-
esteem; (vi) somatic symptoms (e.g., pain, fatigue, dizziness, tinnitus, etc.); and (vii) stress— 
stressful momentary events, stress associated with momentary activity (e.g., “This activity is 
difficult for me,” “I would prefer doing something else”), stress associated with momentary 
company (e.g., “I find being with these people pleasant[reversely coded to reflect stress]”).For 
use in routine clinical practice, a sampling scheme with eight random signals per day and no 
more than 30 items to rate is generally feasible4. With adequate software, subjects can rate 
responses within 1 min, only minimally disturbing the flow of normal daily routines. A 
sampling scheme of less than eight times per day yields insufficient measurements, given a 
normally 20–30% beep attrition in natural circumstances4. Furthermore, care must be taken 
to include only items that can vary momentarily (e.g., “I am angry”) rather than items reflecting 
trait, that do not vary momentarily (“I am clever”). 
ESM has a number of advantages4. First, it gives the clinician insight in the contingencies of 
experience and behavior, based on prospective data. Second, ESM observations have, 
contrary to clinical interactions, ecological validity, reflecting real life variation in response to 
real life challenges. Third, ESM makes use of in-the-moment reports not subject to memory 
biases and “global evaluation” distortions. Fourth, although ESM requires considerable 
motivation on the part of the patient, this motivation likely correlates with motivation for 
change in the context of treatment. Given that this is an important clinical variable, ESM can 
be revealing, to both patient and attending clinician with respect to motivation for change. 
Fifth, ESM allows for a prospective, within-person approach to diagnosis and treatment, 
contrasting with the between-person, “average patient” approach of traditional evidence-
based practice. Sixth, evidence indicates that ESM empowers patients to become actively 
involved in collecting data, pertinent to treatment and assessment, in their own 
environments, thus becoming minimally co-participant10 and possibly part-owner of the 
process of care11. 
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Although ESM can be combined with a range of sensor-based data (movement, position, 
activity) and ambulatory physiological measures (e.g., salivary cortisol, heart rate, blood 
pressure, voiding behavior, etc.), more research is required on their added value to ESM 
ratings of experience and behavior. Furthermore, while a range of physiological measures 
can be measured in daily life, their relevance for mental health diagnosis and treatment 
remains to be established. 
 
 
Figure 1 
Principles of experience sampling methodology (ESM) or ecological momentary assessment (EMA). 
Notes: At 10 random moments during the day, mental states (e.g., anxiety, low mood, paranoia, being happy) 
and contexts (stress, company, activity, drug use) are assessed. The arrows represent examples of prospectively 
analyzing the impact of mental states and contexts on each other over time, allowing for the construction of 
composite measures such as stress-sensitivity (impact of stress on negative affect), reward experience (impact 
of positive events on positive affect), or the autocorrelation (the impact of the mental state on itself from one 
moment to the other, resulting in more or less persistence over time). 
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Clinical applications of ESM 
From group-based data to n=1 predictions 
A local database with a large number of observations pertaining to different patient groups 
is helpful as a reference for the interpretation of clinical ESM data in individual patients. Next, 
a number of clinical applications of ESM will be illustrated using data from the ESM database 
that is being managed at Maastricht University (version 4.6). The database contains ESM 
studies that were conducted on different populations with comparable ESM lists, although 
not all ESM items were available in each group. Version 4.6 of the ESM database contains 
data on 276 healthy controls, 601 healthy twins from the general population, 178 relatives 
of patients with a psychotic disorder, 293 patients with psychotic disorder, 115 patients with 
depression, 129 patients with residual depression, and 106 individuals with variable levels of 
psychometric risk for psychotic disorder. We will show that ESM patterns at the group level 
are highly informative and form an attractive basis for testing hypotheses in single patient 
ESM data. 
Assessing psychopathology variation and reactivity across time and place  
Figures 2 and 3 display the simple variation over time and place of momentary “feeling low” 
in controls, individuals with residual depression, and individuals with depression. The graphs 
show clear differences in terms of severity, pattern of variation over time (Fig. 2), and pattern 
of reactivity as a function of place (Fig. 3). In controls, the mood item remains constant at low 
levels, showing little variation as a function of location. From individuals with residual 
depression to individuals with depression, “feeling low” is progressively more severe and 
showing progressively more diurnal variation. Furthermore, the data in the depressed 
groups show more reactivity as a function of location, with the greatest severity being 
associated with health care locations, as well as during transport. 
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Figure 2 
Momentary, beep-level self-reports (maximum of 60 beeps) of the mean of the ESM item “feeling down,” 
collected over 6 days, in three samples of, respectively, controls (N = 251, n = 12,394 beep moments), patients 
with residual depression (N = 129, n = 6,420 beep moments), and depression (N = 45, n = 2,287 beep moments). 
 
  
Figure 3 
Self-reports of the ESM item “feeling down,” collected over 6 days in daily life, summarized as mean level per 
location in three samples of controls (N = 251, n = 12,394 beep moments), patients with residual depression 
(N = 129, n = 6,420 beep moments), and depression (N = 45, n = 2,287 beep moments). 
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Although the Figures 2 and 3 thus suggest clear and meaningful differences between groups, 
the interpretation of individual ESM data remains a challenge. Figure 4 shows individual 
trajectories of momentary variation of the mood item “feeling low,” separately for each 
patient in the depression group. These individual trajectories show very substantial variation 
from beep to beep and day to day, between and within persons. Such variation nevertheless 
has a meaningful and clinically interpretable pattern within individuals, differing from other 
persons, and is not entirely random. Therefore, ESM allows for clinical inspection and 
interpretation of data at both the group and individual levels. 
 
 
Figure 4 
Trajectories of momentary (n = 1), beep-level ESM self-reports of “feeling down,” collected over 6 days, in a 
sample of depressed patients (N = 45, n = 2,287 beep moments). 
 
Assessing dynamic system ability to bounce back from disturbance 
An emerging concept in psychopathology is the ability to bounce back given disturbance and 
impending mental decompensation in a dynamic system model of psychopathology12,13. For 
example, alterations in mood may cause a person to perceive the environment as 
threatening or alien. Initially, the person may be able to “shake off” this impression of 
aberrant salience, indicating resilience and stability, with a rapid return of the altered mental 
state to baseline in the face of disturbing influences. However, in more advanced stages, the 
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person may not rapidly return to the baseline mental state and progressively spend more 
and more time in the altered mental state of aberrant salience14. ESM data are suitable to 
capture this process of progressive loss of flexibility and ability to bounce back given system 
disturbance by plotting the autocorrelation of successive mental states. The autocorrelation 
of a mental state in ESM is the similarity between observations as a function of the time lag 
between them, or the tendency of the mental state to persist from one moment to the other 
over time14. In Figure 5a, controls have low variability in the ESM item indexing paranoia, 
therefore the autocorrelation function is low and not necessarily informative on the ability to 
bounce back from paranoid mental state deviations. In patient groups, ESM data are less 
ambiguous in this regard, allowing for interpretation of the autocorrelation. Thus, those with 
residual depression have altered bounce back ability (less rapid return to baseline), whereas 
individuals with psychotic disorder show paranoia inflexibility (Figure 5a). Figure 5b shows 
that from controls to residual depression to depression, there is a decrease in bounce back 
ability from mental states deviations characterized by anxiety. However, no such differences 
are seen for the item of “difficulty concentrating” (Figure 5c), suggesting that alterations of 
mental state flexibility may occur independently across different mental states, and that 
there may be a “hierarchy” (within and between persons) in the level of volatility in emotions 
and experiences, ranging from extreme volatility to “trait”-like persistence. In addition, 
charting the autocorrelation as a function of resilience to “bounce back” from disturbance 
may inform on environmental or genetic risk factors, as shown in Figure 5d, which depicts 
altered capacity to bounce back from the mental state of anxiety as a function of parental 
divorce. Alterations in the ability to bounce back from disturbance can also be studied within 
individuals, particularly in longer ESM trajectories, as a function of treatment response and 
prediction of outcome13. Conversely, a greater autocorrelation in PA, that is, a greater level 
of momentary transfer of positive emotions, may be protective, as it was associated with a 
greater recovery rate and prevention of depressive episodes15. To date, however, lengthy 
ESM-based time series remain rare in the research literature.
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Assessing the impact of symptoms on each other  
The above example provides indirect evidence of how one mental state (low mood) affects 
another mental state (paranoia), increasing levels of low mood apparently giving rise to 
progressively higher levels of paranoia. However, ESM data also allow for a more direct 
examination of this process, by modeling the prospective relationships between mental 
states and symptoms. Given the fact that ESM data represent a time series, it is possible to 
examine the impact of, for example, the level of anxiety at the preceding beep (time point t 
− 1) on low mood at the next beep (time point t). Similar analyses can be carried out at other 
levels of aggregation, for example, at day-level. These types of analyses have to take into 
account natural “breaks” in the data, avoiding, for example, that an ESM item pertaining to 
the first beep of one day is predicted by an ESM item pertaining to the last beep of the 
previous day. In Figure 6, prospective relationships are assessed between momentary 
anxiety and depression, and between momentary feeling happy, on the one hand, and 
anxiety and depression, on the other. In those with low momentary levels of depression at t 
- 1, anxiety at t - 1 drives the incidence of depression at t in a dose-response fashion. Vice 
versa, momentary depression at t - 1 drives incident anxiety at t. The two mental states can 
thus be said to mutually impact each other’s momentary incidence in a reinforcing loop. In 
contrast, feeling happy at t - 1 protects, in a dose-response fashion, against the onset of both 
anxiety and depression (Figure 6). Dynamic prospective relationships between mental states 
and symptoms can be extended to a full network of mutually impacting momentary mental 
states, involving multiple symptoms16. Although between person analyses are helpful to 
examine dynamics at the group-level, ESM allows for examination of within-person 
relationships and their impact on treatment. The concept of ESM clinical network analysis was 
recently introduced to describe the possibility of collecting ESM data for an extended period 
to help patients gain insight in the dynamics of the underlying psychopathology to decide 
which are the best connected points in the network where change likely will affect the most 
other symptoms and to assess the impact of treatment in the network9. For example, Bak, 
Drukker, Hasmi, van Os9 showed the example of a person with disabling auditory 
hallucinations that were fueled by a mutually reinforcing loop of paranoia and low mood, 
allowing for a more focused treatment approach. 
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Figure 6 
Predicting the incidence (i.e., mean level of mood state at t in those with the lowest score of that mood state at 
beep t - 1), as a function of the level of another mood state at beep t - 1, in a sample of individuals with residual 
depression (N = 223, n = 10,582 beeps). For example, in those with the lowest score of “feeling down” at t - 1, 
higher levels of anxiety at t - 1 predict progressively greater levels of feeling down at t, and higher level of feeling 
happy at t - 1 predict progressively lower scores of feeling down at t. 
 
Assessing the impact of the environment 
One of the important advantages of ESM is the ability to link momentary measures of 
experience and behavior to self-reports of the environment. In Figure 7a, momentary reports 
of low mood as a function of activity stress (the rating of the momentary activity in terms of 
“I would rather do something else”) are compared between a control group and a group with 
residual depression. The results show that low mood in controls has constant low values, not 
responding much to increases in activity stress, whereas low mood in individuals with 
residual depression appears to be much more reactive to the stressor. Similarly, momentary 
events rated as more pleasant neutralize momentary low mood in controls to a small degree, 
whereas a much greater protective effect is seen in patients with residual depression (Fig. 
7b). This latter finding of greater reductions in negative affect following positive events is 
consistent with an independent report in the literature in patients with depression17. The 
“buffering” effect of positive events is considerable: in Figure 7b, the level of low mood in the 
patient group at the highest level of pleasant event exposure approaches that of the control 
group. In other words, individuals with depression have higher levels of low mood, and are 
also more responsive to perceptions of environmental stress and environmental reward, 
which is in agreement with findings from other ESM studies18-20. The origins of increased 
momentary mood reactivity in depression have been linked to genetic liability for 
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depression20,21 as well as to childhood trauma22, suggesting that ESM measures of reactivity 
can provide information on the mechanism whereby genes and environment confer 
vulnerability and resilience to depression. For example, one study found that in individuals 
with genetic liability for depression, the ability to generate positive emotions in response to 
the environment prevented the expression of genetic risk in low mood states23. 
 
 
Figure 7 
(a) Mean of self-reported ESM item “feeling down,” collected over 6 days in daily life, summarized over increasing 
levels of activity-related stress in a sample of controls (N=212, n=10,142 beep moments) and a sample of 
patients with residual depression (N=129, n=6,425 beep moments).  
(b) Mean of self-reported ESM item “feeling down,” collected over 6 days in daily life, summarized over increasing 
levels of how pleasant momentary events were rated of in a sample of controls (N = 212, n = 9,777 beep 
moments) and a sample of patients with residual depression (N = 129, n = 6,250 beep moments).  
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Assessing ecological cognition 
Contextual sensitivity is related to the cognitive ability to detect environmental changes. 
Environmental adaptation strategies or optimized coping assume that subjects are able to 
detect clues and use these in a learning process (in which PA and avoidance of stress function 
as rewards). There is a need to understand whether the cognitive skills are influenced by the 
changing environment, or by the way individuals assess these skills in daily life. It is therefore 
important to understand changes in cognition within the same time frame as changes in 
emotions and context. The assessment of variation in cognitive function in daily life is a 
challenge. The first reason is that the tests used in traditional cross-sectional assessments 
often rely on repeated trials lasting some minutes. This is difficult to implement in daily life 
given the time restraints of ESM—disruption should be restricted to 1–2 min maximally. 
Second, cognitive tests need contextual standardization to be reliable. The circumstances of 
the daily life assessments are highly variable and make it difficult to fully focus on the test. 
Third, ESM measurements are typically replicated 10 times each day for days or weeks. Such 
a sampling scheme requires a battery of parallel tests with limited training effects. More 
knowledge is required to design tests that can be used to assess different dimensions of 
cognitive functioning in daily life. Currently, pilots are being conducted to test the 
implementation of short cognitive tasks in ESM. These pilot studies are relate  to memory 
(i.e., recall and recognition, both with and without intermediate tasks), concentration (i.e., 
coding tasks or elementary computations), reasoning (i.e., mathematical problem solving), 
and planning, in addition to tests that are related to cognitive biases and social cognition 
such as “jumping to conclusions” and “theory of mind”. 
ESM as a tool for positive emotion enhancement 
Given ecological validity, low cost, and smartphone availability, there is increasing interest in 
using ESM in the context of trials24. For example, there is evidence that monotherapy with 
psychotropic medication may not constitute optimal care for common mental disorders. 
Instead, treatment combining medication with some form of behavioral intervention appears 
more effective than treatment with medication alone25. Given the fact that (i) behavioral 
interventions, complex or simple, appear to have similar effect sizes in the treatment of 
common mental disorder26 and (ii) simple mHealth self-monitoring interventions can add to 
the treatment of mental disorders27, there is interest in the concept of adding self-monitoring 
interventions to medication in the treatment of common mental disorder as a strategy to 
enhance the effect that would have been obtained with medication alone. A recent 
randomized trial added an ESM-based self-monitoring intervention, combined with feedback 
on how to improve patterns of generating PA in daily life, based on ESM self-monitoring data, 
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to medication in patients treated for depression. This type of feedback can consist simply of 
systematically examining instances of positive emotions in daily life, and discussing strategies 
to increase the frequency of such moments and/or increase the persistence of positive 
emotions in daily life. Patients receiving the combination of medication and the ESM-based 
self-monitoring and positive emotion enhancement tool did better than patients receiving 
medication alone28. These data suggest that ESM self-monitoring and positive emotion 
feedback paradigms may be added routinely to treatment with psychotropic medication in 
clinical practice. It has been suggested that antidepressant medication may work by 
facilitating the process of practice-induced plasticity29. ESM, as a context-sensitive tool to 
help individuals optimizing environmental interactions and coping30, may be well placed to 
enhance the practice required for the plasticity-enhancing effect of antidepressants. 
Momentary assessment interventions may be used to enhance nonpharmacological 
interventions as well. For example, Depp, Ceglowski, Wang, Yaghouti, Mausbach, Thompson, 
Granholm31 showed that adding an ecological momentary intervention targeting self-
management of mood symptoms increased the effect of a brief psychoeducation on 
depressive symptoms. However, results also showed that the benefits only lasted as long as 
the mobile intervention was ongoing31. Batink, Bakker, Vaessen, Kasanova, Collip, van Os, 
Wichers, Germeys, Peeters32 introduced an ESM-based mHealth paradigm as an add-on 
intervention to help patients practice with acceptance and commitment therapy (ACT) in their 
daily lives. The intervention proved practicable and feasible for patients, with high levels of 
adherence. Although no short-term effects could be demonstrated, the authors 
hypothesized that effects of ACT may take longer to transpire32. 
ESM as a tool for tapering and dose finding of psychotropic medication 
Symptoms of anxiety, depression, and psychosis are sensitive to a range of pharmacological 
interventions. There are considerable challenges in finding the right dose for a given 
individual and there is widespread variation in the level of difficulties patients experience 
when coming off psychotropic medications. There is growing awareness that personalized 
dosing of psychotropic medication has been— and still is—a neglected area in clinical 
psychiatry, as is the personalized approach toward reducing or stopping psychotropic 
medication. ESM studies have shown that intensive sampling of emotions and context 
represents a sensitive tool to pick up the early effects of changing dose and reducing 
medications9,22,33-35, as well as picking up early changes after dose reduction that may predict 
imminent relapse13. Given the potential of ESM to empower the patient to cocreate diagnosis 
and treatment evaluation, as well as the observed synergistic effects between ESM as a self-
management tool and psychotropic medication, described earlier, a case could be made for 
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the routine use of ESM when initiating or reducing psychotropic medication. For example, 
when starting antidepressant medication, ESM in the first week can pick up signs of early 
response in the form of increases in the ability to use natural rewards (variation in positive 
emotions after positive events in daily life22); or reduction of antipsychotic medication can be 
monitored with ESM for alterations in subtle experiences of aberrant salience as a sign of 
dopamine supersensitivity syndrome36. 
In Figure 8, we show descriptive ESM data of early response to an antidepressant in a 
randomized, placebo-controlled trial of imipramine in a group of patients with depressive 
disorder described previously22,37,38. Only participants randomized to the imipramine group 
with valid ESM data and outcomes at 6 weeks are shown (n = 26). Response at 6 weeks was 
defined as a reduction of 50% or more in baseline Hamilton Depression Rating Scale (HAMD) 
score. Figure 8 shows the ESM momentary levels of PA, stratified by future responder status, 
during the first 3 days of imipramine treatment. Future responders have higher levels of PA 
(Figure 8). Thus, ESM trajectories may index information on future response in routine clinical 
practice. 
 
 
Figure 8 
ESM momentary levels of positive affect (PA—the mean of eight momentary positive emotions) in 26 patients 
with depression during the first 3 days of imipramine treatment, stratified by responder status (50% reduction 
in HAMD) at 6 weeks (n = 26, 578 beep moments). 
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ESM as a tool for collaborative care in somatic settings  
Experiential and behavioral outcomes are central in the diagnosis and treatment of a range 
of stress-related somatic syndromes, ranging from Alzheimer and Parkinson’s disease to 
irritable bowel syndrome, pain, tinnitus, Chronic Obstructive Pulmonary Disease (COPD), 
diabetes, and urinary incontinence. ESM studies show that mood states and contextual 
factors interact with specific experiential outcomes in these disorders, and that ESM can 
facilitate management and collaborative care approaches in the hospital39-46. For example, 
deep brain stimulation is used in Parkinson’s disease, however, it is often very difficult to 
assess subtle experiential, cognitive, and behavioral side effects associated with this 
treatment. A pilot study has shown that ESM can be used to assess both the mental and the 
motor symptoms in Parkinson’s disease39; follow-up work is required to assess the effects of 
deep brain stimulation in this condition. Similarly, the effects of treatment on irritable bowel 
syndrome are very difficult to capture using conventional methods; it has been suggested 
that ESM may be used routinely in randomized trials in this disorder44. 
ESM as a form of routine outcome monitoring with a focus on positive mood states 
There is consistent evidence that the impact of both pharmacological and 
nonpharmacological treatments is mediated by enhancing positive emotions, more than 
reduction of negative emotions, although interventions can be shown to also impact negative 
emotions and reactivity to negative events47. In a randomized controlled trial of 
antidepressants, improvement in the ability to generate positive emotions differentiated 
responders and nonresponders to antidepressants medication21. Similarly, in another 
investigation, it was shown that early improvement in ESM-based positive emotions was a 
better predictor of outcome than improvement in momentary negative emotions48. Trial 
evidence indicates that mindfulness training is effective for the treatment of depression and 
anxiety49 and for preventing depression relapse50. In a randomized trial of mindfulness 
training in depression, the underlying emotional mechanism was investigated with ESM. The 
results revealed that, similar to antidepressant medication, clinical improvement was 
mediated by greater ability to generate momentary positive emotions, as well as longer 
momentary persistence of positive emotions51. Another study reported evidence that the 
effect of physical exercise on mood is also mediated by changes in positive emotions52. The 
importance of ESM measures of positive emotions was further shown by a study reporting 
that experienced PA, even over a single day, displayed a graded relationship with survival in 
elderly persons that was not caused by baseline health status or other covariates53. Thus, 
positive emotions appear to play a crucial role in facilitating the mobilization of resilience in 
the face of adversity, with important consequences for coping and health54. 
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Given the importance of positive emotions, it has been proposed that ESM is routinely used 
in clinical practice, not only to improve diagnosis, empower patients, or enhance the effects 
of medication, but also as a means to collect routine outcome data that, contrary to symptom 
based measures, yield insight in daily life adaptation37 and changes in resilience in the form 
of positive emotions. One study found that of the different measures in ESM that can be 
used as routine outcome measurement (ROM), changes in positive emotions were the most 
sensitive to change, suggesting this dimension represents a suitable measure for ROM in 
mental health services38. 
If ESM is used routinely in a specific mental health treatment setting, it is possible to generate, 
using anonymized patient data, group-based reference data of ESM patterns of emotions 
and behavior, as described in this article, against which ESM trajectories pertaining to 
individual patients can be interpreted, similar to the current analyses4. In the foreseeable 
future, machine learning techniques may be used to help test hypotheses in single patients 
against a large population base of ESM reference data55. 
Starting to use ESM in clinical practice  
To start using ESM in clinical practice, one may commence with 5-day periods of ESM (eight 
beeps per day) at intake and after 6 weeks of treatment. At both baseline (diagnosis) and 
after 6 weeks (treatment response), clinician and patient can discuss the online feedback 
pattern of emotions and reactivity, as shown in the figure for the PsyMate app (Figure 9). In 
addition, the clinician can encourage the patient to engage in ESM over the entire 6-week 
period at a rate of, for example, 3–4days of ESM per week. ESM can then be combined with 
a focus on PA and a simple program aimed at enhancing frequency and persistence of PA in 
daily life. In addition, in PsyMate, aspects of acceptance and commitment and mindfulness 
exercises can be programmed in the time series32, thus providing an opportunity to combine 
pharmacological or psychological treatment with mHealth ACT or mindfulness-based 
exercises.
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Conclusion 
ESM is of low cost and high impact. Given widespread availability of personal digital devices, 
intensive data collection based on ESM is now sufficiently practicable to allow widespread 
use in psychiatry and indeed medicine. ESM is empowering, providing co-ownership of the 
process of diagnosis, treatment evaluation, and patient-reported ROM. Blended care, based 
on a mix of face-to-face and ESM-based outside-the-office treatment, has the potential to 
reduce costs and improve outcomes. ESM makes it possible to develop insight into previous 
implicit patterns of thought, experience, and behavior, particularly if rapid personalized 
feedback is available. ESM-based self-monitoring and feedback can enhance resilience by 
strengthening the capacity to use natural rewards. Personalized trajectories of starting or 
stopping medication can be more easily initiated and predicted if sensitive feedback data are 
available in real time. In addition, personalized trajectories of symptoms, cognitive abilities, 
symptoms impacting on other symptoms, the mental capacity to “bounce back” from 
dynamic system disturbance and patterns of environmental reactivity yield uniquely personal 
data to support shared decision making and prognostication in clinical practice. 
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Abstract 
Background: Routine Outcome Monitoring (ROM) should provide a dynamic, within-
treatment forward feedback loop to guide individual treatment decisions across diagnostic 
categories. It has been suggested that the Experience Sampling Method (ESM), capturing the 
film of daily life adaptive processes, offers a flexible, personalised and transdiagnostic 
feedback system for monitoring and adapting treatment strategies. This is the first study that 
uses an ESM application (the PsyMate™) as a routine mobile-ROM (mROM) tool in an 
ambulatory mental health setting.  
Objective: To demonstrate adequate psychometric properties of the PsyMate™ app 
assessing both symptom severity levels as well as daily life functioning.  
Method: In a transdiagnostic sample of 64 outpatients, an mROM protocol (ESM for 6 days, 
at 10 semi-random moments a day) and a standard ROM instrument (HADS) were 
administered at baseline and at three-month follow-up. We measured positive affect (PA), 
negative affect (NA), quality of sleep, positive social interaction, activity-related stress, 
tiredness, and feeling unwell.  
Results: Subjects completed 53% of the measurements at baseline (N = 64) and 48% at 
follow-up (N = 29). Factor analysis and subsequent reliability analysis of PA and NA confirmed 
the two constructs. Significant and meaningful correlations were found between PA, NA and 
HADS scores (ranging from r =.4 to r =.7). Multilevel analyses yielded significant change scores 
for all measures.  
Conclusion: The ESM-based, transdiagnostic mROM tool can be used reliably in clinical 
settings: it shows adequate psychometric properties, as well as concurrent validity and 
sensitivity to change over time with respect to relevant ROM constructs. Person-tailored 
items can be added. In addition, mROM offers added value over standard symptom-based 
ROM, as it provides information on adaptive functioning in the daily environment of patients. 
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Introduction 
Routine Outcome Monitoring (ROM) in mental health care refers to the process of collecting 
clinical data, which can serve as feedback to guide informed treatment decisions1. ROM 
should be transdiagnostic, flexible and follow the flow of the clinical process. Furthermore, it 
must be adjusted to the needs and wishes of individual patients2. Given these requirements, 
there is considerable debate as to what degree clinical ROM measures in mental health care 
can serve as input to benchmark outcomes across clinicians and institutions – a process 
referred to as Benchmark-ROM3. Benchmark-ROM requires rigid standardization, both in 
terms of instruments and data collection, to allow cross-patient and cross-centre 
comparisons. The implementation of rigid benchmark-ROM negatively influences clinical 
ROM, which requires a more flexible approach4-6. Clinical ROM requires repeated 
assessments at specific time points over successive diagnostic and treatment phases. 
Although there is no agreed measure for ROM in mental health care, many ROM scales have 
been developed for use in clinical practice7-9. In the literature, ROM is often referred to as 
patient-reported outcome measures (PROM), stressing the need for unbiased assessments 
of outcome collected by the patient rather than the treating clinician10,11. ROM instruments 
should be sensitive to change over time. Selected scales can be generic and, therefore, 
relevant across populations, or, in contrast, target specific patient groups. Moreover, ROM 
instruments should map several outcome domains, including psychopathology, daily life 
functioning, personal recovery, and quality of life3,12. Unfortunately, current ROM 
implementations mainly focus on psychopathology13, disregarding the other outcome 
domains. In addition, measures of psychopathology, expressed as total scores from 
traditional technical scales, do not reflect outcomes that are important to patients14,15.  Given 
that ROM is part of clinical routine, instruments should be time efficient. Furthermore, ROM 
should be set up in such a way that it allows the patient to become the empowered co-owner 
of the process of diagnosis and treatment. Therefore, ROM should be constructed as an 
informed forward feedback loop: the iterative process that includes clinical decision-making, 
outcome evaluation, treatment adjustment, and further outcome evaluation. 
A wide variety of ROM instruments exists, often developed to assess psychopathology in 
specific patient populations (e.g., mood disorders and psychosis) using traditional rating 
scales that lack relevance to the daily life of patients. Comprehensive assessment batteries 
that incorporate all different outcome domains are cumbersome and time consuming. 
Inclusion of clinicians (or trained personnel) as assessors dramatically adds to the complexity 
and cost of data collection logistics and potentially introduces bias. In many cases, a trade-
off has to be made between brevity and completeness7. Finally, ROM assessments often rely 
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on retrospective assessments, which are vulnerable to recall bias and limit sensitive 
assessment of change16. Most individuals are poor assessors when asked retrospectively to 
assess emotional experiences17. The most essential problem with traditional ROM 
assessments is that they only marginally inform adequate treatment selection as they do not 
inform on personal goals in real life settings and are not set up in such a way that a 
constructive forward feedback loop arises. For customized treatment selection, symptom 
variability and contextual variation is relevant. Mental health problems and related 
disabilities occur in the flow of daily life. Effective treatment should address the issue that 
patients are most vulnerable and consider the coping strategies available within their daily 
routines. Traditional rating scales, completed in a clinical setting, are often not representative 
of daily life functional adaption. A successful recovery process assumes functional adaptation 
and increasing resilience against mental illness. Resilience factors, such as experience of 
positive mood states and the strength of social connections, are increasingly being 
recognized and used in mental health treatment18. 
Thus, ROM measurements should target contextual factors and positive mood states in 
addition to negative mood states and symptomatology, rather than being exclusively focused 
on negative symptomatic states. Experience sampling techniques take into account all of 
these factors. The Experience Sampling Method (ESM), also referred to as Ecological Momentary 
Assessment (EMA), is an umbrella term for several ambulatory assessment strategies that 
randomly sample mental state in the context, following the flow of daily life. ESM is a 
structured diary technique, in which patients are asked to complete short questionnaires in 
response to auditory cues (beep signals), at semi-random moments during the day, for a 
number of consecutive days. Patient assessments include momentary emotional 
experiences (e.g., positive and negative mood), symptoms, cognition, context information 
(e.g., activity, company and location), and an appraisal of the context. Because ESM is a 
repeated assessment strategy, additional constructs, such as stress-sensitivity or coping 
strategies, can be quantified18. ESM was proposed as a comprehensive, generic ROM 
instrument and has several advantages over typical ROM assessments3,18,19. First, ESM 
increases ecological validity, because reports are provided in the patient’s natural 
environment. Second, memory bias is minimized because patients report in the moment. 
Third, ESM is contextualized, allowing for a better understanding of the person-environment 
interactions that give rise to psychopathology. Being aware of environmental reactivity and 
pattern changes over time will aid the understanding of treatment progress18,20. Fourth, ESM 
is highly relevant to the individual and is person-tailored when used as a clinical tool, thus 
creating transparency and facilitating patient engagement when discussing the data with the 
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clinician. Last, ESM facilitates and enhances shared decision making processes, because 
patients are actively participating in the data collection, and data can be used to improve 
treatment efficiency. Study results show that ESM during treatment can enhance feelings of 
empowerment and the ability for self-management21. Across the psychopathology spectrum, 
ESM has been proven feasible and can be successfully applied, in combination with feedback, 
as a treatment method for depression22. Moreover, ESM has been found valuable for a range 
of uses, including ROM in clinical practice23. 
Van Os and colleagues studied the use of ESM as a mobile ROM (mROM) tool. They assumed 
that ESM data was sensitive to change over time, using several clinically relevant parameters. 
Observational analyses were performed using data from the treatment arm of a randomized 
control trial in patients diagnosed with major depressive disorder24-26. The results confirmed 
the assumption, with the greatest sensitivity to change found for measures of positive 
adjustment, positive affect, and increases of positive affect due to natural rewards in daily 
life. These results show that resilience factors, such as positive affect, are informative for 
outcome assessment. Positive mood states are relevant for treatment outcomes across 
mental disorders27,28 and can be seen as a generic trans-diagnostic indicator of underlying 
resilience that can be captured  in ROM. Research showed that positive affect and negative 
affect are related but different dimensions, i.e., they are not the extremes of a single 
continuum. Positive affect is non-heritable and an indicator of resilience, whereas negative 
affect is highly heritable and an indicator of vulnerability29. As both dimensions are important 
in clinical context, both should be captured in ROM. With the advent of modern mHealth 
applications for use on mobile devices, such as smartphones, ESM can now be carried out 
cheaply and routinely23. We refer to mHealth ESM for the purpose of ROM as mROM. There 
are multiple ESM mobile applications available (e.g., https://www.lifedatacorp.com/, 
http://experiencesampler.com/, https://pielsurvey.org/). Here, we present the first study that 
uses a mobile device to implement mROM in an ambulatory mental health setting, using an 
open trial design with PsyMate™, one of these ESM mobile applications (www.psymate.eu). 
Objective 
The aims of this study were twofold. First, to demonstrate transdiagnostically adequate 
psychometric properties of routine mROM with a PsyMate™ moderated mROM application 
and second, to investigate sensitivity to change during treatment. Based on previous work, it 
was expected that (i) the psychometric properties of the PsyMate™ method would be 
adequate and suitable for therapeutic monitoring; and (ii) change over time could be 
demonstrated for a series of variables (e.g., mood, activity-related stress, and sleep quality) 
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indexing both psychopathology and daily life functioning. In this regard, we expected to find 
a weak to moderate association between a traditional rating scale (the Hospital Anxiety and 
Depression Scale30) and the mROM mood measures, leaving sufficient room for the added 
value of mROM. 
 
Methods 
Sample 
Patients were recruited at the outpatient mental health service of the Maastricht University 
Medical Centre (MUMC+). In total, 115 consecutively attending patients were asked to 
participate in routine mROM, of whom 75 provided their consent. All patients were 18 years 
or older and capacity for consent was established by the psychiatrist providing the care to 
the patient. Exclusion criteria for inclusion in the analysis were not being able to read Dutch 
or not being able to handle a mobile device with the PsyMate™ app. 
Procedures 
Analysis Design 
mROM with the PsyMate™ app is applied routinely in MUMC+. There were two measurement 
periods, one at baseline (t = 0), the second at follow-up approximately three months later (t 
= 1). Due to logistical reasons, the second visit did not always take place exactly 3 months 
later (M = 111.6 days later, SD = 27.3, range 80-189 days). Each measurement period 
consisted of six consecutive ESM sampling days and the administration of a traditional ROM 
questionnaire at the beginning of the ESM sampling days.  
Briefing 
During the baseline session, patients were helped while downloading the Psymate™ 
application on their smartphone via the App Store or Google play store. A specific code was 
required to enter the study protocol. However, a free demo app is available in different 
languages, for those wishing to implement the app in routine clinical practice. In case a 
patient could not use his own device, an iPod was provided for the duration of the mROM 
period. A clinician explained the PsyMate™ procedure during a briefing session and coached 
patients through the PsyMate™ items. Patients were instructed to continue their normal 
routine during the Psymate™ data collection period. After the briefing, a sampling period of 
six consecutive ESM days started, not including the briefing day on which the PsyMate™ 
protocol was activated. 
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The standing medical ethical committee approved the anonymous use of routine clinical 
data, if patients provided informed consent. Thus, all patients provided informed consent to 
use routine clinical data for the purpose of scientific investigation. 
mROM 
For the purpose of mROM, the Psymate™ application was programmed to emit 10 random 
beeps each day. Signals notify when a short questionnaire has to be completed (lasting 
approximately 1 minute). Beeps were semi-randomised in ten blocks of 90 minutes, between 
7:30 AM and 10:30 PM. The questionnaire consisted of 13 mood items, 5 context items (what, 
where, and with whom the patient was spending time and whether they were enjoying it), 5 
items about important events happening since the last beep, 1 item questioning specific 
somatic complaints, 5 items assessing patients’ physical condition, and 1 item assessing 
levels of beep disturbance. In addition to the beep questionnaire, patients filled in some 
extra questions at the beginning and the end of each day. The morning questions were 
related to the quality of sleep of the night before, while the questions in the evening required 
the patient to give an estimate of their average mood and somatic complaints over the past 
day. Most items were presented on a 7-point Likert scale, ranging from 1 (not at all) to 7 
(very). 
In order to assess change over time, items were clustered to form measurable constructs. 
Previous work showed positive and negative mood items reliably form a Positive Affect (PA) 
and a Negative Affect (NA) cluster31. In this analysis, PA consisted of the items: I feel cheerful, 
satisfied, relaxed and globally feeling well. The remaining nine mood items (I feel lonely, guilty, 
worried, down, threatened, insecure, irritated, frightened, and suspicious) formed the NA 
scale. The quality of sleep was assessed using the (ordinal-coded) items: (1) time needed to 
fall asleep, (2) number of times the person woke up during the night, (3) the time lying awake 
before getting up, (4) whether the person felt rested, and (5) how the person globally felt 
about their sleep quality last night. Approximately three months after the initial visit, patients 
were asked to participate again in the second part of the PsyMate™ mROM procedure. 
Debriefing 
After each sampling period, a debriefing session was scheduled. Patients were asked 
whether the past week was representative for their daily life and whether the Psymate™ 
interfered with their thoughts, feelings, activities, or social contacts. Furthermore, patients 
were asked whether unusual incidents occurred, and to what degree the use of Psymate™ 
was bothersome.  
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HADS 
The Hospital Anxiety and Depression Scale (HADS)30 is a reliable and validated rating scale32,33 
which is often used for mental health ROM purposes worldwide, particularly in somatic 
hospital settings34. The HADS consists of fourteen items (scaled from 0 to 3) assessing 
aspects of anxiety and depression experienced during the last week. The HADS was 
administered twice digitally (via the Psymate™) at the end of each briefing session. 
Statistical analyses  
Analyses were performed to investigate the structure of the 13 mood items. First, a principal 
component analysis (PCA) was conducted on these items with orthogonal rotation (varimax), 
requiring two factors to be extracted. Second, a reliability analysis (i.e., Cronbach’s alpha) was 
performed on each factor to determine the internal consistency of each scale. 
The data collected with ESM have a multilevel structure - successive beeps (level 1) are nested 
within patients (level 2). Multilevel regression analyses took the variability of both levels into 
account. With respect to the analyses of change, there were 7 a priori dependent variables: 
NA, PA, quality of sleep, preferring to do something else (activity-related stress), enjoying 
company (social stress), feeling unwell, and feeling tired. The following items were 
incorporated as covariates in the multilevel models: age, sex, a dichotomous variable 
indicating whether a patient participated in one or both measurement periods, and DSM-IV-
TR diagnosis prior to participation (i.e., a dichotomous variable indicating whether or not a 
patient had been previously diagnosed with a mental disorder (e.g., depressive disorder, 
panic disorder, somatoform disorder, no diagnosis, etc.)). Additionally, when examining the 
variable feeling unwell, a dichotomous variable describing the presence or absence of somatic 
complaints was taken into account and added as a covariate in the statistical model. The 
predictor variable of main interest was measurement period, indicating a possible change 
over time.  
Analyses were carried out using SPSS Statistics version 23.0. Two-sided p-values < .05 were 
considered significant. All dependent variables were checked for approximately normal 
distribution before performing further analyses. 
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Results 
Sample  
In the period from February 2015 until May 2016, 75 patients at the MUMC outpatient mental 
health service fulfilled criteria for inclusion in the analysis. In case a patient completed less 
than ten beeps during a measurement period (either baseline or follow-up), the 
measurement period was excluded from further analysis. There were 11 patients who did 
not complete sufficient beeps during both measurement periods, leading to a final dataset 
of 64 patients. Thirty-six patients completed one measurement period, 28 patients 
completed both measurement periods. A logistic regression model examined whether these 
two groups differed with respect to age, sex and being diagnosed (yes or no). This was not 
the case for either the omnibus model (-2 LL = 78.9; df = 3; p = .18) or for the univariate tests 
(all p-values > .075). 
The average age of the N = 64 analysable group was 48.7 years (SD = 13.9, range 18-73). 
There were 39 women and 25 men. All but 11 patients received a clinical diagnosis by the 
treating psychiatrist, based on DSM-IV-TR criteria. The 11 non-diagnosed patients did 
experience a degree of mental discomfort and were therefore included in the analysis. 
Diagnoses included depression (N = 25), panic disorder (N = 18), somatoform disorder (N = 
4), posttraumatic stress disorder (N = 2), bipolar disorder (N = 1), anxiety disorder (N = 1), 
dysthymia (N = 1) and psychotic disorder (N = 1). 
App statistics 
The complete protocol presented 120 beeps per patient (6 days x 10 beeps x 2 
measurement periods). At baseline, the response percentage was 52.7% of 3780 presented 
beeps, comparable to the 48.2% of 1740 presented beeps at follow-up. 
In October 2015, an update of the PsyMate™ app was introduced. Since then, the number of 
errors concerning the Internet connection considerably reduced. The proportion of valid 
beeps with no missing items within the beep increased substantially after this update: from 
71.1% to 86.2%. 
Compliance 
There was no suggestion of relevant differences in response rates between the days of the 
week at either baseline or three-month follow-up. However, the data suggest that there is a 
difference in response rate over consecutive days of the ROM protocol (Figure 1). During the 
first day and last day of the protocol, patients tend to complete less beeps than on the 
remaining days. At both baseline and follow-up, a reduction in response rate over time was 
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apparent. At follow-up, the reduction started two days earlier (day 3), compared to baseline. 
Regarding the hours of the day, there was a slight increase in response over time, as 
illustrated in Figure 2. The lowest response was in the early hours of the day (7:30 am – 10:30 
am). 
Factor structure of PA and NA 
The principal component analysis of the 13 PA and NA items resulted in two factors, each 
having a value larger than 1 (7.1 and 1.5 respectively), with a cumulative percentage of 
explained variance of 66.1%. An item was assigned to a factor when the factor loading 
exceeded .45 with a difference larger than .1 for both factor loadings. Using these criteria, all 
items could be assigned unambiguously to either the PA or the NA factor. As a next step, a 
reliability analysis was performed. Cronbach’s alphas for factor 1 and 2 (NA and PA) were .91 
and .92 respectively.  
Consequently, the PA subscale was constructed by computing the sum of the 4 positive affect 
items, the NA scale by computing the sum of the 9 negative affect items. Sub-scores 
containing missing items were computed by inserting the mean value of the available items. 
A maximum of two missing items for PA and 4 items for NA was allowed. PA and NA could 
not be computed for 41 beeps, leaving an analysable number of beeps (records) of 2832. 
 
Figure 1 
This figure shows the average number of beeps that were completed per day per subject, both for the baseline 
assessment and the three-month follow-up assessment, over the 6-day ESM period. 
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Validation analyses 
A correlation matrix with the patient-level means of the PA and NA scores (beep-level data) 
and the patient-level means of HADS total, HADS anxiety, and HADS depression was 
computed (Table 1). The results confirmed the a priori hypothesized relationships between 
these five variables. Next, an analysis was performed to investigate whether a change in PA 
and NA over time correlated with a change on the HADS total score. Significant correlations 
between change scores (baseline versus 3 months) were found: ΔPA with ΔHADS -0.634 p = 
0.002, ΔNA with ΔHADS 0.603 p = 0.004. 
 
 
Figure 2 
This figure shows the average number of responded beeps, per time window, within a day.  
(A) Number of beep responses within the day, derived from baseline ESM data.  
(B) Number of beep responses within the day, derived from the three-month follow-up ESM data. 
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Table 1   
Pearson correlates between positive affect scores, negative affect scores and Hamilton anxiety 
and depression scale scores  
Variables 1 2 3 4 5 
1. NA mean -
2. PA mean -.71*** - 
3. HADS anxiety  .71*** -.51*** - 
4. HADS depression  .56*** -.45*** .66*** - 
5. HADS total  .66*** -.51*** .89*** .92*** - 
Note. Correlations between 1 and 2 were performed over N = 63. All others were performed over N = 59. NA = Negative 
affect, PA = Positive affect, HADS = Hamilton Anxiety and Depression Scale. NA and PA represent mean scores over all 
subjects for one measurement period.  HADS anxiety, HADS depression, and HADS total represent subject scores for 
one measurement period. *p < .05. **p < .01. ***p < .001. 
Sensitivity to change 
Analyses were performed with multilevel regression to examine whether the positive change 
that was a priori expected could be demonstrated (Table 2). Each model used the same set 
of predictor variables (i.e., a dichotomous variable for the assessment moment, and age, sex, 
being diagnosed yes or no, and participation in both measurement periods as covariates). 
As reported in table 2, the mROM Psymate™ was able to detect significant changes over time 
in all the variables. 
Table 2  
Multilevel regression model estimates for the effects of measurement period on several variables 
Dependent Variables B (SE) t-values p-values 
Positive affect   .65 (.19)  3.45 .002 
Negative affect  -.37 (.14) -2.61 .015 
Quality of sleep 1.89 (.85)  2.23 .033 
Positive social interaction   .44 (.15)  3.69 .001 
Activity-related stress  -.37 (.18) -2.10 .046 
Feeling tired  -.54 (.18) -2.94 .007 
Feeling unwell  -.67 (.21) -3.17 .003 
Note. The analyses are based on 2874 beeps nested within 64 persons. SE = standard error.  
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Discussion 
This study examined the applicability of a routine mobile-ROM tool within an ambulatory 
mental health setting. The PsyMate™ application was used to implement experience 
sampling methodology (ESM). The first aim was to demonstrate adequate psychometric 
properties of mROM, by investigating the reliability and validity of the mROM application in 
PsyMate™. The second aim was to investigate sensitivity to treatment change using 
PsyMate™ data. 
Results demonstrated adequate psychometric properties of the PsyMate™ app when used 
with the present mROM protocol. The reliability of the method was examined by exploring 
user characteristics of the PsyMate™. Compliance rates during both the baseline and follow-
up periods (a period consisted of 60 possible beeps per person; 10 per day, for 6 days), were 
around 50 percent, in terms of beeps completed. Although ESM compliance may seem lower 
compared to previous ESM findings, which showed compliance rates around 80 percent35, 
sufficient beeps were completed for reliable data analyses. There are a number of possible 
reasons for the reduced compliance. Even conscientious patients miss some beeps due to 
daily life demands. Furthermore, the compliance rates found in earlier studies were based 
on traditional sampling techniques, using booklets combined with wristwatches or Personal 
Digital Assistants. Therefore, a direct comparison to the PsyMate™ app is misleading. In 
addition, there were technical issues with the first release of the app, leading to data loss 
when the Wi-Fi communication was unstable. After a system update, these problems were 
reduced. Hence, the compliance with the PsyMate™ app is considered acceptable. Different 
strategies may be used to improve compliance. The briefing session is important. It should 
create transparency about the reasons to collect mROM data: to optimize treatment, 
participate in clinical research and/or to comply with administrative requirements. The 
briefing session is the start of building an alliance in which clinicians try to understand needs 
arising in the context of daily life. It helps to discuss ESM sampling situations that shed light 
on aspects of resilience and vulnerability (with the possibility to customize ESM-
questionnaires if necessary). Elements of ‘gamification’ can be included to motivate patients 
to fill in the ESM sampling sheets. A crucial factor is the personalized feedback on daily life 
strengths and vulnerabilities. The PsyMate™ includes an automated web-based ESM 
feedback that clinicians and patients can consult. The option should be better advertised 
because it makes data collection more relevant to individual patients. Looking at the 
response behaviour at week level, few differences were found across the days of the week, 
although the first and last day of the ESM protocol were characterised by slightly fewer 
responses. During the baseline assessment, the first day showed the lowest response rate, 
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whereas in the follow-up period, the last day had the lowest response rate. A lack of 
familiarity with the ESM routine is arguably the reason for the low response rate on the first 
day, while the anticipation of completing the ESM period might account for the low numbers 
on the final day36. Considering data at day level, fewer beeps were completed in the morning 
hours. Again, this is to be expected, since patients were instructed to follow their own daily 
pattern and sometimes were still asleep at the early pre-programmed moments. When 
considering attrition rates, only 28 patients completed both measurement periods, or 37% 
of the 75 patients initially included. Some patients were excluded because there was not 
enough data and others did not complete the follow-up measurement. The loss of patients 
at follow-up could indicate that the method is too burdensome or not experienced as 
relevant. This seems unlikely, given that previous research has shown that the method was 
feasible in patients with a wide variety of mental disorders23 and current findings indicate 
feasibility within a single measurement period. Furthermore, a substantial proportion was 
already discharged from the mental health service by the time of the three month follow-up, 
as can be expected within the dynamics of a hospital outpatient mental health setting. After 
three months, patients that were seen in the context a diagnostic assessment would already 
have been referred back. Other patients would have discontinued treatment in the high-
attrition risk context of referral from a somatic department to a mental health setting. To a 
degree, limited follow-up may reflect the natural flow of a general hospital mental health care 
setting. Future research should further examine this issue. From a clinical perspective, 
mROM is most relevant at the beginning and during treatment, when data can be used to 
customize interventions. Nearer the end of treatment, patients motivation may naturally 
decrease as they start to leave the episode of mental distress behind37. 
The constructs Positive Affect (PA) and Negative Affect (NA) were selected based on the 
existing ESM literature31. Factor analysis of these items confirmed the structure of the two 
concepts and the subsequent reliability analyses yielded excellent internal consistency 
coefficients. To assess the concurrent validity of mROM, comparisons where made between 
the traditional ROM questionnaire used in the hospital (HADS; assessing anxiety and 
depression) and the PsyMate™ moderated mROM protocol. Overall, significant and clinically 
relevant correlations were found between the PA and NA constructs on the one hand, and 
the HADS (total, anxiety, and depression) scores on the other. Although the measures show 
substantial overlap, the ESM based PsyMate™ moderated mROM protocol offers a unique 
contribution to clinical routine outcome assessment given that recall bias and contextual 
biases are controlled for to a great extent. In addition, the ecological measures within the 
mROM protocol inform on daily life adaptive functioning. Seven measures (PA, NA, positive 
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social interactions, quality of sleep, activity-related stress, tiredness, and feeling unwell), 
considered relevant in mental health care, were assessed and compared over baseline and 
follow-up. All measures changed significantly over time. Thus, the mROM measurements are 
sensitive to change over time. At follow-up, scores on NA, activity-related stress, tiredness 
and feeling unwell were reduced, whereas scores on PA, positive social interactions, and 
quality of sleep were increased. This overall sensitivity to change is in line with previous ESM 
research2,21. 
The study sample was heterogeneous, although mood and anxiety disorders were most 
prevalent in this general hospital setting.  Despite a degree of heterogeneity, the same 
Psymate™-moderated mROM protocol was used transdiagnostically for all patients. The ESM 
questionnaires used in different mental health target populations typically share 80% of the 
items, in order to generically assess contextualized  symptom variability and well-being in 
daily life20. The mROM tool shows initial usefulness as a transdiagnostic instrument. However, 
the small sample size and limited heterogeneity in our sample warrant further investigation 
across more diagnostic groups. Moreover, in contrast to traditional ROM tools, the data 
collection is not restricted to symptom intensity, but also includes assessment of functioning 
and quality of life. The ESM procedure allows for patient-reported outcome measures that 
index adaptive daily life functioning, avoiding potentially biased data collection methods 
based on clinical interviews conducted by the treating therapist. Self-reports of mental states 
can have their own biases; the ESM sampling procedure is designed to avoid these risks, 
which may be especially advantageous in general hospital patients with somatic complaints 
due to underlying mental conditions38,39. 
The logistics of ESM data sampling, and thus the mROM data-collection, were simplified by 
using modern smartphones. Patients can use their own device to collect data in daily life. The 
Psymate™ methodology allows customization; beeps can be programmed, questionnaires 
adapted and person-tailored items can be added. Collected data is immediately sent to the 
database whenever a connection is available and remains continually available for feedback 
through a website with understandable graphs and figures (Figure 3). The improved logistics 
broaden the applicability of the ESM method from limited use in research centres to routine 
use in clinical care40. 
ROM is often positioned as a management tool, which suggests that ROM-data can be used 
to benchmark different centres. ESM methodology, applied as an mROM tool, assures that 
ROM data has a far broader applicability. The high level of patient involvement increases its 
clinical relevance to users of services41. Moreover, clinical and patient relevance is further 
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impacted by the possibility of accessing and viewing the data independent from services. 
Thus, in order to make ROM relevant to both the patient and the clinician, ESM may be rolled 
out routinely. 
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As a medical student, and thereafter as a psychiatry resident, I (JL) spent more than ten years 
studying diagnosis, treatment and prevention of mental, emotional and behavioural 
disorders. After several years of clinical experience, I thought I had gained some insight into 
what mental suffering is about. However, as I found out, nothing out there can prepare you 
for what it is really like. 
Here, I describe my journey towards finding meaning in depression, and how low mood 
becomes a psychotic prism through which the world is observed - my life the last few years. 
In the spring of 2017, my life took an unexpected turn as I suddenly found myself in the other 
chair: a patient instead of a student in psychiatry. The year before that, I had been using 
bupropion, an antidepressant, to help me with attention deficit and improving structure in 
everyday life. At that time, I was working in an outpatient clinic for mood disorders, treating 
patients and prescribing medications if necessary. I was therefore quick to recognize side 
effects, like muscle tension and cramps in my jaw and upper legs, associated with my own 
treatment. Together with my psychiatrist, we decided to discontinue the bupropion, as I was 
doing well. With the wisdom of hindsight, we should perhaps have considered a risk, given a 
personal history of depression, a family history of mood disorders and a particularly busy 
period at work. In the first weeks after stopping, no problems arose. The muscle cramps 
disappeared and I was relieved not to have to take medication every day.  
However, after a while I began feeling tired, had trouble concentrating, and found it 
increasingly difficult to get up in the morning. At some point, I decided to use light therapy 
for 20 minutes each morning, hoping it would help me get out and about more easily. It did 
not work. Sleeping, getting started in the morning, and staying motivated throughout the day 
was not self-evident anymore, but increasingly felt as hard labour. I also felt less confident at 
work. Internal struggles arose because I was feeling down and it seemed inappropriate that 
I would be helping others while secretly struggling myself. People around me started noticing 
changes and finally my colleagues gently but clearly indicated I should seek help. In April
2017, I called in sick and visited my psychiatrist. He confirmed a major depression and 
together we started to look for new treatment options.   
A difficult period started during which I felt utterly lost. I do not remember much from the 
first weeks, as everything was blurred. My thoughts and movements went as if in slow-
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motion. I could not enjoy even the smallest things and suddenly my future perspective was 
gone. I experienced psychosis – perceiving a world that was bleak, threatening, lonely and 
devoid of meaning. The only part of my psychiatry training that – fortunately – continued was 
the compulsory trajectory of personal psychotherapy. I was also prescribed antidepressants. 
One evening, when I felt a little better and found myself able to take perspective, I wondered 
if I could monitor the lived experience of my suffering, making it somehow part of my training 
and my desire to have a future as a psychiatrist. As my concentration was at a low point, I 
required a relatively simple way to document my journey.   
I send an email with a query to a professor I knew. Although I felt embarrassed immediately 
afterwards, his reaction was supportive, saying my story was important. It made me feel 
validated and even generated a tiny bit of confidence. He suggested monitoring the recovery 
process by using the Experience Sampling Method in the form of a freeware smartphone 
application called the PsyMate. Experience sampling is a self-monitoring tool for momentary 
data collection, capturing the evolution of mood, cognition, and behaviour over time. The 
person is required to complete multiple short questionnaires of 1-minute duration at several 
moments per day, in response to auditory signals. These data can then be displayed in 
graphs and figures, making patterns in daily life visible. Experience sampling is used in 
research and has relevance for clinical practice. Often, for short sampling periods of one 
week. In the past, I had used the PsyMate during a research internship. Back then, it had no 
personal significance and soon the routine became annoying. Not so, it turned out, when I 
was ill.   
Together with an ESM expert, I began the process that eventually would result in over 2 years 
of data collection. The app consists of a standard set of questions, monitoring mood (e.g., “I 
feel anxious”), current context (e.g., “what am I doing right now”) and appraisal of context 
(e.g., “I like this company”) at 10 random moments per day. In addition to these assessments, 
a morning and evening questionnaire are available to capture sleep quality and overall 
feelings at the end of the day. This was our starting point. Every week, we sat together to look 
at my results on the PsyMate website. In the beginning, this process of weekly contact and 
daily monitoring, thereby contributing to research, provided an anchor of meaning and 
purpose.  
Over the following weeks, we personalized items to include other relevant symptoms and 
experiences. For example, we added “I feel numbed”, an overwhelming feeling at the time. 
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Important was that we made sure the list remained balanced and contained positive items 
as well, to prevent a negative influence on my mood. We also decided to monitor medication 
more closely by adding a category to the question ”Since the last beep I used…”. In addition, 
we added an item about meditation, because we were wondering if the classes I started 
would impact my mood. Not everything could be personalized; beeps were programmed 
between 8.30AM and 10.30PM, which frequently resulted in missed beeps in the morning.  
As the collected data was growing, multiple interesting patterns became visible. Often, we 
would see changes, which made me conscious of minor shifts that I could not have 
consciously formulated in advance, but which I then recognized were present. In the 
beginning, few fluctuations were apparent in my mood and I was feeling down all the time. 
After some time, my treatment started to have effect and more reactivity became visible 
during the day.  Antidepressants often take some time before taking effect, which was also 
reflected in the data. PsyMate became a way to help me assess treatment effects and 
propose changes. Examining time-budgets was also helpful and a little confronting at first. I 
was spending a lot of time at home and by myself, although we learned, by graphically 
combining mood with activities or company, that being outdoors and with others resulted in 
an increase in positive feelings (see Figure 1).  
 
Figure 1  
The pie chart (left) displays my answers on the question “Who am I with” during 2 weeks of sampling, indicating 
that I was alone 52 times and with others 15 times. The bar graph (right) shows how cheerful, down and 
numbed I felt when I was alone versus when I was with others. I felt more cheerful, less down and less numb 
when with others.  
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There were many incredibly discouraging drawbacks in my recovery process. However, 
because I kept monitoring my mood, we could always inspect the ‘bigger picture’ showing 
overall slow progress over the momentary hollows. This helped me realize I was still moving 
forward, even though it sometimes did not feel remotely as if my mental state had improved 
(Figure 2).  
 
Figure 2 
Online feedback graph showing my experience sampling data over a period of 2 years. Part A) displays the 
mood items cheerful and down over time with answers averaged by day. Fluctuations in my mood can be seen, 
next to how the feelings relate to each other. Part B) displays the item numbed over time with answers averaged 
by month. A general decline can be seen in how numb I felt, showing my overall recovery.   
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After two gruelling years, I am doing better now. Monitoring helped me to appraise my 
situation objectively and kept me on top of my depression instead of being lived by it. 
Recently, I restarted my psychiatry residency training. Having experienced the benefits of 
monitoring during different stages of recovery, I would definitely encourage others to 
integrate such tools into their therapy. Early on, it provides an easy way to keep track of what 
is going on without having to think too much. Later on, it provides concrete clues for change, 
guiding treatment choices. At the end, it displays a story about you, as a person, with all the 
thousands of literally ups-and-downs as a lived reality. In a strange way, it is both comforting 
and aiding in a sense of control that one can never completely disappear into the darkness. 
Having constructed the journey of my lived experience, I am confident that I will be a better 
doctor. It gives me courage to share my story and inspire healthcare professionals to do the 
same.  
Closing perspective - I (SV) feel privileged to have been able to reflect on the experiences collected 
by Jaimie. Working together on personalizing PsyMate and finding meaning in a challenging period 
of life has been a valuable and special experience. As a researcher and psychologist, I learned what 
is important in experience sampling and what is less relevant. The key is to attempt to reduce 
complexity to simplicity. Pervasive patterns, once discovered, are turning points in guiding change 
or finding understanding. I am proud of Jaimie, it takes courage and endurance to open up and 
use one’s own experience and share it for the benefit of others. 
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Abstract 
Background: Mental healthcare needs person-tailored interventions. Experience Sampling 
Method (ESM) can provide daily life monitoring of personal experiences. This study aims to 
operationalize and test a measure of momentary reward-related Quality of Life (rQoL). 
Intuitively, quality of life improves by spending more time on rewarding experiences. ESM 
clinical interventions can use this information to coach patients to find a realistic, optimal 
balance of positive experiences (maximize reward) in daily life. rQoL combines the frequency 
of engaging in a relevant context (a ‘behavior setting’) with concurrent (positive) affect. High 
rQoL occurs when the most frequent behavior settings are combined with positive affect or 
infrequent behavior settings co-occur with low positive affect.  
Method: Resampling procedures (Monte Carlo experiments) were applied to assess the 
reliability of rQoL using various behavior setting definitions under different sampling 
circumstances, for real or virtual subjects with low-, average- and high contextual variability. 
Furthermore, resampling was used to assess whether rQoL is a distinct concept from positive 
affect. Virtual ESM beep datasets were extracted from 1058 valid ESM observations for virtual 
and real subjects.   
Results: Behavior settings defined by Who-What contextual information were most 
informative. Simulations of at least 100 ESM observations are needed for reliable 
assessment. Virtual ESM beep datasets of a real subject can be defined by Who-What-Where 
behavior setting combinations. Large sample sizes are necessary for reliable rQoL 
assessments, except for subjects with low contextual variability. rQoL is distinct from positive 
affect.  
Conclusion: rQoL is a feasible concept. Monte Carlo experiments should be used to assess 
the reliable implementation of an ESM statistic. Future research in ESM should asses the 
behavior of summary statistics under different sampling situations. This exploration is 
especially relevant in clinical implementation, where often only small datasets are available. 
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Introduction 
Mental health care is becoming more patient-centered. Every person is unique and the 
current classification systems miss relevant nuances for customized therapeutic 
interventions1,2. Van Os3 argued to innovate assessment by making it more person-tailored 
and actively involve patients in the process. Clinicians should focus less on group 
characteristics and more on the individual’s daily adaptation strategies and need for care3. 
Over the years, diagnostic procedures have become more time consuming. Results are often 
complex latent structures that are not transparent and do not facilitate a collaborative 
communication between clinician and patient3,4. The main purpose of mental health care is 
to improve functioning as well as quality of life, in an empowering way. Most psychological 
interventions require motivation and engagement. An alienating communication does not 
help to engage patients in treatment. The ultimate goal is to assist patients in becoming more 
resilient, improve autonomy, reduce the impact of mental illness and improve well-being.  
Resilient individuals are able to reduce their vulnerability by reducing the impact of 
symptoms and complaints in daily life. The reference point for therapeutic success is the 
actual moment-to-moment experience and functioning. The Experience Sampling Method 
(ESM) is a structured diary technique specially developed to appraise subjects in their daily 
interactions5. The technique makes it possible to study subtle dynamic changes in 
momentary affective states that are difficult to assess in cross-sectional questionnaires. ESM 
has high ecological validity6,7 and allows person-tailored data collection. Since it reflects the 
subject’s own daily life, the data facilitates transparent communication and collaborative 
care. ESM has been used for numerous research purposes in the general population8, 
somatic health care9 and mental health care10. The method proved valuable in monitoring 
treatment effects11 and can be used as a treatment intervention12. 
Quality of Life (QoL) is an important outcome indicator. Mental illness often decreases QoL, 
resulting in lowered subjective well-being and functioning13,14. QoL can be defined as “an 
individual’s perception of their position in life in the context of the culture and value systems 
in which they live and in relation to their goals, expectations, standards and concerns” 15, p.
1405. Researchers and clinicians essentially consider QoL as a subjective concept. A broad 
operationalization combines different domains, such as social contact, physical health and 
environmental resources15,16. Affect, cognition, behavior and physical functioning influence 
experienced QoL17. The World Health Organization Quality of Life Assessment (WHOQOL) 
was developed to assess this comprehensive, multi-domain view of QoL15. Other cross-
sectional QoL measures either assess the impact of mental illness14,18 or monitor successes 
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in treatment19-21. Structured interviews are used in the assessment of patients with a severe 
mental illness, both for subjective information (e.g., self-assessment) and objective 
information (e.g., social functioning)22,23. Lehman24 showed that patients with severe mental 
illness were able to give an account of experienced QoL, similar to subjects from the general 
population.  
Barge-Schaapveld and colleagues25 used ESM to study subjective well-being in daily life for 
patients with depression. They assumed that QoL varies from moment-to-moment and 
assessed momentary QoL (mQoL) repeatedly, using the question “In general, how is it going 
with you right now?” ESM questionnaires were administered ten times a day for six 
consecutive days. Results confirmed between-subject and within-subject (temporal) variation 
in mQoL. Compared to healthy control subjects, depressed subjects reported lower mQoL, 
less activity, and experienced more negative affect and less positive affect. In addition, the 
variation of mQoL was higher in the depressed group. Furthermore, situational factors had 
a large influence on mQoL in both groups25. ESM is a feasible method for the assessment of 
momentary health-related QoL26. QoL can be measured in the moment, under different daily 
life situations and varies between and within persons25,26. ESM is a compelling and 
comprehensive method because it assesses different factors that influence QoL, namely 
momentary affect and contextual variability.  
To date, mQoL was an outcome statistic. Repeated self-assessments are made for a 
representative sample of moments during a specified period. Individual mQoL assessments 
are aggregated, yielding a statistic that represents pre or post intervention mQoL for a 
subject. The clinical relevance is limited, because these aggregated mQoL scores miss the 
necessary information to inform patients and clinicians on how to improve QoL dynamically 
over time. This requires an mQoL statistic that directly links treatment aims such as 
improving well-being with adaptation strategies in the moment and informs individuals and 
clinicians about choices in daily life. 
The mechanism of reward or the process of reward seeking can be relevant to improve 
mQoL. Subjective well-being is related to reward experiences. Moreover, subjective well-
being and reward-related neural activity are related27. Reward experiences are the drivers of 
operant learning28. In operant conditioning, people learn from the consequences of their 
response and use that knowledge to guide future behavior choices28,29. Stimulus-response 
associations are computed internally and updated frequently, allowing people to predict the 
outcome and choose responses from their repertoire accordingly. This implicit associative 
learning is driven by reinforcement. According to behavior theory, reinforcement 
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strengthens or weakens the selection of behavior in a similar situation. Positive 
reinforcement occurs when a certain response to a new stimulus results in a valuated 
outcome and is thus rewarded, thereby increasing the likelihood of similar behavior in the 
future30. 
In mental health research, mechanisms of operant conditioning and reward are repeatedly 
linked to well-being. Lewinsohn and colleagues31 hypothesized that depression is a 
consequence of low levels of response-contingent positive reinforcement. In a sample of 
college students, they correlated depressed mood with time spent on pleasant activities. 
Increased time in pleasant activities was viewed as an indicator of positive reinforcement. 
The results showed a moderately negative association: where pleasant activities decreased, 
experienced depression increased31,32. A causal link between the two variables could not be 
established33. Other studies have demonstrated positive affective experiences and reward 
experiences in relation to resilience in depressive subjects34,35. A randomized control trial 
(RCT) conducted by Geschwind, Peeters, Drukker, van Os and Wichers36 showed that 
mindfulness-based cognitive therapy aimed at increasing positive affect and the enjoyment 
of reward experiences during daily life was associated with a reduction in experienced 
depression.  
Kramer and colleagues37 used an ESM-based intervention (ESM-I) to examine whether self-
monitoring of positive affect (PA) is beneficial for depressive patients in addition to treatment 
as usual. ESM-derived feedback was used as a therapeutic tool to gain insight in implicit 
dynamic patterns that arise over time. Through person-tailored feedback sessions, hidden 
patterns were made explicit using visualization in graphs and figures37. Weekly ESM-I 
feedback sessions influenced the treatment of depression positively, with an effect still 
present at six-month follow-up37. Contrary to these long-term effects, they found no 
significant impact of the ESM-I on daily experienced PA during the intervention or shortly 
after38. Another RCT in young adults with depression also provides evidence that ESM-I may 
have positive impact on pleasure and PA by providing personalized lifestyle advice39. Wichers 
and colleagues40 used ESM as a tool to prospectively observe implicit learning processes for 
reward-seeking and punishment-avoidant behavior in the context of daily life. They 
hypothesized that current behavior could be predicted by the experience of related behavior 
at previous time points. Results confirmed that affect moderates this association over time, 
both at beep and day level40.  
ESM is rooted in ecological psychology where contextual embeddedness is widely 
recognized41. Barker introduced the term ‘behavior settings’, to reflect the mutual relation 
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between human behavior and the environment42. Behavior settings are eco-behavioral 
entities which exist independent of persons and form self-regulating systems43. They 
represent stable and identifiable constructs with both spatial and temporal indices and can 
provide opportunities or constrain the actions of persons42,44. The term behavior setting puts 
emphasis on processes and structures that often go unnoticed in the daily life of 
individuals44. 
Imagine yourself on a market. Being there with friends will likely provide a different 
experience than being alone. In addition, activities influence the experience. You could be 
working, buying a last ingredient for dinner or simply enjoying yourself. Other factors play a 
role as well, such as the location of the market, its attributes, the weather and time of day. 
All ingredients form the behavior setting – the rich and meaningful context.  
Future research should emphasize the linkage between a person’s affective experience and 
behavior setting characteristics, including the beliefs and know-how of this behavior 
setting44. With ESM, information on momentary affect can be gathered in the context of daily 
life5. Behavior settings are important because they provide insight in the contextual variability 
of positive or negative affect. Clinicians can coach patients to engage in contexts (i.e., future 
behavior selection) to maximize individual patterns of positive affect and avoid negative 
affect, leading to more experienced QoL.  
In line with the literature above, subjects can improve QoL by engaging more often and for 
longer time in affectively rewarding situations. Some may argue that extremely rewarding, 
low frequency behaviors can boost QoL (e.g., a holiday travel compensates for a boring job). 
However, exceptional situations do not rule moment-to-moment experiences, while 
frequent minor events that occur naturally in the flow of daily life have an impact on mental 
well-being45. The pursuit of reward cannot be a unidimensional focus. QoL does not increase 
linearly (more is better), but optimizes by balancing challenges of daily life. Even the most 
enjoyable job will be perceived differently when there is no time to relax anymore. 
Maximizing reward experiences in daily life, means spending most of our time in rewarding 
situations (eliciting high PA) and avoiding situations with low PA. Depressive patients, for 
instance, are out of balance and spend insufficient time on pleasant activities31,45-47. Their 
time budgets are not optimized and too much time is spent in behavior settings with low PA. 
The reward-related QoL function (rQoL) reflects the momentary fit between context and 
optimal affective experience. ESM can monitor this process in treatment37. rQoL can be used 
in shared decision-making. Feeling good in some situations and bad in others is a 
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transparent communication and most patients understand this intuitively. The collaborative 
ESM feedback sessions between patients and clinicians are the setting to discuss reward 
optimization. In a shared decision process, patients and clinicians select rewarding situations 
and explore how to increase the occurrence of well-being in daily life. 
Can these situations be detected and personal profiles computed? When applied in clinical 
practice, does this improve the subject’s overall well-being? This paper describes the 
development of a reward-related QoL function (rQoL) and the proof of concept of its 
applicability. A reward statistic is defined. It reflects individual daily life moment-to-moment 
variation in reward efficiency, by combining the actual (positive) affect with the occurrence 
frequency of the actual behavior setting. Data is collected using ESM. To our knowledge, this 
is the first study that uses mechanisms of reward to design a momentary quality of life 
measure.  
Method 
Sample 
To assess the feasibility of the rQoL concept, ESM data from an existing dataset ― the D-
STIGMI study48 p. 103 was used. The D-STIGMI study evaluates a psycho-educational coping 
skill training in people with severe mental illness using a RCT. The aim of the training was to 
increase resilience against stigmatization. The ESM data collection was an optional add-on to 
explore innovative outcome parameters. The Medical Ethics Committee of Maastricht 
University Medical Centre approved the study protocol under the number of NL3179406810. 
In the current study, only baseline ESM assessment data were used as seeds for the random 
simulated sets. ESM data were available for 27 participants.   
Measurements  
Experience sampling method (ESM). ESM is a structured diary technique to assess moment-
to-moment mental state changes in relation to situations in the daily life of individuals5,49. 
The data of the D-STIGMI study was collected with the PsyMate™ device, a palm-top 
assessment tool developed for ESM data collection (http://www.psymate.eu/). The PsyMate™ 
was programmed to emit ten beeps each day for six consecutive days. Beeps were generated 
at semi-random moments, within 90-minute blocks, between 7.30 and 22.30 hours. An 
auditory and visual signal indicated the availability of a short questionnaire. Responding 
lasted less than a minute. The questionnaires remained available for 15 minutes and subjects 
were instructed to promptly reply. Daily life experiences are captured in items assessing 
current affect, activities and context. Most items were rated on a 7-point Likert scale (ranging 
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from 1 = ‘not at all’ to 7 = ‘very’). A bipolar scale (-3 = negative, 0 = neutral, to 3 = positive) was 
used to assess stressful events. Context (activity, location and person present) and the use 
of substances were assessed with multi-optional checklists. The item ‘Overall, I feel well at 
the moment’ was added to assess mQoL. Beeps are considered valid when the whole 
questionnaire is completed. Each subject could respond to a maximum of 60 beeps. In line 
with ESM guidelines, subjects were included in the analyses when they completed at least a 
third of the beeps (20 valid beeps)5.  
Assessment of rQoL  
Momentary reward-related quality of life (rQoL) is defined as the fit between frequency of 
situations (behavior setting) and actual mental state. rQoL can be computed for each 
moment and provides feedback to clinicians and patients to collaboratively select 
intervention strategies that optimize the mental state in daily life and lead to more overall 
well-being. The related rQoL statistic uses the subject’s own data to assess if he/she 
optimizes the selection of contexts to maximize positive mental states, meaning that 
rewarding situations should occur often and less rewarding situations should be avoided. 
The ingredients of the function are: 
Mental states. The ESM questionnaire contains mood items that assess PA: I feel ‘cheerful’, 
‘satisfied’, ‘relaxed’ and ‘enthusiastic’. Momentary PA was normalized by subject (zPA(ij) = PA(ij) 
– PA(i.) – with ‘i’ for subjects and ‘j’ for moments). zPA(ij) yields positive scores for better than
average mental states and negative scores for below average mental states. Better than 
average mental states are assumed to be rewarding.  
Behavior setting. A meaningful situation is a behavior setting. Time, place, persons and 
activities define them. The ESM definition of a behavior setting uses the context information 
available in the beep-level questionnaires: the time of the day (morning, afternoon, evening), 
persons present (‘with whom am I’: ‘partner’, ‘resident family’, ‘family living away from home’, 
‘friends’, ‘colleagues’, ‘acquaintances’, ‘strangers/others’ and ‘nobody’), activity (‘what am I 
doing’: ‘resting’, ‘work/school’, ‘household/groceries’, ‘hygiene’, ‘eating/drinking’, ‘relaxation’, 
‘doing something else’ and ‘nothing’) and location (‘where am I’: ‘home’, ‘someone else’s 
home’, ‘work/school’, ‘public place’, ‘on the go’ and ‘somewhere else’). This results in 3 x 8 x 8 
x 6 = 1152 potential combinations, of which many infrequently occur or never occur and 
result in empty cells for individual subjects. The detailed number of situations does not allow 
the selection of high and low frequency behavior settings for each subject. Therefore, the 
time of the day was omitted and the number of options for who, what and where limited to 
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six each. For persons present, ‘partner’ was included into ‘resident family’ and ‘colleagues’ 
into the ‘acquaintances’ category. For activity, we combined ‘resting’ with ‘doing nothing’ and 
‘household/groceries’ with ‘hygiene’. The options for location remained unchanged. The 
occurrence (as a proportion) of the 216 resulting behavior settings was computed for each 
individual subject. The cumulative proportion was computed with a break at 0.5 to 
differentiate the large set of infrequent situations and the much smaller set of frequent 
situations. 
Reward function. The momentary rQoL statistic combines the frequency of the momentary 
behavior setting with the actual mental state. Specifically, the function uses the normalized 
positive affect score by individual (zPA(ij)) and weights it with the frequency of occurrence of 
the individuals’ behavior setting (cp(BSij)i). Reward efficiency occurs when high frequency 
situations yield positive moods. High rQoL occurs when high frequency situations are 
combined with positive mental states or low frequency is limited to negative mental states. 
Low rQoL situations combine poor mental states with high frequency situations or elevated 
mental states with infrequent behavior settings. These characteristics are reflected in the 
formula:  
𝑟𝑄𝑜𝐿ሺ𝑃𝐴ሻ௜௝ ൌ 𝑧𝑃𝐴୧୨ ൈ ቀ𝑐𝑝൫𝐵𝑆௜௝൯௜ െ 0.5ቁ
in which: 
rQoL(PA)ij is reward-based QoL computed on PA for subject i on moment j; 
zPAij is the standardized PA score for subject i at moment j; and 
cp(BSij)i is the cumulative proportion for subject i of occurrence of the current behavior 
setting for that subject i on moment j. 
-0.5 is used to generate a cut-off score for high and low proportions. Other cut-off scores 
were explored (and are further explained in the analyses section).  
Using this formula, a specific rQoL score was generated for each ESM moment. Negative 
scores (e.g., -0.1) represent low rQoL, whereas positive scores (e.g., 0.9) represent high rQoL. 
An alternative reward function can be defined with negative affect (NA) but PA was selected 
in line with other scholars in the field35,40. The rQoL statistic was computed using a small 
program written in a Stata™ (v13.0) script. 
Analyses 
To assess the feasibility of the rQoL function, we assessed the impact of different choices 
using resampling methods (Monte Carlo experiments) to generate ESM data for virtual 
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subjects. The sample size (N) is the number of ESM observations or beeps drawn from D-
STIGMI dataset used as seeds. Different selections of contextual domains and different cut-
off scores were explored to generate rQoL. Simulations were run using virtual subjects with 
data extracted from all beeps from the D-STIGMI seeding database. Because real subjects 
have more specific frequency distributions in behavior settings, virtual datasets were 
extracted for subjects with low, average and high situational diversity. 
Which sample size do we need to reliably assess behavior setting in individuals? A Monte 
Carlo experiment was executed to study the effect of the number of available beeps on the 
average number of unique context combinations (behavior settings). Three different 
definitions for behavior setting were explored: a What only definition (BS_W – 6 situations), a 
What and Who -based definition (BS_WW – 6 x 6 = 36 situations) and a What, Who and Where 
definition (BS_WWW – 6 x 6 x 6 = 216 combinations). Resampling made it possible to explore 
the alternative behavior setting definitions for different sampling sizes (20, 40, 60, 80, 100, 
250, 500, 750, 1000, 2000, 3000, 4000, 8000, 10000 ‘valid’ observations by virtual subject).  
Which sample size do we need for optimal variation in reward (rQoL)? A second Monte Carlo 
experiment was executed to study the effect of available observations on the average scores 
and variation of rQoL, independently for BS_W, BS_WW and BS_WWW. This was done to 
provide insight in the number of observations needed to reliably generate rQoL. Initially, 
different cut-off scores (.50, .40, .30, .20) were explored to differentiate low and high 
frequency situations. Only the cut-off score .50 proved sensitive enough for meaningful rQoL 
detection and was therefore used in further analyses. Sample sizes that were explored, are 
20, 40, 60, 80, 100, 250, 500, 750, 1000, 2000, 3000, 4000, 8000 and 10000 observations for 
the virtual subjects in the simulation. 
What is the effect of the actual contextual variation in real subjects? In contrast to virtual 
subjects who live in the contexts of the group of individuals, actual subjects live in 
environments that are more restricted. We selected subjects with different levels of behavior 
setting differentiation (the number of non-empty BS_WWW categories) and ranked these 
individuals to compute percentiles. A Monte Carlo experiment was executed to simulate the 
rQoL functions for subjects with low (5th percentile), average (50th percentile) and high (95th 
percentile) variability in contextual domains. Sample sizes that were explored are 20, 40, 60, 
80 and 100 ‘valid’ observations by virtual subject. 
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Is reward-related rQoL something different than positive affect? A final Monte Carlo 
experiment was executed to assess whether momentary PA and rQoL were separate 
concepts. Pearson’s product-moment correlations between PA scores and rQoL scores were 
computed for each resampled set of momentary data, using varying sampling sizes. This was 
done separately for BS_WWW, BS_WW and BS_W in the overall sample.  
The seeding data for the Monte Carlo experiments were selected using ESM observations 
from real subjects combined together as the sampling domain. When not enough unique 
empirical data were available (simulated samples exceeding available observations), we 
sampled with replacement. For each simulation, 1000 samples were drawn. Analyses were 
performed in Stata™ (v13.0). The do-file is added a supplementary material. 
Results 
Subject characteristics 
Twenty-seven patients with a severe mental illness were included in the ESM baseline 
measurement of the D-STIGMI study. Four patients had insufficient valid beeps (<1/3), thus 
23 patients were included as seeds for Monte Carlo experiments. The sampling set includes 
1058 valid beeps, at average 48 per subject (SD = 9.03, range 22 - 63). No significant 
differences were found between the original sample and the seed-sample on age (p = .97) 
and sex (p = .53). Demographic information is summarized in table 1.  
Which sample size do we need to assess behavior settings in individuals reliably? 
Figure 1 shows the number of unique behavior settings generated by the resampling 
procedures for different sample sizes. The theoretical number of behavior settings was 216 
but the beeps actually only contained 113 options (the empirical ceiling). The graph has three 
phases: from N = 20 (mean = 13; SD = 1.75) to N = 100 (mean = 33; SD = 3.31), from N = 100 
to N = 1000 (mean = 92; SD = 3.6) and from N = 1000 to N = 10,000 (mean = 113; SD = 0.16). 
Around N = 8000 (mean = 113; SD = 0.16), saturation is reached. Standard errors are low in 
small samples (SEM = .39; N = 20) and increase over the second phase (max SEM = 4.08; N = 
500) and finally to reduce again (SEM = .002; N = 10,000). Figure 1b and 1c reflect simulations 
for the BS_WW (theoretical 6 x 6 = 36 options, sample 36 options) and BS_W behavior settings 
(theoretical 6 options, sample 6 options). The same pattern replicates but the ceiling is 
reached with smaller samples (around 500 observations in the BS_WW and 100 in the BS_W 
situation). 
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Table 1 
Demographics and characteristics of the 23 participants seed-sample 
Characteristics N (%) Mean SD Range Details 
Age (years) 46 9.95 29-62 
Gender 
   Female 60% 
   Male 40% 
DSM-IV diagnostics 
   Single diagnosis 61% 
   Multiple diagnoses 35% 
   Missing diagnostics 4% 
Clinical classification 
   Primary psychotic vulnerability 68% 
(292.12/295.30/295.70 
/298.9/296.40) 
   Primary non-psychotic vulnerability 32% 
(296.31/299.80/301.83 
/301.83/309.81) 
GAF symptoms 46.45 14.27 28-70 
GAF handicap 45.00 9.83 31-70 
Beep characteristics (N = 1058) 
   Positive affect (overall beeps) 4.00 1.41 1-7 
   Positive affect (by subject) 4.00 0.99 1.3-6.3 
Number of context combinations 
   Unique BS_WWW combinations 113 Possible = 216 
   Unique BS_WW combinations 36 Possible = 36 
   Unique BS_W combinations 6 Possible = 6 
Context combinations per subject 
   Low BS variability subject 5 
   Average BS variability subject 17 
   High BS variability subject 28 
Note. 292.12 = Induced psychotic disorder, with hallucinations. 295.3 = Schizophrenia: Paranoid type. 295.7 = 
Schizoaffective disorder. 298.9 = Psychotic disorder NOS. 296.4 = Bipolar I disorder, most recent episode hypomanic. 
296.31 = Major depressive disorder, mild. 299.8 = Rett’s disorder; Asperger’s disorder; Pervasive developmental 
disorder NOS. 301.83 = Borderline personality disorder. 309.81 = posttraumatic stress disorder. GAF = Global 
Assessment of Functioning. BS = Behavior Setting.  
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Figure 1  
Figure 1a: Monte Carlo Experiment (MCs) to Explore Average-, Minimum- and Maximum Number of Unique 
Context Combinations with Increased Sample Size for Behavior Settings Including Who, What, Where 
Information (BS_WWW) 
Figure 1b: Monte Carlo Experiment (MCs) to Explore Average-, Minimum- and Maximum Number of Unique 
Context Combinations with Increased Sample Size for Behavior Settings Including Who, What Information 
(BS_WW). 
Figure 1c: Monte Carlo Experiment (MCs) to Explore Average-, Minimum- and Maximum Number of Unique 
Context Combinations with Increased Sample Size for Behavior Settings Including What Information (BS_W). 
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Which sample size do we need for optimal variation in reward quality of life (rQoL)? 
For different sampling sizes, the rQoL was computed at each moment of the simulated virtual 
subject. As expected, all samples had an average of 0.00, the neutral point of the rQoL 
function. Standard errors of the mean were low and are considered negligible (SEM = .06 to 
SEM = .003). For BS_WWW and BS_WW (figure 2a and b), the range of rQoL scores increased 
up to sample sizes of 500 beeps. For BS_W the range was more restricted but reached its 
maximum for sampling sizes of 60. 
What is the effect of the actual contextual variation in real subjects? 
The selected subjects (low-, average-, high variability in behavior setting) responded reliably 
to respectively 31, 45 and 55 beeps, with respectively 5, 17 and 28 different behavior settings 
(using the BS_WWW combination). Results are presented in Figure 3. Part 3a shows the 
increase in average rQoL scores for the subject with low behavior variability (p5; 5th 
percentile), average behavior setting variability (p50; 50th percentile) and high behavior 
setting variability (p95; 95th percentile). Increases in sampling size did not affect the scores 
for subjects with low behavior variation (1.1 mean difference), but did for subjects with high 
variation (12.6 mean difference). Part 3b shows the range of minimum and maximum scores. 
This confirms the previous observation. Smaller sampling sizes are possible in subjects living 
restricted lives. 
Is reward-related QoL something different than positive affect? 
The Pearson’s product-moment correlations of the Monte Carlo experiments on sampled 
sets of PA scores and rQoL are summarized in figure 4. Looking at the average correlation 
scores, weak associations were found between PA and rQoL for BS_WWW, BS_WW and BS_W 
(range r(18) = .11, p < .001  to r(9998) = .005, p = <.001). The range between minimum and 
maximum correlational scores in all three variations of behavior setting is large in smaller 
sample sizes (highest difference from min = -.91 to max = .90) and decreases with larger 
sample sizes (lowest difference from min = -.02 to max = .04).  
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Figure 2  
Figure 2a: Monte Carlo Experiment (MCs) to Explore Average-, Minimum-, Maximum- and Standard Deviation 
Scores of rQoL(PA) with Increased Sample Size for Behavior Settings Including Who, What, Where Information 
(BS_WWW). 
Figure 2b: Monte Carlo Experiment (MCs) to Explore Average-, Minimum-, Maximum- and Standard Deviation 
Scores of rQoL(PA) with Increased Sample Size for Behavior Settings Including Who, What Information (BS_WW). 
Figure 2c: Monte Carlo Experiment (MCs) to Explore Average-, Minimum-, Maximum- and Standard Deviation 
Scores of rQoL(PA) with Increased Sample Size for Behavior Settings Including What Information (BS_W). 
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Figure 4 
Figure 4a: Monte Carlo Experiment (MCs) to Explore the Relationship between PA Scores and rQoL Scores with 
Increased Sample Size for Behavior Settings Including Who, What, Where Information (BS_WWW), Using 
Pearson’s Product-Moment Correlations.  
Figure 4b: Monte Carlo Experiment (MCs) to Explore the Relationship between PA Scores and rQoL Scores with 
Increased Sample Size for Behavior Settings Including Who, What Information (BS_WW), Using Pearson’s 
Product-Moment Correlations. 
Figure 4c: Monte Carlo Experiment (MCs) to Explore the Relationship between PA Scores and rQoL Scores with 
Increased Sample Size for Behavior Settings Including What Information (BS_W), Using Pearson’s Product-
Moment Correlations. 
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Discussion 
General conclusion 
The purpose of the current proof-of-concept study is two-fold. First, a momentary rQoL 
statistic was defined. Second, Monte Carlo experiments were performed with samples of 
beep-level data for virtual subjects to check the feasibility and initial validity of the statistic. 
Momentary rQoL integrates affective experience (positive affect) and situations (behavior 
setting). A cut-off score of .50 of the cumulative proportion was chosen to separate low and 
high frequency situations. This proved to be the best choice to detect relevant contexts for 
reward efficiency in most subjects. Results show that the rQoL statistic is feasible. The rQoL 
statistic is defined at the moment level, allowing assessment of change over time. At a specific 
moment in time, a positive rQoL score indicates good reward efficiency, whereas a negative 
score indicates bad reward efficiency.  
Persons present (Who), activity (What) and location (Where) were used to define different 
conceptualizations of a behavior setting, namely Who-What-Where (BS_WWW), Who-What 
(BS_WW) and What (BS_W). For Who-What-Where combinations, not all theoretical 
possibilities were available in the reference beep dataset. This dataset included 113 unique 
combinations out of the 216 theoretical options. Some situations had low frequencies (e.g., 
working with your partner or doing household/groceries at work) or simply did not occur in 
the group of patients with a severe mental illness. First, Monte Carlo experiments were 
performed to check which sample size is needed for reliable behavior setting calculations in 
individuals. Overall, large sample sizes were needed to generate realistic frequency 
distributions (time budgets) in virtual subjects (saturation was reached at N = 8000 for 
BS_WWW, N = 500 for BS_WW and N = 100 for BS_W). Next, Monte Carlo experiments were 
performed to explore which sample size is needed to detect optimal rQoL variation. The 
range of rQoL scores increased up to generated samples of 500 beeps for BS_WWW and 
BS_WW, whereas the limit was reached at 60 beeps for BS_W. Therefore, a behavior setting 
defined by Who-What proved most useful: it provides sufficient behavior setting variation to 
generate a reliable frequency distribution at acceptable sample sizes. An optimal spread in 
rQoL variation is obtained after collecting 500 observations, meaning that all possible 
behavior-setting combinations are present in the sampling period (see figure 2B). However, 
a minimum of 100 beeps is required to reliably calculate the rQoL statistic. The sample sizes 
needed for BS_WWW are unrealistic in ESM. These results suggest that an extended sampling 
period is needed before the rQoL statistic can be integrated as an active part of treatment.  
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Further, Monte Carlo experiments were used to explore actual situational variations in real 
subjects with low, average and high behavior setting variation with combinations of persons 
present, activity and location as behavior setting. This behavior setting definition was chosen 
because it theoretically provides the largest chance of finding a decent spread in unique 
situations in this patient group. Results show that small sample sizes are possible in subjects 
with low behavior setting variations (N > 40), whereas larger sample sizes (N > 100) are 
needed for subjects with average and high behavior setting variations. It is difficult to assess 
which definition of behavior setting is sufficient for individual subjects. For now, behavior 
settings defined by Who-What-Where combinations seem the best option because the 
restricted living environments of individual subjects results in less overall situational 
variation.  
Finally, Monte Carlo experiments were run to see whether momentary rQoL is distinct from 
PA. Only weak correlations were found and results confirmed that the concepts assess 
different aspects of daily life mental states. Additionally, the momentary rQoL scores were 
correlated with ‘In general, how is it going with you right now’ (mQoL). For this, the overall 
beep sample of 1058 valid observations was used. Results show a moderate positive 
correlation (r(1056) = .33, p <.001), with mQoL explaining 11 percent of the variation in rQoL. 
Strengths 
To our knowledge, this is the first study that combines affective experience with behavior 
settings in an operationalization of rQoL in daily life. A main strength is the use of ESM data 
collected in the flow of daily life, making the rQoL statistic highly specific to the situation of 
the subject. Monte Carlo experiments are especially suited for exploration of properties and 
sampling characteristics of specific combined statistics50. Researchers compute different 
parameters, but insufficiently realize the relation and biases due to sampling characteristics. 
Knowing how a statistic responds to different sampling characteristics is particularly 
important when applied in treatment.  
Limitations 
The choices made to operationalize momentary rQoL can seem arbitrary. Other options 
could be explored. For example, the rQoL statistic can be computed with negative affect. 
Additional cut-off scores could be explored to differentiate low and high frequency situations. 
The behavior settings are defined on persons present, activity and location, although more 
aspects of the environment could be relevant. Behavior settings are complex entities which 
include a number of contextual variables42. Here we excluded, for example, temporal indices 
such as the time of the day and limited the categorical options so that a critical mass of 
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workable data remains. With advances in technology, other factors such as heart rate or 
weather reports could be more easily combined with ESM data, thereby increasing the 
accuracy of the behavior setting. In the future, it is possible to harvest big data, such as GPS 
location, sensor data, or geo-political events to enrich the situational information without 
increasing subject burden.  However, the main purpose of this study was to explore a first 
operationalization based on available ESM data and test the behavior of the momentary 
rQoL statistic using Monte Carlo experiments.  
Furthermore, the generated samples using real subject data (for the analysis of subjects with 
low-, average- and high behavior setting variability) were oversaturated and the same records 
were used repeatedly (due to replacement). The used sample included insufficient subjects 
with large beep datasets (>1000 observations). It would be interesting to replicate these 
analyses when longer series become available.  
Another limitation is the use of a specific sample of patients with severe mental illness as 
seeds for the Monte Carlo experiments. These subjects often lead restricted lives with limited 
variation in daily life activities31,51. It would be interesting to see how the frequencies in 
behavior setting differ between these patients and the general population. This first 
operationalization was made from a clinical perspective, to explore the possibility of an rQoL 
statistic that is meaningful to patients with severe mental illness. However, the basic 
components of the rQoL statistic could be relevant across clinical populations. For example, 
patients with depression or anxiety could also use the statistic within treatment to optimize 
their balance in rQoL. Future research should use Monte Carlo simulations on ESM data 
collected in other populations; to see how the frequency in behavior setting is distributed, to 
calculate which sample size would work best, and to see in what situation the rQoL statistic 
can be meaningfully calculated. It is conceivable that situational variability differs between 
populations (and between individuals).  
Implications and further research 
This proof-of-concept study indicates that momentary rQoL is a feasible statistic. Monte 
Carlo experiments provide valuable insight in the behavior of the statistic under different 
sampling restraints. The methodology can be used to further improve rQoL. Monte Carlo 
experiments should be used more frequently in ESM studies. Several suggestions were made 
for future research. The question remains whether reward-related optimized well-being is 
actually quality of life; maybe a better description is more adequate. The link between the 
rQoL statistic and mQoL could further be explored, as well as the relation of rQoL with other 
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(cross-sectional) measures of QoL. Furthermore, the statistic should be explored in other 
populations that engage in more diversified behavior settings.  
It is interesting to explore whether the rQoL statistic improves targeted communication with 
patients. The statistic could be used to identify situations that result in low rQoL, so that 
changes can be made in daily life and progress can be monitored (see the supplementary 
material for a hypothetical case example). A previous ESM-based feedback intervention37 
improved therapeutic outcome. The question remains if well-being can be improved by a 
person-tailored rQoL feedback intervention that monitors reward experiences in daily life. 
Shared decision-making is facilitated when clinicians and patients share the same 
information. ESM data, disclosed by smart feedback, can provide this context. By integrating 
the clinician’s expertise with the goals and knowledge of patients and relatives, and by looking 
at environmental daily life challenges and opportunities, more suggestions that are realistic 
can be made for optimizing reward in daily life, possibly leading to improved well-being and 
QoL.  
Chapter 6 
110 
References 
1. McGorry P, van Os J. Redeeming diagnosis in
psychiatry: timing versus specificity. Lancet. 
2013;381(9863):343-345. 
2. Evans SC, Reed GM, Roberts MC, et al.
Psychologists' perspectives on the diagnostic
classification of mental disorders: Results from
the WHO-IUPsyS Global Survey. Int J Psychol.
2013;48(3):177-193. 
3. van Os J. De DSM-5 voorbij! Persoonlijke diagnostiek 
in een nieuwe GGZ. . Leusden: Diagnosis
Uitgevers; 2014. 
4. van Staden WC. Diagnostic understanding and
diagnostic explanation in psychiatry. Curr Opin
Psychiatry. 2003;16(6):667-671. 
5. Delespaul P. Assessing schizophrenia in daily life:
The experience sampling method. Maastricht:
Universitaire Pers Maastricht; 1995. 
6. Myin-Germeys I, Oorschot M, Collip D, Lataster J,
Delespaul P, van Os J. Experience sampling
research in psychopathology: opening the black
box of daily life. Psychol Med. 2009;39(9):1533-
1547. 
7. Trull TJ, Ebner-Priemer UW. Using experience
sampling methods/ecological momentary 
assessment (ESM/EMA) in clinical assessment 
and clinical research: introduction to the special 
section. Psychol Assess. 2009;21(4):457-462. 
8. Jacobs N, Menne-Lothmann C, Derom C, Thiery E, 
van Os J, Wichers M. Deconstructing the 
familiality of variability in momentary negative 
and positive affect. Acta Psychiatr Scand. 
2013;127(4):318-327. 
9. Parati G, Omboni S, Bilo G. Why is out-of-office
blood pressure measurement needed? 
Hypertension. 2009;54(2):181-187. 
10. Walz LC, Nauta MH, aan het Rot M. Experience
sampling and ecological momentary assessment 
for studying the daily lives of patients with anxiety 
disorders: A systematic review. J Anxiety Disord. 
2014;28(8):925-937. 
11. Munsch S, Meyer AH, Milenkovic N, Schlup B,
Margraf J, Wilhelm FH. Ecological Momentary 
Assessment to Evaluate Cognitive-Behavioral 
Treatment for Binge Eating Disorder. Int J Eat 
Disord. 2009;42(7):648-657. 
12. Wichers M, Hartmann J, Kramer I, et al.
Translating assessments of the film of daily life 
into person-tailored feedback interventions in 
depression. Acta Psychiatr Scand. 
2011;123(5):402-403. 
13. Williams E, Sands N, Elsom S, Prematunga RK.
Mental health consumers' perceptions of quality 
of life and mental health care. Nurs Health Sci. 
2015;17(3):299-306. 
14. Fayers PM, Machin D. Quality of life: the
assessment, analysis and interpretation of patient-
reported outcomes. John Wiley & Sons; 2013. 
15. the WHOQOL Group. The World Health
Organization quality of life assessment
(WHOQOL): position paper from the World
Health Organization. Social science & medicine.
1995;41(10):1403-1409. 
16. Saxena S, Orley J, Group W. Quality of life
assessment: the World Health Organization
perspective. European psychiatry. 1997;12:263s-
266s. 
17. Spilker B. Quality of life assessments in clinical trials. 
New York: Raven Press; 1990. 
18. Auquier P, Simeoni MC, Sapin C, et al.
Development and validation of a patient-based
health-related quality of life questionnaire in
schizophrenia: the S-QoL. Schizophr Res.
2003;63(1):137-149. 
19. Fleury MJ, Grenier G, Bamvita JM, Tremblay J,
Schmitz N, Caron J. Predictors of quality of life in
a longitudinal study of users with severe mental
disorders. Health Qual Life Outcomes.
2013;11(1):92-92. 
20. Ruggeri M, Nose M, Bonetto C, et al. Changes and 
predictors of change in objective and subjective
quality of life: Multiwave follow-up study in
community psychiatric practice. Br J Psychiatry.
2005;187(2):121-130. 
21. Yamauchi K, Aki H, Tomotake M, et al. Predictors
of subjective and objective quality of life in
outpatients with schizophrenia. Psychiatry Clin
Neurosci. 2008;62(4):404-411. 
22. Oliver J, Huxley P, Priebe S, Kaiser W. Measuring
the quality of life of severely mentally ill people
using the Lancashire Quality of Life Profile. Social
Psychiatry and Psychiatric Epidemiology.
1997;32(2):76-83. 
23. Priebe S, Huxley P, Knight S, Evans S. Application 
and results of the Manchester Short Assessment 
of Quality of Life (MANSA). International journal of 
social psychiatry. 1999;45(1):7-12. 
24. Lehman AF. The well-being of chronic mental
patients: Assessing their quality of life. Arch Gen
Psychiatry. 1983;40(4):369-373. 
25. Barge-Schaapveld DQ, Nicolson NA, Berkhof J.
Quality of life in depression: daily life
determinants and variability. Psychiatry Res.
1999;88(3):173-189. 
26. Maes IH, Delespaul PA, Peters ML, et al.
Measuring health-related quality of life by
experiences: the experience sampling method.
Value Health. 2015;18(1):44-51. 
27. Gilleen J, Shergill SS, Kapur S. Impaired subjective 
well-being in schizophrenia is associated with
reduced anterior cingulate activity during reward 
processing. Psychol Med. 2015;45(3):589-600. 
ESM and reward related quality of life  
111 
28. Skinner BF. Two types of conditioned reflex: A
reply to Konorski and Miller. J Gen Psychol.
1937;16(1):272-279. 
29. Staddon JER, Cerutti DT. Operant conditioning.
Annu Rev Psychol. 2003;54(1):115-144. 
30. Flora SR. The power of reinforcement. Albany: State 
University of New York Press; 2004. 
31. Lewinsohn PM. A behavioral approach to
depression. Essential papers on depression.
1974:150-172. 
32. Lewinsohn PM, Graf M. Pleasant activities and
depression. J Consult Clin Psychol. 1973;41(2):261. 
33. Sweeney PD, Shaeffer DE, Golin S. Pleasant
events, unpleasant events, and depression. J Pers 
Soc Psychol. 1982;43(1):136-144. 
34. Wichers Mc, Myin-Germeys I, Jacobs N, et al.
Evidence that moment-to-moment variation in
positive emotions buffer genetic risk for
depression: a momentary assessment twin
study. Acta Psychiatr Scand. 2007;115(6):451-457. 
35. Peeters F, Wichers MC, Barge-Schaapveld DQCM, 
et al. Reduced Stress-Sensitivity or Increased
Reward Experience: The Psychological
Mechanism of Response to Antidepressant
Medication. Neuropsychopharmacology. 
2009;34(4):923-931. 
36. Geschwind N, Peeters F, Drukker M, van Os J,
Wichers M. Mindfulness Training Increases
Momentary Positive Emotions and Reward
Experience in Adults Vulnerable to Depression: A 
Randomized Controlled Trial. J Consult Clin
Psychol. 2011;79(5):618-628. 
37. Kramer I, Simons CJP, Hartmann JA, et al. A
therapeutic application of the experience
sampling method in the treatment of depression: 
a randomized controlled trial. World Psychiatry.
2014;13(1):68-77. 
38. Hartmann JA, Wichers M, Menne-Lothmann C, et 
al. Experience sampling-based personalized
feedback and positive affect: a randomized
controlled trial in depressed patients. PloS One.
2015;10(6):e0128095. 
39. Van Roekel E, Vrijen C, Heininga VE, Masselink M, 
Bos EH, Oldehinkel AJ. An Exploratory
Randomized Controlled Trial of Personalized
Lifestyle Advice and Tandem Skydives as a Means 
to Reduce Anhedonia. Behav Ther. 2017;48(1):76-
96. 
40. Wichers M, Kasanova Z, Bakker J, et al. From
Affective Experience to Motivated Action:
Tracking Reward-Seeking and Punishment-
Avoidant Behaviour in Real-Life. PloS One.
2015;10(6):e0129722. 
41. Heft H. An ecological approach to psychology. Rev 
Gen Psychol. 2013;17(2):162. 
42. Barker RG. Explorations in ecological psychology. 
Am Psychol. 1965;20(1):1. 
43. Barker RG. Ecological psychology: Concepts and
methods for studying the environment of human
behavior. Stanford University Press; 1968. 
44. Wicker AW. Perspectives on Behavior Settings:
With Illustrations From Allison’s Ethnography of a 
Japanese Hostess Club. Environ Behav.
2012;44(4):474-492. 
45. Peeters F, Nicolson NA, Berkhof J, Delespaul P,
deVries M. Effects of daily events on mood states 
in major depressive disorder. J Abnorm Psychol.
2003;112(2):203. 
46. Thompson RJ, Mata J, Jaeggi SM, Buschkuehl M,
Jonides J, Gotlib IH. The everyday emotional
experience of adults with major depressive
disorder: Examining emotional instability, inertia, 
and reactivity. J Abnorm Psychol. 2012;121(4):819. 
47. Roekel E, Bennik EC, Bastiaansen JA, et al.
Depressive symptoms and the experience of
pleasure in daily life: An exploration of
associations in early and late adolescence. J 
Abnorm Child Psychol. 2016;44(5):999-1009. 
48. van Zelst CJAM. Inside out: on stereotype
awareness, childhood trauma and stigma in
psychosis [Doctoral dissertation]. Maastricht,
Maastricht University; 2014. 
49. Jacobs N, Van Os J, Derom C, Thiery E, Delespaul 
P, Wichers M. Neuroticism explained? From a
non-informative vulnerability marker to
informative person–context interactions in the
realm of daily life. British Journal of Clinical
Psychology. 2011;50(1):19-32. 
50. Mooney CZ. Monte carlo simulation. Vol 116: Sage 
Publications; 1997. 
51. Holloway F, Carson J. Quality of life in severe
mental illness. International Review of Psychiatry.
2002;14(3):175-184. 
Internet site: www.psymate.eu 
Chapter 6 
112 
Supplementary material  
List of abbreviations  
ESM Experience Sampling Method (or EMA: Ecological Momentary Assessment) 
rQoL reward-related Quality of Life 
mQoL Momentary Quality of Life 
MCs Monte Carlo simulations 
BS Behavior Setting (context or situation) 
BS_W BS: What = situation defined by current activity 
BS_WW BS: What Who = situation defined by combining current activity and company 
BS_WWW BS: What Who Where = situation defined by combining current activity, company, location 
PA Positive Affect 
NA Negative Affect 
N Number of observations or so-called beeps 
Clinical implications rQoL statistic –hypothetical case example- 
Patient X has used ESM for several weeks to monitor her progress towards recovery. She 
struggles with her daily routine and does not feel satisfied with the way her life is going at the 
moment. However, she does not really know what to change in her life to feel satisfied again. 
Together with her clinician,  ESM data are discussed using an online reporting page that 
explores the subject’s mental state and context using interactive graphs and figures. The 
reporting page is intended as a tool for collaboration and can be used to generate functional 
analyses. For each beep moment, a rQoL score is presented on the screen, ranging from 
negative to positive, with 0 as a neutral point. A positive score represents feeling good in a 
situation that also occurs frequently (plus-plus) or feeling less good in a situation that is 
infrequent (minus-minus). Negative scores reflect an imbalance in daily life reward 
experiences (feeling good in infrequent (plus-minus) or bad in frequent situations (minus-
plus). Series of rQoL scores are displayed over time, to identify time trends and outliers. At 
each time point, the rQoL score can be explored to zoom into the behavior setting of that 
moment. The exploration assesses both strengths and weaknesses of the individual. 
Together with the clinician, patient X decides on action points that could lead to small 
changes in daily life that are deemed realistic. Continued monitoring provides the necessary 
feedback to see if progress can be made towards improved reward-efficiency and ultimate 
to well-being.  
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STATA™ (v13.0) do file for Monte Carlo experiments 
*ssc install egenmore
clear all 
program define mc_reward, rclass 
file open Total_OK using "C:\...\result_file_of simulations.csv", write 
replace 
* writing header
file write Total_OK "Iteration" 
file write Total_OK _tab 
file write Total_OK "cnt catheg" 
file write Total_OK _tab 
file write Total_OK "Mean rPA" 
file write Total_OK _tab 
file write Total_OK "sd rPA" 
file write Total_OK _tab 
file write Total_OK "min rPA" 
file write Total_OK _tab 
file write Total_OK "max rPA" 
file write Total_OK _tab 
file write Total_OK "corr PArPA" 
file write Total_OK  _n 
set more off 
* iterations
forvalues xi=1(1)1000 { 
clear
use "C:\...\reward_datafile_of_ESM_seeds.dta"
bsample 100
egen cnt_bs=nvals(behav_setting)
egen mPA=mean(sub_pa)
egen sdPA=sd(sub_pa)
gen zPA=(sub_pa-mPA)/sdPA
so behav_setting
by behav_setting:egen cfreq=count(behav_setting) 
so cfreq behav_setting 
egen crfreq=rank(cfreq)
generate crprop=crfreq/_N
gen rPA=zPA*(crprop-.50)
summarize cnt_bs
file write Total_OK "Iteration" 
file write Total_OK (`xi') 
file write Total_OK _tab 
file write Total_OK (string(r(mean))) 
summarize rPA
file write Total_OK _tab 
file write Total_OK (string(r(mean))) 
file write Total_OK _tab 
file write Total_OK (string(r(sd))) 
file write Total_OK _tab 
file write Total_OK (string(r(min))) 
file write Total_OK _tab 
file write Total_OK (string(r(max))) 
correlate sub_pa rPA 
file write Total_OK _tab 
file write Total_OK (string(r(rho))) 
file write Total_OK  _n 
} 
file close Total_OK 
clear 
import delimited "C:\...\result_file_of simulations.csv" 
su  
histogram cnt catheg 
histogram mean rpa 
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Abstract 
Background: Neurocognitive alterations are common in mental disorders and often persist 
after symptom remission, influencing aspects of daily interpersonal functioning. Few studies 
have focused on the dynamics of cognition in relation to mood and symptom changes that 
span episodes and within-day fluctuations. In bipolar disorder, mood states change, and 
cognition is affected, offering an attractive paradigm for investigating cognition related 
changes in daily life.  
Objective: Investigating the feasibility of two momentary cognition tasks as add-on to 
experience sampling in patients with bipolar disorder in remission, and exploring 
associations between mood, context, and cognition.  
Method: A symbol-task measuring processing speed and a quiz-task measuring liberal 
acceptance bias were implemented as a pilot in the Experience Sampling Method (ESM). 
Patients completed ESM ten times daily, for six days and were randomized to either a symbol-
task (n=5) or a quiz-task (n=5) protocol. Personal ESM experiences were collected afterwards. 
Positive affect, negative affect, and cognition outcomes (speed; accuracy; liberal acceptance 
bias) were calculated.  
Results: ESM completion was 82% (including the symbol-task), and 59% for the quiz-task. 
Patient experiences were sufficiently represented, with few uncertainties, and a minimal 
assessment burden. Participants completed on average 14 trials within 30-seconds (speed), 
with 98% correct (accuracy) on the symbol-task. A liberal acceptance bias occurred in 3% of 
the assessments and was only present in two patients. Power problems limited further 
explorations.  
Conclusion: ESM-cognition implementations are feasible and especially the symbol-task 
warrants further research. Both tasks need adjustments for a fluent daily life integration. 
More data is needed to examine cognitive variation in relation to affective fluctuations and 
contextual factors. Future studies should assess general- and patient populations to further 
test and improve feasibility and to examine clinical information about relevant micro-
dynamics in daily life.  
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Introduction 
People with mental disorders often experience cognitive alterations and sometimes do not 
regain baseline cognitive abilities for long periods after symptom remission1,2. Cognitive 
alterations have been postulated as endophenotypes or underlying vulnerabilities, being 
also present – albeit to a lesser extent- in the healthy first degree relatives3,4. In patients with 
bipolar disorder, variability in cognitive alteration was found during shifting states of 
depression and mania5. Furthermore, neurocognitive alterations cluster in domains of 
executive functioning, verbal learning, memory, attention, and processing speed3,6-8. 
Cognitive alterations can impact functioning, sometimes resulting in dissociation between 
symptomatic and functional recovery. Persisting neurocognitive alterations are thought to 
represent important determinants of psychosocial disability9-11 and are therefore a relevant 
research and treatment target. 
The exact origin of the neurocognitive problems in psychopathology is unknown and appears 
to be multi-factorial. Neurocognitive complaints differ among individual patients within a 
similar diagnostic category and within individuals over time12,13. These heterogeneities 
combined with the evidence for cognitive alterations as endophenotypes, suggest a 
neurodevelopmental origin. However, clinical factors such as social marginalization due to 
chronicity and despair caused by a history of psychosis or manic episodes increase the 
likelihood of neurocognitive alterations14,15.  
Social cognition is an important domain in psychopathology research because it is assumed 
relevant for daily interpersonal functioning16. Social cognition alterations are less evident in 
patients with bipolar disorder, compared to patients with a psychotic disorder17,18. A meta-
analysis of social cognition in euthymic bipolar patients found alterations in emotion 
processing and theory of mind. However, there was much heterogeneity and it was 
suggested that the results were caused by a subgroup of patients19. Furthermore, social 
cognitive functioning in bipolar disorder seems state dependent and varies with symptoms18. 
It may be productive to study the bipolar phenotype for research linking cognition to mood 
states. However, longitudinal studies of (social) cognitive functioning in relation to clinical 
symptoms are lacking. It remains unclear whether patients only experience social cognitive 
alterations during mood episodes and how mood influences social performance. 
Sporadically, mood is experimentally induced in labs and changes in cognition assessed20. 
However, most research to date has used an episodic timeframe. Scholars argue that 
cognition also varies with mood changes in reaction to environmental cues21,22. The 
timeframe to assess the relation of mood and cognition then shifts from illness episodes 
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(months) to daily life (hours). This provides a powerful rationale for investigating these 
processes in context.  
The Experience Sampling Method (ESM), also called Ecological Momentary Assessment 
(EMA), is an assessment strategy to study symptoms in daily life23,24. ESM uses a structured 
diary technique and provides ecologically valid real-time and real-world monitoring of mood, 
behavior, and symptomatology in relation to contextual factors21. Repeated assessments are 
performed in normal daily life. Consequently, ESM typically provides information of 
symptoms and situational characteristics over hours and days. Bipolar disorder research 
may benefit from measuring within-day mood shifts, as symptoms fluctuate dynamically over 
time25. Prospective ESM assessments avoid recall bias and are better suited to record micro 
level processes within the individual21. Adding objective cognitive assessments to ESM would 
provide a relevant extension that could help shed light on underlying mechanisms and the 
daily life functioning of patients.   
Two momentary cognitive tasks were developed for the assessment of cognition in daily life, 
as part of a large ESM study in patients with severe mental illness (EU-GEI HEALTH-F2-2009-
231909)26. The current pilot study investigated the feasibility of both objective momentary 
tasks as an add-on cognition assessment to experience sampling in patients with remitted 
bipolar disorder. Furthermore, the within-subject longitudinal design of ESM was used to 
explore the relation between cognition, mood, and symptomatology and untangle the 
determinants of their fluctuations. Knowledge in this regard could aid the future 
development of meaningful cognitive assessments for both research as well as clinical 
purposes.  
Method 
Participants 
Ten patients with either bipolar I disorder or bipolar II disorder in remission, were recruited 
from outpatient mental health clinics in the Netherlands. Inclusion was based on a lifetime 
presence of a diagnosis of bipolar I or bipolar II disorder according to DSM-IV criteria. All 
participants were between 18 and 65 years old, with sufficient knowledge of the Dutch 
language. Exclusion criteria were not being able to provide informed consent (as judged by 
the clinician), current alcohol abuse (i.e., within the last 3 months), frequent drug use (i.e., > 
2 times a week), mental retardation (as defined by IQ scores below 70), a history of 
neurological illness or traumatic brain injury with loss of consciousness, and 
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electroconvulsive treatment in the past year. The local medical ethics committee approved 
the study (NL5168.068.15) and all participants provided a written informed consent.  
Measurements 
Questionnaires 
Participants were interviewed with the Dutch adaption of the Questionnaire for Bipolar 
Illness (QBP-NL, part A and B)27. The QBP-NL is a well-validated questionnaire, which takes 
approximately 60 minutes to complete. Demographic characteristics, illness history, and 
medication and drug use were recorded. Severity of depressive and manic symptomatology 
was assessed using the Quick Inventory of Depression Symptomatology – short version 
(QIDS-C). This depression rating scale consists of 16 items and is completed by the clinician28. 
The Young Mania Rating Scale (YMRS) consists of 11 items and is also completed by the 
clinician, and was used to assess current manic symptoms29. 
Experience sampling protocol 
Experience-sampling data was collected using the palm-top PsyMate™ device 
(http://www.psymate.eu/). Sampling occurred ten times a day, for six consecutive days 
(Thursday to Tuesday) using a short questionnaire lasting approximately two minutes. These 
self-report questionnaires were programmed at semi-random intervals of 90 minute blocks, 
between 7.30 AM and 10.30 PM. Beeps signaled when a questionnaire had to be completed 
and patients were instructed to respond immediately. The beep questionnaire consisted of 
ten mood items, eight psychopathology items, three context items (activity (what), location 
(where), company (with whom)), and an item assessing beep disturbance. See supplementary 
materials table 1 for an overview. Most items were rated on a seven-point Likert scale (1=not 
at all, 4=moderate, 7=very much), with the exception of the item “How (un)pleasant was the 
event?” which was rated on a seven-point bipolar scale (-3=very unpleasant, 0=neutral, 
3=very pleasant). The context items were pre-coded in categories. After the sampling week, 
patients completed two short questionnaires to evaluate the ESM period. Items included 
both seven-point Likert scale ratings as well as open-ended questions, assessing possible 
difficulties with the device and its use in daily life.  
Two momentary cognition tasks were implemented as add-on to the ESM procedure, 
focusing on assessments of processing speed (neuro-cognition) and a liberal acceptance 
bias (related to social cognition).  
Cognition in daily life 
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The neuro-cognition task is a momentary Digit Symbol Substitution task - or symbol task in 
short, partly derived from the Symbol Substitution-Coding subtest of the Wechsler Adult 
Intelligence Scale30. The original task measures both information processing speed and 
short-term working memory. The modified version for ESM primarily assesses information 
processing speed. After the regular beep questionnaire, patients saw a row of digits (1 to 9) 
and directly under these, nine corresponding symbols (encoding information) at the top of 
the screen. At the bottom, a row of the same nine symbols was presented, but in a different 
random order. Each symbol at the bottom was an active response button and in the middle 
of the screen, one digit was presented. Patients were instructed to select the button 
representing the symbol in the bottom row that matches the digit according to the top row 
code and to complete as many trials as possible within 30 seconds, while making as few 
mistakes as possible. See figure 1 for a visual representation of the task. There were sixty 
sessions (similar to the beep total), with a maximum of 45 trials per beep questionnaire. To 
minimize learning, ten unique encoding combinations with corresponding answer keys were 
presented at random. The outcome measures were number of trials within a 30-second 
timeframe (speed) and the percentage of correct trials (accuracy).  
 
 
Figure 1 
Momentary Digit Symbol Substitution task on the PsyMate™ device.  
 
The social cognition task was derived from an earlier laboratory study that used a forced 
choice reasoning task with quiz questions to assess liberal acceptance bias31. This task is the 
same as the one used by Reininghaus and colleagues32. The mobile Probabilistic Quiz task 
(previously called experimental ESM task) – or quiz task in short - used sixty moderately 
difficult multiple choice quiz questions. They were randomized and one was presented for 
each beep. Answer options were selected that had a similar face-value likelihood of being 
correct (e.g., “To which country belongs Greenland?” “A: Iceland, B: The Netherlands, C: 
Denmark, D: Canada”).      
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After viewing the quiz question, patients were required to provide probability estimates for 
all four answer options to the question: “What is the chance that A, B, C, or D is correct?”. Ratings 
were presented in 10%-step categories (i.e., 0%, 1-9%, ..., 90-99%, 100%). After selecting a 
probability answer for each of the multiple-choice options, patients were asked if they 
wanted to endorse a specific answer (yes or no). If the answer was yes, patients were 
required to indicate which one (A, B, C, or D). The next question was whether they wanted to 
reject a specific answer (yes or no), followed by which one (A, B, C, or D).  
According to Reinighausen and colleagues32, a liberal acceptance bias or reasoning bias is 
apparent if patients select an answer they had given a low subjective probability estimate. 
This suggests a low decision threshold compared to a rational expectation. One out of four 
answers is always correct, so the likelihood of guessing the right answer at random is 25%. 
Assuming that patients are unfamiliar with the right answer, endorsing a multiple-choice 
option with 20-29% or lower personally rated likelihood is illogical, so that a liberal 
acceptance bias or reasoning bias is assumed apparent. Another indicator of a (more 
pronounced) bias is an incorrect decision to endorse an answer (as being correct), that 
participants rated having a low probability estimate (<= 20-29%). Thus, the two outcome 
measures are a liberal acceptance bias 1) based on any decision and 2) based on an 
endorsed answer being incorrect.  
Procedure  
Participants were provided with the PsyMate™ device on which the ESM protocol was 
activated. They received either ESM followed by the symbol task or ESM followed by the quiz 
task, depending on randomization. During an hour-long briefing, the ESM procedure was 
explained and test trials were completed to familiarize participants with the device, the 
questions, and the cognition task. The participants were instructed to practice on the briefing 
day, and that the six-day ESM period would start on the following day. On the second day of 
data collection, participants were contacted by phone to check whether everything was 
working well and to ask any remaining questions. After the ESM period, a debriefing session 
took place. Participants handed in the device and completed the debriefing questionnaire.  
Analyses 
Descriptive statistics (averages and frequencies) were used to assess patient characteristics, 
feasibility, and acceptability. The completion rate was defined as the overall percentage 
completed beeps, calculated from the total number of possible beeps per individual, 
averaged over individuals. Principal Component Analysis (PCA) with varimax (orthogonal) 
rotation was performed over the averaged mood item scores per participant to assess the 
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structure of the 10 ESM mood items. Thereafter, reliability analyses (i.e., Cronbach’s alpha) 
were run to determine the internal consistency of each factor. Retrospectively, the ESM data 
was combined with either the symbol task or the quiz task outcome measures. Pearson 
pairwise correlations were used to examine the relation among the mood variables and 
cognition outcomes. To see whether cognitive performance varied over time, to assess 
possible learning effects (within-day and between-day time effects), and to explore relations 
with ESM mood items, psychopathology items, and context, Pearson’s pairwise correlations 
were calculated and exploratory multilevel-regression analyses were run. The multilevel 
structure is recommended because ESM data consists of beep assessments (level 1) nested 
within participants (level 2). Two dummy variables were created for location (at home vs. 
somewhere else) and company (alone vs. with others). However, these explorations yielded 
limited information due to power constrictions (5 participants per cognition task) and were 
therefore excluded from the results. A two-sided significance level of .05 was used and all 
analyses were performed using STATA, version 13.133.  
 
Results 
Patient sample 
In the period from March until September 2016, ten patients were included. All participants 
were Dutch and of white ethnic group. The average age was 48 years (SD=14.42, range 23-
64) and 70% were women. Six patients were diagnosed with a Bipolar II disorder and four 
patients with a Bipolar I disorder according to the DSM-IV-TR criteria, with three patients in 
partial remission and seven in full remission. Compliance rates with the ESM protocol were 
good, with no participant reporting less than 20 beeps (i.e., the cut-off score for reliable ESM 
analyses34). In total, 486 beep moments were collected with a mean of 49 completed beeps 
per patient (SD=4.58, range=38-55). On average, participants completed 82% of the total 
possible responses.  
Subjective ESM evaluation 
The ESM items represented participant experiences relatively well (M=5.2, SD=.88). Some 
difficulties were encountered with the distinction between mood items in the same 
conceptual domain (e.g., angry and agitated). The categorical questions related to context 
were not always inclusive and participants sometimes struggled to find a good fit for their 
activities. The ESM procedure had little influence on mood (M=2.4, SD=1.90), activities (M=2.2, 
SD=1.62), and social contacts (M=2.7, SD=1.95). Sometimes, participants felt that they made 
mistakes when navigating the device (M=2.9, SD=.99). These mistakes were often the result 
of going too quickly, and correcting the mistake by going back to a previous item was not 
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possible. The PsyMate™ was easy to use (reverse coded: M=1.5, SD=.97), with few unclear 
questions (M=3.2, SD=1.40). Problems were reported with ambiguous mood ratings. Two 
participants specifically mentioned the item “It feels as if everything goes by itself” as unclear. 
The ESM procedure was experienced as minimally burdensome with regard to the amount 
of beeps (M=3.6, SD=2.20), the duration of an assessment (M=2.8, SD=1.87), and the sound 
of the beep (M=1.9, SD=1.3). One participant remarked that the ESM procedure was feasible 
for a short period, but not longer. She advised to make the questionnaire less redundant, to 
avoid annoyance in repeated assessments. Another advice was to implement the PsyMate™ 
in a smartphone app: a more convenient tool and less easy to forget. The participants who 
completed the symbol task remarked that the screen sometimes responded too fast or too 
slow (three times). Some participants who completed the quiz task experienced the 
questions as difficult and therefore frustrating (two times).  
Factor structure ESM mood items 
The exploratory within-subject PCA of the ten mood items resulted in three factors, each 
having a value larger than 1 (4.03 for cheerful, satisfied, relaxed and enthusiastic; 1.25 for 
insecure, lonely, anxious and down; 1.04 for agitated and guilty) with a cumulative explained 
variance of 63%. Range item loading; factor 1 (N=487, range .70-.80), factor 2 (N=487, range 
.51-.85), factor 3 (N=487, range .72-.82). Next, reliability analyses were performed, with a 
Cronbach’s alpha of .84 for factor 1 (positive mood), and .74 for factor 2 and 3 together 
(negative mood). Consequently, we calculated a positive affect subscale by computing the 
sum of the four positive mood items (M=4.28, SD=.80, range 3-5.45), and a negative affect 
subscale form the six negative mood items (M=1.84, SD=.84, range 1.04-3.79). A Pearson’s 
pairwise correlation between the positive and negative affect scales yielded a negative 
correlation (r=-.35, p<.001).   
Momentary digit symbol substitution task 
Five patients were presented the additional symbol task following the beep questionnaires. 
In total 247 (82% of the total beeps) symbol task beep moments were collected, with a mean 
of 50 completed beeps per participant (SD=3.99, range = 43-55). Each task consisted of 45 
trials, of which patients completed on average 14.19 trials (SD=2.56, range 5-22) within the 
30 second timeframe. In total, 98% of the trials were correct (SD=3.75, range 75%-100%). 
Pearson’s pairwise correlation yielded a positive correlation of .14 (p=.03) between both 
symbol task outcome measures.  
Pearson’s pairwise correlations were also used to correlate the cognition outcomes with 
relevant ESM items (see supplementary materials table 2 for person-centered averages). 
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Number of trials was positively associated with PA (r=.34, p<.001). Furthermore, the speed 
outcome was positively associated with feeling energetic (r=.45, p<.001), ‘as if everything goes 
by itself’ (r=.42, p<.001), harried (r=.19, p=.003), talkative (r=.43, p<.001) and impatient (r=.35, 
p<.001). Number of trials correct (accuracy) was positively associated with feeling as if 
everything goes by itself (r=.03, p=.03). No correlations were found between speed and 
respectively NA (r=.04, p=.57), the item busy in my head (r=.03, p=.63), feeling suspicious (r=-
.09, p=.15), worrying (r=-.04, p=.53), company (r=.11, p=.09), location (r=.01, p=.83) and beep 
disruption (r=-.10, p=.11). Accuracy did not correlate with PA (r=-.001, p=.98), NA (r=.04, 
p=.58), the item busy in my head (r=.11, p=.09), worrying (r=.06, p=.39), feeling energetic 
(r=.001, p=.99), harried (r=-.03, p=.61), suspicious (r=-.07, p=.31), impatient (r=.17, p=.09), and 
talkative (r=-.04, p=.51).  Furthermore, accuracy did not correlate with company (r=-.04, 
p=.56), location (r=-.08, p=.23), and beep disruption (r=-.05, p=.41)  
Mobile probabilistic quiz task 
Data from one patient was excluded because that patient reported searching for the correct 
answers on the internet. In total, four patients provided a sample consisting of 178 quiz 
moments (59% of the total beeps), with a mean of 48 completed beeps per participant 
(SD=4.97, range 38-52). In 51% of the time, a decision to endorse an alternative was made 
(91 out of 178). Based on the criteria of endorsing an answer combined with the probability 
estimate they gave for that specific answer, a liberal acceptance bias was present in 2.8% of 
possible instances (5 out of 178). The same script was run with the difference of looking at 
correct or incorrect items as criteria, instead of just looking at the decision yes or no. Here, 
a liberal acceptance bias was also present in 2.8% (5 out of 178): providing an incorrect 
answer with a low probability estimate. In 36% of instances, an incorrect decision was made 
as opposed to a correct or no decision (64 out of 178). Looking at individual data, only two 
patients showed a liberal acceptance bias. Individual results are summarized in Table 1.  
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Table 1 
Individual outcomes on the mobile probabilistic quiz task 
Participant 
1 2 3 4
Decision to endorse n(%) 25 (86%) 9 (18%) 20 (44%) 33 (63%) 
LA bias (any decision) n(%) 0  2 (4%) 0  3 (6%) 
Incorrect decision n(%) 19 (66%) 6 (12%) 15 (33%) 24 (46%) 
LA bias (incorrect decision) n(%) 0 2 (4%) 0 3 (6%)
Probability estimate M(SD; range) 8.7(2.2; 5-12) 7.4(3.5; 5-12) 10.1(2.0; 2-11) 9.3(3.9; 1-12) 
Note. LA = Liberal Acceptance Bias. 
Discussion 
The aim of this pilot study was to assess the feasibility of an add-on experimental cognition 
task to experience sampling in patients with explicit mood shifts (bipolar disorder). It is 
important to understand the micro-level processes that are involved with cognition and 
mood states in the context of daily life.  
General ESM findings  
Adding a cognition task to the ESM protocol did not alter ESM completion as compared to 
other ESM studies35-37. Furthermore, patients reported both tasks as feasible and acceptable 
in addition to the ESM questionnaire. Participant feedback suggests that some adjustments 
may be helpful. In order to assess mood states intuitively, the mood items need to be distinct 
and vary across time35. Items that remain vague are frustrating and increase assessment 
burden; an example is the item “It feels like everything goes by itself”. Some patients showed 
variation on this item, whereas others did not. Non-varying items can be informative, but 
become redundant when assessed repeatedly38. The items agitated and guilty seem to have 
a slightly different connotation from the other negative affect items (insecure, lonely, anxious, 
and down). However, reliability was still sufficient to calculate a separate PA and NA score for 
further cognition explorations. These aggregations are in line with other ESM studies in the 
mental health field that focus on dynamic mood21,39. Although helpful, large between-
individual differences exist between the single mood items, next to subtle valence 
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differences. In future studies, it might be necessary to consider single mood items in relation 
to cognitive performance.  
Symbol task findings  
Participant ratings and task outcomes indicate the momentary digit-symbol substitution task 
to be acceptable and feasible for repeated assessments in everyday life. Patients reported 
to have made mistakes due to the (fast or slow) responsiveness of the device. This needs to 
be addressed in future task adaptions. However, the subjective mistakes were incongruent 
with task outcome, showing a high ceiling effect (98% correct) with few actual mistakes. The 
original processing speed measure also proves highly accurate, whereas speed is more 
sensitive to cognitive performance variability30. In the symbol task, patients completed on 
average 14 trials and although the standard deviation (SD=3) and range (5-22) seem to 
indicate variability, firm conclusions cannot be drawn. Tentative evidence towards 
meaningful cognitive variation in relation to mood and context was found when exploring 
overall ESM correlations. PA, feeling energetic, harried, impatient, and talkative were 
associated with speed, and “feeling like everything goes by itself” with both speed and accuracy. 
All items seem to imply a high energy level and a relation with speed is therefore 
unsurprising. Fatigue as the inverse of high energy has been associated with decrements in 
information processing performance40.  Exploratory analyses on learning effects (examining 
within-day time effects and between-day time effects) showed a trend towards variability 
over time for speed. Initial multilevel-regression explorations also yielded tentative evidence 
for a negative association between distraction, as well as being in company of others, with 
speed. Detrimental performance while distracted or in busy environments is intuitively logic 
and fits with previous findings41,42. However, a power problem limited the statistical 
exploration with multilevel regression analyses. Future studies should explore these findings 
further.  
Quiz findings 
The mobile probabilistic quiz task was generally experienced as acceptable and feasible, 
although patients reported frustration due to task difficulty. This subjective feeling seems 
reflected in the relatively low response rate (59%), especially when compared to the symbol 
task responses (82%). The lower response rate suggests that patients stopped prematurely, 
either to avoid quiz completion or because they were unable to finish in their current 
environment. Probability estimates judgements were required for each answer option, which 
might be too cumbersome for high frequency sampling. For an intuitive daily life integration, 
the assessment burden should be kept to a minimum38. Finding out what led to lowered 
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response rate is therefore important. Future studies could consider a debriefing 
questionnaire that is dedicated to a subjective evaluation of a new cognition task.  
Task conceptualization was complex and warrants adjustments. One patient confessed to 
have looked up the answers, making the data invalid to assess liberal acceptance bias. 
Reliance on participant compliance and prior knowledge makes it important to control for 
these factors. While implementing momentary probabilistic tasks, intellectual abilities and 
years of education need to be taken into account32. However, fully controlling for someone’s 
level of general knowledge remains difficult. The task is less suited for longer assessment 
periods with a similar sampling frequency, because quiz options would run out and 
participants already may be frustrated. A solution to minimize look-up times is to limit the 
response time to a question. Timestamps or response times were not available and should 
be considered in future adaptations. Only two patients showed some evidence towards a 
liberal acceptance bias (3% of the total), suggesting low task sensitivity, or a limited presence 
of the bias in the current patient group. A lowered decision threshold has previously been 
associated with psychotic symptoms and mechanisms of aberrant salience43,44. A meta-
analysis showed that alterations in cognitive functioning are overall stronger in patients 
suffering from psychosis, compared to bipolar disorder3. It is possible that the task is less 
relevant for bipolar disorder, especially when manic symptoms have remitted. Previously, 
Reininghaus and colleagues have applied the task successfully32. The liberal acceptance bias 
outcome was able to distinguish between patients with psychotic experiences and healthy 
controls. Good concurrent validity with psychotic experiences and clinical status was 
furthermore shown. Interestingly, affective disturbance was not associated with the 
presence of a reasoning bias32. In the current sample, further exploration of the associations 
between mood, symptoms, context, and cognition were omitted due to the low rate of the 
bias. It may be necessary to increase the number of trials within a beep, so that the likelihood 
of capturing a liberal acceptance bias is increased and the possible influence of coincidences 
or distractions minimized.  
The task was meant to assess social cognition, but taps only indirectly into the cognitive 
domain. Social cognitive performance is by definition ecological and embedded in daily life 
45. A more direct measure would be clinically informative, but is difficult to implement without 
asking people to reflect on current social interactions. Future studies should reflect on the 
clinical usefulness and think about the design of a good objective social cognition task, used 
for repeated daily assessments.  
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Conclusion 
This pilot study provided feasibility and initial task-performance information for remitted 
patients with a bipolar disorder. Task adjustments are recommended, with the symbol task 
showing the most promise as a broadly applicable and well-suited task for repeated 
assessments. More research is needed to establish the usability, feasibility and validity of a 
combined ESM and cognition paradigm in varying populations with and without cognitive 
complaints. Larger sample sizes are needed to investigate possible learning effects, time-
varying factors, and associations among relevant ESM outcomes and cognitive performance. 
Comparisons with related cross-sectional cognition measures could establish convergent 
validity. Technological advances have made it possible to use smartphone applications, 
instead of PDA’s for ESM implementation. The use of smartphones greatly improve data 
logistics and seems a promising tool for future ESM research and clinical practice46. Mobile 
cognition measures show promise and insight into dynamic cognitive performance can 
enhance clinical meaningful information for researchers, clinicians and patients alike.  
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Supplementary materials 
Table 1 
Experience sampling method questions – beep level ten times a day 
Negative affect I feel … (1=not at all, 4= moderate,  7= very much) 
Insecure 
Lonely 
Anxious 
Agitated 
Down 
Guilty 
Positive affect  I feel … (1=not at all, 4= moderate,  7= very much) 
Cheerful 
Relaxed 
Enthusiastic 
Satisfied 
Psychopathology I feel … (1=not at all, 4= moderate,  7= very much) 
Energetic 
Suspicious 
Impatient 
Talkative 
Harried 
As if everything goes by itself 
It is busy in my head 
I worry 
Event stress Since the last beep the most important things that has happened is … 
How (un)pleasant was this event? (-3=very unpleasant, 0=neutral, 3=pleasant) 
Context  
 Who am I whit partner, residents, family non-resident, friends, colleagues/classmates, healthcare 
professional, acquaintances, strangers/others, nobody 
 Where am I at home, at family\friends, work or school, healthcare setting, public place, in 
transit, somewhere else 
 What am I doing  
work/school, domestic tasks, groceries, eating/drinking, personal hygiene, 
smoking, active leisure, passive leisure, gaming/internet use, sports, hanging out, 
resting, something else, nothing 
This beep disturbed me (1=not at all, 4=moderate, 7=very much) 
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Table 2 
Person centered averages of experience sampling outcomes (N=5 symbol-task subsample) 
M SD min max
Positive affect 4.75 .74 3.53 5.45
Negative affect 1.41 .34 1.04 1.80
Energetic 4.31 1.12 2.47 5.17
Suspicious 2.30 .63 1.56 3.10
Impatient 1.66 .77 1.04 2.67
Talkative 3.06 1.89 1 4.98
Harried 1.40 .62 1 2.48
As if everything goes by itself 3.39 1.74 1.08 4.95 
It is busy in my head 2.09 1.28 1 4.07 
I worry 2.82 .86 1.10 2.95
Beep disruption 2.31 .62 1.56 3.10
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Abstract 
Background: People with depression, anxiety, or psychosis often complain of confusion, 
problems concentrating or difficulties cognitively appraising contextual cues. The same 
applies to people with neurodegenerative diseases or brain damage such as dementia or 
stroke. Assessments of those cognitive difficulties often occurs in cross-sectional and 
controlled clinical settings. Information on daily moment-to-moment cognitive fluctuations 
and its relation to affect and context is lacking. The development and evaluation of a digital 
cognition task is presented. It enables the fine-grained mapping of cognition and its relation 
to mood, intrapersonal factors and context.  
Method: The momentary Digit Symbol Substitution Task is a modified digital version of the 
original paper-and-pencil task, with a duration of 30 seconds and implemented in an 
experience sampling protocol (8 semi-random assessments a day on 6 consecutive days). It 
was tested in the healthy population (N=40). Descriptive statistics and multilevel regression 
analyses were used to determine initial feasibility and assess cognitive patterns in everyday 
life. Cognition outcome measures were the number of trials within the 30-second sessions 
and the percentage of correct trials.  
Results: Subjects reported the task to be easy, pleasant and do-able. On average, participants 
completed 11 trials with 97% accuracy per 30-second session. Cognitive variation was related 
to mood, with an interaction between positive and negative affect for accuracy (% correct) 
(p=.001) and an association between positive affect and speed (number of trials) (p=.01). 
Specifically, cheerful, irritated and anxious seem to covary with cognition. Distraction and 
location are relevant contextual factors. The number of trials showed a learning effect 
(p<.001) and was sensitive to age (p<.001).  
Conclusion: Implementing a digital cognition task within an experience-sampling paradigm 
shows promise. Fine-tuning in further research and in clinical samples is needed. Gaining 
insight into cognitive functioning could help patients navigate and adjust the demands of 
daily life. 
Cognition in everyday life 
 
141 
 
Introduction 
Various patient populations experience confusion, difficulties to concentrate or problems to 
cognitively grasp contextual cues1-5. To assess an individual’s ability to function and cope in 
everyday life, neuropsychological tests are crucial. The information generated can be 
included in evaluating whether someone is, for example, capable of independent living or 
self-care6. Given these far-reaching consequences, it is important that the performance 
measured with a neuropsychological test accurately reflects performance in daily life. A 
review by Chaytor and Schmitter-Edgecombe (2003) suggests, however, that, when the 
relationship between tests and measures of daily functioning is considered, 
neuropsychological tests might only have moderate ecological validity for predicting 
everyday cognitive functioning7. 
While the general use of neuropsychological tests has gained importance in recent years, the 
tests themselves as well as the standardized context of administration remained largely the 
same8. Often, a battery of cognition tests (e.g., CANTAB) are used to determine someone’s 
cognitive potential on a range of domains9. Individual tests often take several minutes to 
administer. Furthermore, they are performed in the presence of a professional in minimum 
distraction environments. The goal is to determine a stable cognition factor that provides 
insight into the individual’s general strengths and vulnerabilities8. However, the clinical test 
conditions sharply contrast with everyday environments. Everyday life is comprised of multi-
sensory elements such as distracting sounds, smells, lights, or tactile stimuli. Furthermore, 
daily stressors and mental states can influence an individual’s cognitive ability10,11. Mood, for 
example, follows a dynamic pattern in everyday life12 and its effect on cognition from one 
moment to the next is seldom considered. Moreover, cognition is known to fluctuate over 
the day, depending on factors such as the level of alertness or food intake13,14. To improve 
the understanding of cognition in everyday life, the assessments need to take place in natural 
daily environments. Ideally, other domains such as mood and behavior are monitored 
simultaneously so that underlying associations can be learned. Insight into these implicit 
patterns would enrich treatment for cognitive complaints and provide additional clues for 
recovery and rehabilitation, next to opportunities to tailor interventions to the individual15. 
By providing cognitive assessments within the Experience Sampling Method (ESM) this 
strategy becomes possible.  
ESM, also called Ecological Momentary Assessments (EMA), is a (digital) structured self-
assessment diary technique that allows insight into the everyday life of an individual16. At 
several (semi-) random times during the day, eHealth technologies such as Personal Digital 
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Assistants or smartphone apps give signals (beeps) to prompt the collection of momentary 
experiences. At those moments, participants are asked to reflect on their current mood, 
environmental context, and activities and report their real-time information to the eHealth 
technology used. ESM is characterized by a high ecological validity as it collects experiential 
and contextual data in situ17. In-the-moment reflections reduce the recall bias that troubles 
retrospective self-reports18. Furthermore, repeated ESM measures allow a better 
understanding of between- and within-person variability in psychopathology and beyond12. 
As ESM can be experienced as time-consuming, the questionnaires need to be kept short 
and the design transparent to avoid overburdening17.  
The initial feasibility and acceptability of cognition tasks in an ESM paradigm are supported 
by a small number of studies , including domains such as working memory, attention, or 
processing speed19. The feasibility of a digital trail making test assessing processing speed in 
everyday life, for example, was found to be feasible in Chinese patients with depression20. 
Another study investigated the reliability and validity of three ambulatory cognition tasks 
measuring different cognitive domains (i.e., Symbol search, Dot memory, and an N-back 
task)21. Results indicated that all three tasks are feasible within an ESM paradigm and show 
excellent between-person reliability, reliable within-person variability, and construct validity 
with cross-sectional cognitive assessments21. In young adults, a digital processing speed task 
was not only feasible, but also sensitive to blood alcohol concentration22. 
Notably, most studies on daily life cognition focus only on a limited number of contextual 
factors in relation to cognitive performance. As everyday life is extremely complex, more 
research is needed to contextualize daily cognition with extensive intrapersonal (e.g., mood, 
age, fatigue) and contextual factors (e.g., location, company). Additionally, cognition tasks in 
everyday environments that take multiple minutes to perform23 might, on one hand, provide 
valuable information on daily cognitive functioning. On the other hand, the length of the task 
can result in a relatively low sampling frequency to not overburden the participant and thus 
limit the exploration of cognitive fluctuations over the course of the day. In order to learn 
which factors influence cognitive variation over time, a higher sampling rate is required with 
shorter beep durations to minimize burden. This strategy would enable to study the 
influence of different daily situations on cognition. Ultimately, the test results could be 
reported back to patients and discussed together with a clinician in relation to other relevant 
health domains.  
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The present study aims to build an objective cognition task with a short duration for repeated 
assessments and to implement this task into a daily life setting. Accordingly, a modified digital 
version of the Digital Symbol Substitution Task was used within the ESM-based PsyMate™ 
application on an iPod for six consecutive days by healthy individuals. This digital cognition 
task is called momentary Digital Symbol Sustitition Task (mDSST).  
First, the utility and feasibility of the mDSST was determined through the participants’ 
compliance rate and retrospective subjective experience. Second, the focus lay on validation 
via comprehensive contextualization of daily cognitive performance. The relationship 
between intrapersonal as well as contextual factors and the mDSST performance was 
investigated using high frequency ESM sampling (eight times a day).  
Prospectively, digital cognition tasks in everyday life may be relevant for improved prevention, 
treatment, and rehabilitation of psychopathology. 
Methods 
Participants 
Individuals from the general population were recruited via poster advertisement at 
Maastricht University and through social media as seeds for snowball sampling24. Sample 
size was based on recommendations for pilot studies and other exploratory ESM studies25-
27. In total, 45 participants provided written informed consent. All individuals were 18 years 
or older, had sufficient command of the Dutch language, and were able to handle an iPod 
with the PsyMate™ app. Exclusion criteria were medication use that influences cognitive 
performance and current treatment for mental illnesses or cognitive complaints. Ethical 
approval was obtained by the standing ethical committee of the Faculty of Psychology and 
Neuroscience, Maastricht University (ref.no.183_02_09_2017).  
Measurements 
PsyMate™  
The PsyMate™ is a web-based platform for moment-to-moment assessment of mood and 
behavior in daily life. It includes an App (iOS and Android), cloud-based data storage, and 
reporting tool. The PsyMate™ was developed by Maastricht University and Maastricht UMC+ 
(www.psymate.eu) and programmed to prompt participants using auditory signals eight 
times a day to complete a self-report questionnaire (approximately two minutes). Signals 
(beeps) were provided between 7.30 AM and 10.30 PM in semi-random time blocks of 112,5 
minutes. The self-report questionnaire assessed mood, physical status (i.e., fatigue, hunger), 
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and context (i.e., location, activity, and persons present). The mood items were combined in 
two independent constructs: Positive Affect (PA) by averaging ‘cheerful’, ‘energetic’, ‘relaxed’, 
‘enthusiastic’, and ‘satisfied’, and Negative Affect (NA) using ‘insecure’, ‘down’, ‘irritated’, ‘lonely’, 
‘anxious’, and ‘guilty’. The mood and physical status items were rated on a 7-point Likert scale 
(1=not at all, 4=moderate, 7=very) and the context items were assessed categorically. The 
complete item list is included as supporting information (see supplementary materials S1). 
In addition to the self-report questionnaire on the beep level, participants were asked to 
complete a morning and an evening questionnaire. These additional questionnaires 
consisted of self-report items that assessed respectively sleep duration and sleep quality, 
and general appraisal of the day. Most items of the morning questionnaire were assessed 
categorically, whereas all the items of the evening questionnaire were rated on a 7-point 
Likert scale (1=not at all, 4=moderate, 7=very). Participants were included in the analyses if 
they completed a minimum of sixteen valid beep moments (1/3 of total), conform with ESM 
guidelines28. All participants were provided with an iPod on which the PsyMate™ app (version 
2.0.0.) was installed to standardize the administration of the momentary Digit Symbol 
Substitution Task (mDSST). To evaluate the PsyMate™ procedure, debriefing questionnaires 
were provided after the ESM completion.  
PsyMate™ mDSST 
The mDSST is based on the Digit Symbol Substitution Task from the Wechsler Adult 
Intelligence Scale (WAIS)29. It measures information processing speed and short-term 
working memory. The modified mDSST primarily assesses information processing speed, but 
not short-term working memory due to design choices (e.g., short duration, one-by-one 
presentation) that are part of the ESM set-up. The task was selected after consultations with 
psychiatric and neuropsychological healthcare professionals and scholars of daily life 
assessment. The constraints were that the digital cognition task could be performed multiple 
times per day and therefore had to be short, sensitive to cognitive fluctuations, and show no 
or only a small learning effect. The mDSST is thought to fulfill these criteria.  
The mDSST started after the standard ESM beep questionnaire. Participants viewed an 
instruction screen including a button to start the task. The item screen displays the numbers 
1 to 9 with a corresponding symbol at the top of the screen (encoding information). For each 
trial, a number was presented one-by-one in the middle of the screen. Participants had to 
select the corresponding symbol at the bottom of the screen (see Fig 1). Symbols were kept 
similar to the original Digit Symbol Substitution Task. The task duration was 30 seconds and 
participants were instructed to complete as many trials as possible while also being as 
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accurate as possible. Five unique combinations of numbers and symbols with corresponding 
answer keys were programmed beforehand and presented in random order over the course 
of the 48 beeps. Outcome measures of the PsyMate™ mDSST are the number of trials (how 
many one-by-one trials are completed within 30-second sessions) and the percentage of 
correct trials (the number of correctly answered trials divided by the total number of trials).  
Figure 1  
Momentary Digit Symbol Substitution Task in the PsyMate™ application. 
Debriefing questionnaire 
Participants received a debriefing questionnaire with three parts using open-ended and 7-
point Likert scale questions: 1) to assess the general experience of participants throughout 
the week (e.g., was this a normal week, did participation influence your mood, social contact 
or activities); 2) to evaluate the usability of the PsyMate™ in general (e.g., was the PsyMate™ 
difficult to use , was the number of questionnaires burdensome, were there any technical 
issues); and 3) to assess the experiences with the mDSST (e.g., how well do you think you 
performed on the task, was the task difficult, was the task enjoyable). 
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Procedure 
After participants provided written informed consent, a briefing session of one hour took 
place. Participants provided sociodemographic information including gender, age, living 
situation, education level, current occupation, and ethnicity. Additionally, current medication 
use and treatment for mental illnesses and cognitive complaints were assessed through self-
reports. Furthermore, participants received an iPod (5th generation) with the PsyMate™ 
(v2.0.0.) preinstalled. They were instructed how to use the PsyMate™ and performed a test 
trial to familiarize themselves with the ESM procedure. Then, the participants used the 
PsyMate™ for six consecutive days, starting on the day after the briefing session. On the 
second day of the ESM period, participants were contacted by telephone to assist with 
potential problems or answer questions. After the ESM period, a debriefing session of one 
hour took place in which participants completed the debriefing questionnaire and returned 
the iPod.  
Statistical analyses 
Descriptive statistics were used to assess participant characteristics, initial feasibility, and 
acceptability (frequencies) of the ESM protocol. The completion rate was calculated by 
comparing the mean percentage of valid beep moments to the total number of beep 
moments. The data collected with the PsyMate™ have a multilevel structure; beeps (level 1) 
were nested in participants (level 2). Average scores of the variables of interest were person-
mean centered to take into account the within-person effect. In order to look at 
contextualized variation, dummy variables were created for location (at home versus 
somewhere else), company (alone versus with others), and coffee use since the last beep 
(yes or no). Furthermore, activity-related stress was conceptualized as an average of the 
items ‘I would rather be doing something else’, ‘This is difficult for me’, and ‘I can do this well’ 
(reverse coded).  In order to look at learning effects, a log transformation of the replication 
(sequence number of responded beeps within subjects ranging from 1 (first beep) to 48 (last 
beep)) was calculated as a proxy measure of time across the six day period. Additionally, 
within-day time effect was explored using hour of the day and its quadratic function. To 
assess cognitive variation over time and to check for learning effects, multilevel regression 
analyses were run with the number of trials within the 30-seconds interval and the 
percentage of correct trials (for each assessment moment) on the mDSST as dependent 
variables and respectively time (i.e., log transformation of replication), hour, squared hour, 
and a log transformation of day number (from day 1 to day 6) as independent variables. 
Furthermore, multilevel analyses were run to assess the association between positive affect, 
negative affect, its interaction, and various other contextual factors (e.g., fatigue, distraction) 
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as independent variables and both cognition outcomes as dependent variables. Additionally, 
multilevel stepwise regression procedures were used to explore the effect of individual mood 
items on cognition. Both forward and backward strategies were applied. The individual mood 
items and various other contextual factors were seen as independent variables and cognition 
as dependent variable. Quadratic function of age, gender, possible learning effects, and 
within-day effects were considered as covariates in all multilevel models. Analyses were 
carried out using Stata version 13.030. A two-sided significance level of .05 was used.  
Results 
Participants  
Forty-five participants were included in the ESM protocol, resulting in 1330 valid beep 
records. Two participants were unable to finish the ESM protocol due to problems with the 
iPod device (loss of 11 records, 0.83%), one participant was excluded because the iPod was 
stolen (loss of 9 records, 0.68%), and two participants did not reach the criteria of at least 16 
valid beeps due to various reasons (loss of 20 records, 1.50%). The complete dataset 
consisted of 40 participants with 1293 valid beep records. The participants’ age ranged from 
21 to 72 years of age with a mean of 30.4 (SD=14.79, Mdn=23.0). On average, participants 
completed 33 beeps (SD=4.9, range 21-43) of the 48 scheduled beeps. ESM completion rate 
was 69%. See Table 1 for descriptive statistics of the healthy population sample. 
Table 1  
Descriptive statistics for the healthy population sample (N=40) 
N (%) 
Gender (women) 29 (72.5%) 
Education level  
   Secondary vocational education  5 (13%) 
   Bachelor degree  20 (50%) 
   Master degree 15 (37%) 
Occupation 
   Students 25 (62%) 
   Fulltime work 10 (25%) 
   Part-time work 3 (8%) 
   Voluntary work 1 (2,5%) 
   No occupation 1 (2,5%) 
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Feasibility 
In order to assess feasibility, the available data from the debriefing questionnaire was used. 
One participant, whose iPod was stolen, did not complete this evaluation questionnaire, 
leaving 44 participants in the sample. All other analyses based on ESM/PsyMate™ data were 
performed with a sample size of forty participants.  
Evaluation PsyMate™ procedure  
Participants reported that the ESM items were a good representation of their experience 
(M=5.1, SD=1.26). They had no difficulty using the PsyMate™ (M=1.59, SD=1.06) and the verbal 
and written instructions were clear (verbal: M=6.64, SD=.53; written: M=6.43, SD=.70). 
Furthermore, completing the items had little influence on their mood (M=2.07, SD=1.26), 
activities (M=1.89, SD=1.5), and social contact (M=1.55, SD=.93). Participating in ESM did not 
hinder their daily activities (M=2.16, SD=1.31). With regard to the burden, participants 
reported that the number of beeps a day (M=3.23, SD=1.46), the duration of beep completion 
(M=2.32, SD=1.29), and the beep sound (M=3.18, SD=1.97) had low impact. 
Evaluation of the mDSST 
Participants were motivated to perform well on the mDSST (M=5.70, SD=.93), the mDSST was 
moderately pleasant to perform (M=4.43, SD=1.37), and participants would recommend the 
task to others (M=5.48, SD=1.17). Overall, the task was experienced as easy (M=1.80, 
SD=1.15). However, when participants had to assess their own performance retrospectively, 
they indicated to have performed moderately on the mDSST (M=4.55, SD=1.19). Also in 
retrospect, they reported to be moderately distracted during the task (M=3.51, SD=1.39).  
Variation in cognition 
Participants completed on average 11.39 trials within 30-second sessions (SD=1.32, range 3-
15), with an average percentage correct of 97.11 (SD=2.01, range 28.6-100).  The number of 
trials was positively associated with time (B=.36, SE=.033, p<.001, 95% CI=.30, .43), with a 
positive within-day effect for hour of the day (B=.03, SE=.007, p<.001, 95% CI=.01, .04), and a 
positive between-day effect for day number (B=.45, SE=.05, p<.001, 95% CI=.35, .54). The 
percentage of correct trials was not associated with time (B=-.26, SE=.19, p=.17, 95% CI=-.63, 
.11), with no within-day (B=-.04, SE=.04, p=.36, 95% CI=-.11, .04) or between-day effect (B=-
.21, SE=.27, p=.45, 95% CI=-.74, .32). 
Mood, contextual factors, and cognition  
Participants experienced high positive affect (M=4.82, SD=.77, range 2.68-6.48) and low 
negative affect (M=1.65, SD=.47, range 1.01–2.98) throughout the study. They were a little 
worried (M=2.52, SD=1.00, range 1.00–4.78) and felt moderately fatigued (M=3.69, SD=1.03, 
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range 1.55–5.77). Furthermore, they experienced low activity-related stress (M=2.68, SD=.61, 
range 1.37–3.73) and were moderately focused on their current activities (M=4.87, SD=.73, 
range 3.39–6.63). On the mDSST, they reported a low to moderate level of distraction during 
this task (M=2.88, SD=.88, range 1.15-4.67). 
Only the main significant aggregated findings from the multilevel regression analyses are 
reported. Single-item analyses are included in the supplementary material (see S1 Table). 
Participants performed more trials (B=.08, p=.04) and made less mistakes (B=.62, p=.001) 
when experiencing high positive affect. They made more mistakes when experiencing high 
negative affect (B=-1.41, p<.001). With regard to the contextual factors, participants 
performed less trials when being at a different location then home (B=-.20, p=.002) and when 
reporting to be distracted (B=-.17, p<.001). They also made more mistakes when distracted 
(B=-.46, p<.001). Fatigue, activity-related stress, worrying, current company, coffee use, and 
being able to focus were unrelated to both cognition outcome measures. With regard to 
possible covariates, less trials were performed with higher age (B=-.001, p<.001), and when 
being male. A positive association was found between the time measures (i.e., the log-
transformed replication variable as time measure, hour, squared hour) and the number of 
trials (e.g., the log-transformed replication variable as time measure; B=.36, p<.001). The 
variables with an association with the cognitive outcome measures were included in further 
multilevel regression models.   
In the final model of the number of trials, participants again performed more trials when 
experiencing high positive affect (B=.20, p=.01). In addition, a positive learning effect was 
present with more trials completed over time (B=.38, p<.001). Moreover, participants 
completed less trials when distracted (B=-.19, p<.001) and at an older age (B=-.0008, p<.001). 
The results of this analysis indicated that the six predictors explained 36% of the overall 
variance (16% within-subject variance and 47% between-subject variance).  
In the final model of the percentage of correct trials, a positive interaction effect was found 
between positive affect and negative affect for the percentage of correct trials. In other 
words, the influence of negative affect on correctness is limited when positive affect is high, 
but stronger when positive affect is low (B=.71, p=.001). Additionally, participants made  more 
mistakes when distracted (B=-.46, p<.001). The results of this analysis indicated that the four 
predictors explained 3% of the overall variance (5% within-subject variance and 0.1% 
between-subject variance). The results of the final models are presented in Table 2 (the 
number of trials) and Table 3 (the percentage of correct trials).  
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Table 2  
Multilevel regression analyses of mood, distraction, time, and age during the mDSST on the number 
of trials 
Number of trials 
B SE p 95% CI
Model 1  <.001* 
Positive affect .20 .08 .01* .04, .36 
Negative affect .27 .17 .12 -.07, .60 
Interaction between  
positive and negative affect 
-.04 .04 .34 -.12, .04 
Distracted -.19 .02 <.001* -.22, -.15
Time$ .38 .03 <.001* .31, .44
Age2 -.0008 .0001 <.001* -.001, -.0005 
Note. CI = Confidence Interval, Time$ = log-transformed replication score, Age2 = squared age. *p < .05.  
Table 3  
Multilevel regression analyses of mood and distraction during the mDSST on the percentage of 
correct trials  
Percentage of correct trials 
B SE p 95% CI
Model 1  <.001* 
Positive affect -.89 .43 .04* -1.73, -.05 
Negative affect  -4.10 .97 <.001* -5.99, -2.21 
Interaction between  
positive and negative affect 
.71 .22 .001* .28, 1.15 
Distracted -.46 .11 <.001* -.67, -.26
Note. CI = Confidence Interval, *p < .05.  
Exploratory analyses on individual mood items 
The pairwise correlation of individual mood items ranged from .42 to .74 for positive affect 
items and from .30 to .54 for negative affect items. These correlations disregard the nested 
within-subject variance. When substracting by subject means to assess within-subject 
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variance only, the correlations were considerably lower (from .24 to .63 for positive affect, 
and from .18 to .40 for negative affect). Results are presented in the supporting materials 
(see S2 Table). 
Exploratory multilevel regression analyses of individual mood items on cognition were 
computed, using mood items as independent variables and cognitive outcome measures as 
dependent variables (see S3 Table for an overview). Only the items cheerful and energetic 
were positively associated with the number of trials (respectively B=.12, p<.001; B=.06, p=.02). 
The positive affect items cheerful (B=.54, p<.001), relaxed (B=.51, p<.001), and satisfied 
(B=.53, p=.001) were positively associated with the percentage of correct trials. All negative 
affect items were negatively associated with percentage of correct trials.  
In order to weigh item covariation, both forward and backward stepwise strategies were 
applied. These results are also presented in the supporting materials (see S3 Table). In the 
backward-approach, cheerful remained the most prominent positive mood variable 
associated with the number of trials (B=.13 p<.001) and the percentage of correct trials 
(B=.36 p=.03). For the negative affect items, irritated showed a positive association with the 
number of trials (B=.07 p=.01), whereas anxious was negatively associated with the 
percentage of correct trials (B=-.69 p=.01).  
Discussion 
A novel digital cognition task, the mDSST, was evaluated for use within a daily life ESM 
protocol. The first aim was to assess the utility and initial feasibility of the mDSST. The second 
aim was to study the preliminary internal validation of measuring cognition in daily life, both 
as varying over time and in relation to contextual and intrapersonal factors. 
Feasibility and Utility of the PsyMate™ mDSST 
ESM data from three participants were removed due to circumstances outside our control 
and two participants did not reach the minimum beep requirements, leaving 40 participants 
with analyzable data. Participants completed on average 33 beeps within a 48-beep protocol, 
resulting in a completion rate of 69%. The participants’ overall experience was positive; ESM 
completion did not hinder daily life and the burden was reported as acceptable. This result 
is satisfactory and similar to other ESM research with and without a cognition task19,23,31,32. 
The cognition task was evaluated as easy and pleasant to perform. Task motivation was high 
and participants felt competitive towards the task, although several participants indicated 
that this competitiveness faded towards the end of the six day assessment period. This is an 
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indication that the task is less suited for longer datacollection periods, as is relevant in clinical 
practice. Solutions in this context should alternate the task with another cognition measure 
or provide cognitive assessments in a subset of beep-moments each day.  
Contextualization of the PsyMate mDSST  
Information processing speed was measured with a modified momentary version of the Digit 
Symbol Subtitution Task that yielded two outcome measures: the number of trials within 30 
seconds and the percentage of correct trials29. On average, participants completed 11 trials 
within 30-second sessions (speed) and answered 97% correct (accuracy). This high 
correctness score indicates that the task is easy, something that is also reflected in the 
participants’ retrospective evaluation. The choice for a DSST-based task was deliberate 
because it proved sensitive to detect cognitive complaints and changes in cognitive 
functioning in clinical samples33,34. As this is a cognitive healthy sample, it is unsurprising that 
participants made little mistakes. Generally, cognitive performance can be viewed as a trade-
off between accuracy and speed. Here, accuracy showed a ceiling effect (with reduced 
variability) while speed is a more sensitive measure. Only the number of trials showed a 
learning effect over time, with a slight increase of trials during the first half of the ESM period 
followed by a stabilization. Additionally, more trials were completed towards the end of the 
day.  
The relationship between mood and the accuracy outcome reflected a positive interaction 
effect between positive affect, negative affect, and the percentage of correct trials. In 
situations were negative affect is high, participants also tend to make more mistakes, an 
effect that is strongest when positive affect is low. Zooming in on individual mood items, only 
cheerful and anxious seemed to be associated with the accuracy outcome. Therefore, it has 
merit to unpack the positive and negative mood aggregations to get relevant information 
and clues for clinical practice. A possible explanation could be that people are less able to 
focus on a task when they feel anxious. This negative influence of mood on cognitive 
performance is observed in clinically depressed patients and might be caused by distractions 
due to ruminations35,36. Here, participants who got distracted during the task also made 
more mistakes. As distraction was assessed after task completion, it is possible that 
participants who noticed that they made mistakes, consequently scored higher on 
distraction. Overall, the explained variance for accuracy in relation to mood and contextual 
factors is neglible (3%) and combined with a ceiling effect it seems to be an irrelevant chance 
finding in a population without cognitive complaints.  
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A small positive association was found between mood (positive affect and more specifically 
cheerful) and the speed outcome. Participant’s who were more cheerful also completed 
more trials irrespective of learning effects. With regard to contextual and intrapersonal 
factors, a small negative association was found between age and speed, indicating that older 
participants overall completed less trials. The original Digit Symbol Substitution task is known 
to be sensitive in identifying age-related performance and processing speed often explains 
a large part of the variance in these studies37. Our modified digital version of the task was 
also age-sensitive. With regard to gender, males seemed to perform slower compared to 
females, an effect that disappeared in the final model. In the original Digit Substitution tests, 
men also seem to perform less well when averaged38,39. In this convenience sample however, 
females were overrepresented (73%) and further research is needed.  
Similar to the accuracy outcome, higher distraction was associated with fewer completed 
trials within a 30-second session. Here, the overall explained variance is clearly higher (36%). 
There is more variation over time with only a small learning effect. Indicating that the speed 
outcome is more suited to assess cognition in the current sample.  
Several daily life factors were explored. Only distraction was associated with cognition, 
whereas other factors such as activity-related stress, company, and being able to focus were 
not. One other study looked at situational cues in relation to cognitive performance within 
an ESM paradigm. They found that working memory performance did not differ for people 
at work versus at home, but that short-term memory improved during worktime40. Possibly, 
processing speed is less sensitive to contextual changes.  
Notably, fatigue did not vary significantly over time and had no effect on cognition. This was 
surprising, since other studies with a young population show a negative impact of tiredness 
on mental processing and increased difficulties with focusing on a task41-43. However, the 
mDSST was only 30 seconds while a standard cognitive assessment is longer (often 2 
minutes). It is likely that the association of cognition with fatigue only occurs in longer or 
more demanding tasks, which are not suited to the ESM paradigm.  
Strenghts and limitations 
The PsyMate™ app with the mDSST can be used on an individual’s own smartphone and is 
not restricted to the provided iPod. The use of cognition tasks on smartphones is feasible44,45. 
By using iPod devices across participants, the device specifications during the initial validity 
were standardized. In the early stages of task development, uncertainty about test 
characteristics, design choices, and device specifications exists. The use of the same device, 
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the iPod, reduced the uncertainties about factors that might influence outcome across the 
study sample. In later stages, the influence of different devices (i.e., own smartphones) will 
become less problematic as the goal shifts towards an evaluation of within-person variability 
for clinical purposes. 
Additionally, the mDSST was developed in an inter-professional context. Researchers (both 
in mental health and somatic care), physicians, neuropsychologists, clinicians, and software 
developers worked together to accomplish a tool that can prospectively be used across 
disciplines and in daily practice.  
Although the study has several advantages, limitations need to be kept in mind. First, our 
sample was mainly restricted to female students (70% women, 61% students, median age 
was 23). The study, however, was intended as a pilot study using convenience sampling to 
assess initial feasibility and validity. The mDSST has shown merit for daily life assessment and 
age sensitivity of the mDSST could already be indicated. Nonetheless, using a more 
heterogeneous population, a broader age range (through stratification), as well as 
populations with cognitive impairments, will increase knowledge about task sensitivity as well 
as a more diverse examination of between- and within-person variance in task performance. 
Second, technical problems have influenced the study outcomes. The beep questionnaire 
was only abailable for ten minutes. When participants initiated the questionnaire within the 
ten-minute boundary, the software should allow them to finish the task. However, the 
PsyMate™ app stopped after 10 minutes sharp, which resulted in 15 unfinished and 
interrupted tasks. The  number of trials statistic was unreliable in these cases. Furthermore, 
the first participants indicated not hearing the beep sound (leading to eighteen missed 
beeps). This problem was resolved by a system update that enabled a louder and more 
intrusive beep sound. The technological issues concerning the mDSST seem unlikely to have 
influenced the performance outcome; the proportion of correct answers was high. 
Nevertheless, participants experienced those issues as unpleasant and in the future a more 
reliable technology should be used.  
Finally, while reflecting on the task, two participants reported making mistakes by accidentally 
pressing the wrong symbol since the buttons were too small. In addition, sixteen participants 
reported that they made mistakes due to the slow processing of the iPod. The mDSST could 
be improved by using smartphones with a larger screen so that the size of the buttons is 
increased. Another option would be to rotate the screen into landscape mode.
Cognition in everyday life 
155 
Future direction 
 In light of the current study results, several questions still remain. Valuable, but limited 
information on the psychometric properties of the 30-second mDDST is gathered. It would 
be interesting to examine if the time interval can be further decreased (e.g., to 15 seconds) 
and still yields reliable data. A shorter duration could increase the feasibility and decrease 
the influence of distractions. The outcome measures of the task can be extended to include 
response time (milliseconds) to get an idea about the influence of distractions on task 
performance. Future research should investigate construct validity by comparing 
performance to the paper-and-pencil version of the DSST. This study is in progress.  
Sleep quality was assessed using the morning questionnaire, but not taken into account here 
due to power problems. Poor sleep quality can negatively influence cognitive performance 
during the day13. More attention needs to be paid to the influence of sleep quality and fatigue 
on cognitive performance in daily life. Smartwatches exist that can accurately track sleep 
patterns. It would be interesting to link objectively gathered sleep data to ESM cognition and 
fatigue outcomes. 
The mDSST predominantly focuses on processing speed, but other tasks measuring 
additional cognitive constructs could be designed for use in an experience-sampling 
paradigm. This would allow to compute the discriminant validity, as was done by Sliwinski 
and colleagues21. However, it is unclear whether a battery of mobile cognitive tasks is 
necessary for clinical purposes. Insight into daily cognitive fluctuations may be possible with 
a nonspecific cognition task. Repeated cognitive testing using ESM technology do not allow 
for a conclusive assessment across cognitive constructs, cross-sectional test batteries are 
more suited for this purpose. Gaining a general sense of cognitive functioning in relation to 
other domains can provide concrete ideas on how to deal with cognitive deficits that are 
individually relevant during everyday life. Although in this study, the various contextual 
factors did not show an effect on cognitive performance it still seems valuable to examine 
possible links more closely.  All these factors arguably influence daily cognitive functioning 
and should further be explored in the context of the rehabilitation process.  
Clinical implications 
This study is moving away from a classic cross-sectional assessment of cognition to an 
ecological assessment of cognitive variation. The combination of the mDSST with experience 
sampling allows for an examination of the link between cognition and contextual and 
intrapersonal information. ESM is used in clinical assessments and to implement in situ 
interventions in various populations. Using this method helps to raise awareness for 
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variability patterns in everyday life and it is used to support self-management and improve 
well-being15. Thus, making ESM a valuable tool to supplement assessments of behavior and 
mood, with the monitoring of cognitive abilities and its daily fluctuations.  
Cognitive impairments are known to influence recovery and self-care behavior in various 
populations. In schizophrenia and depression, there is evidence that cognitive deficits 
contribute to poor psychosocial functioning46,47, while in bipolar disorders there is an 
association between cognitive dysfunction and the course and length of the illness48. A study 
by Cameron et al. (2010) showed that in patients with heart failure, cognitive problems 
hindered decision-making49. Individuals with diabetes, who experienced greater cognitive 
difficulties, were less likely to remain adherent to exercise or diet50. Teaching individuals self-
management techniques is generally recommended for rehabilitation purposes, for example 
after a stroke51.  
Understanding oneself and one’s (cognitive) abilities is important for self-management. By 
monitoring cognition with ESM and by examining the results afterwards, knowledge can be 
gained about previously nontransparent patterns between behavior, mood, and cognition, 
facilitating this understanding15. Learning when difficulties arise and under which 
circumstances, could help patients to adjust their tasks accordingly. Individuals might thus 
plan their days according to their cognitive abilities and, for example, schedule resting 
moments when cognitive exhaustion occurs. Keeping track of minor changes towards 
recovery motivates patients and helps clinicians to adapt treatment plans. Cognition tasks 
like the mDSST can be helpful in supporting future treatment, prevention, and rehabilitation. 
Conclusions 
Adding a digital cognition task to an experience-sampling paradigm proved to be feasible in 
healthy individuals. The mDSST is promising and sensitive to detect cognitive variability in 
relation to mood, intrapersonal, and contextual factors. Although the task seems promising, 
further exploration is needed in more diverse age samples and in clinical populations with 
cognitive complaints. The implementation could be improved by providing some minor 
changes to the task (e.g., larger buttons or screen for visibility). It is clinically relevant to grasp 
how cognition fluctuates over time and relates to daily life functioning. By providing patients 
and clinicians with feedback on this data, cognitive rehabilitation and self-management can 
be improved.  
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Supplementary materials 
S1 
Experience sampling protocol: beep questionnaire  
Item 7-point Likert scale or categorical options 
1 I feel cheerful 1 = not at all 4 = moderate 7 = very much 
2 I feel energetic 1 = not at all 4 = moderate 7 = very much 
3 I feel insecure 1 = not at all 4 = moderate 7 = very much 
4 I feel relaxed 1 = not at all 4 = moderate 7 = very much 
5 I feel down 1 = not at all 4 = moderate 7 = very much 
6 I feel irritated 1 = not at all 4 = moderate 7 = very much 
7 I feel satisfied 1 = not at all 4 = moderate 7 = very much 
8 I feel lonely 1 = not at all 4 = moderate 7 = very much 
9 I feel enthusiastic 1 = not at all 4 = moderate 7 = very much 
10 I feel anxious 1 = not at all 4 = moderate 7 = very much 
11 I feel guilty 1 = not at all 4 = moderate 7 = very much 
12 I’m worrying about things 1 = not at all 4 = moderate 7 = very much 
13 I generally feel well at the moment 1 = not at all 4 = moderate 7 = very much 
14 What am I doing 
work, school/ housekeeping/ self-care/ relaxing/ 
sport/ eating, drinking/ traveling, on the road/ 
having a conversation/ something else/nothing 
15 I can do this well 1 = not at all 4 = moderate 7 = very much 
16 This is difficult for me 1 = not at all 4 = moderate 7 = very much 
17 I would rather be doing something else 1 = not at all 4 = moderate 7 = very much 
18 I am focused 1 = not at all 4 = moderate 7 = very much 
19 Where am I 
at home/ at someone else’s home/ work, school/ 
public space/ on the road/ somewhere else 
20 Who am I with 
partner/ family/ housemates/ friends/ colleagues/ 
acquaintances/ strangers, others / nobody 
21a Company: I like this company 1 = not at all 4 = moderate 7 = very much 
22a Company: I would rather be alone  1 = not at all 4 = moderate 7 = very much 
21b Alone: I like being alone 1 = not at all 4 = moderate 7 = very much 
22b Alone: I would rather be in company 1 = not at all 4 = moderate 7 = very much 
23 I don’t feel well 1 = not at all 4 = moderate 7 = very much 
24 I am tired 1 = not at all 4 = moderate 7 = very much 
25 Since the last beep I have used 
alcohol/ medication/ coffee, caffeine/ smoking, 
nicotine/ cannabis/ other drugs/ nothing 
26 mDSST instruction screen 
mDSST  30 seconds task duration 
27 I got distracted during the task 1 = not at all 4 = moderate 7 = very much 
28 This beep disturbed me 1 = not at all 4 = moderate 7 = very much 
29 Thanks! 
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S1 Table. Individual multilevel regression analyses 
Multilevel regression analyses of the explored ESM items separate for number of trials and 
percentage of correct trials  
Number of trials Percentage of correct trials 
B SE p 95% CI B SE p 95% CI 
Positive affect  .08 .04 .04* .005,  .16 .62 .19 .001* .24,  .99 
Cheerful .12 .03 <.001* .06, .18 .54 .15 <.001* .24, .85 
Energetic .06 .03 .02* .01, .12 .14 .14 .32 -.14, .42 
Relaxed  .01 .03 .78 -.05, .06 .51 .14 <.001* .23, .80 
Satisfied .02 .03 .51 -.04, .08 .53 .16 .001* .22, .83 
Enthusiastic .02 .03 .53 -.04, .07 .13 .14 .34 -.14, .39 
Negative affect -.03 .06 .58 -.14,    .08 -1.41 .28 .000* -1.96,  -.86 
Down -.04 .03 .24 -.10, .03 -.40 .17 .02* -.74, -.06 
Insecure -.01 .03 .80 -.08, .06 -.62 .18 <.001* -.96, -.27 
Irritated -.004 .03 .89 -.06, .05 -.54 .14 <.001* -.81, -.27 
Lonely .02 .04 .68 -.06, .09 -.56 .19 .003* -.94, -.19 
Anxious -.005 .05 .92 -.10, .09 -.90 .25 <.001* -1.39, -.41 
Guilty -.03 .04 .41 -.12, .05 -.65 .21 .002* -1.07, -.23 
Fatigue -.01 .02 .52 -.06,    .03   -.06 .11 .59 - .29,      .16 
Worrying .02 .03 .54 -.04, .07 -.26 .14 .07 -.54, .02 
Focused .01 .03 .70 -.04, .06 .10 .13 .44 -.16, .36 
Distracted -.17 .02 <.001* -.21, -.13 -.46 .11 <.001* -.67, -.25 
Act. stress .02 .03 .44 -.03, .07 -.11 .14 .44 -.38, .17 
Location -.20 .06 .002* -.32, .07 .26 .34 .45 -.41, .93 
Company -.13 .07 .05 -.26, .001 -.02 .35 .95 -.72, .67 
Coffee use -.08 .09 .37 -.25, .09 -.37 .46 .42 -1.28, .53 
Age2 -.001 .0001 <.001* -.001, -.0005 -.0002 .0003 .50 -.0007, .0004 
Gender -1.09 .44 .01* -1.95, -.22 .04 .72 .96 -1.38, 1.46 
Time$ .36 .03 <.001* .30, .43 -.26 .19 .17 -.63,  .11 
Hour .03 .01 <.001* .01, .04 -.03 .04 .36 -.11, .04 
Hour2 .001 .0002 .001* .0003, .001 -.001 .001 .30 -.004, .001 
Note. CI = Confidence Interval, PA = Positive Affect, NA = Negative Affect, Act. Stress = Activity-related Stress. Location = 
dummy variable of being at home versus somewhere else. Company = dummy variable of being alone versus with 
others. Coffee use = dummy variable of coffee use since the last beep versus no coffee use. Age2 = quadratic function 
of age. Time$ = log-transformed replication score. Hour = hours within a day. Hour2 = quadratic function of hour. *p 
< .05.  
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S2 Correlations between mood items  
Table A  
Pearson correlates for single positive affect items  
Variables 1 2 3 4 5 
Overall variance 
1. Cheerful -
2. Energetic .74* - 
3. Relaxed .47* .42* - 
4. Satisfied .59* .55* .57* -
5. Enthusiastic .67* .66* .48* .62* -
Within-subject variance  
1. Cheerful -
2. Energetic .63* - 
3. Relaxed .29* .24* - 
4. Satisfied .43* .39* .41* -
5. Enthusiastic .50* .50* .30* .43* -
Note. All *p< .001. 
Table B 
Pearson correlates for single negative affect Items   
Variables 1 2 3 4 5 6 
Overall variance 
1. Down -
2. Insecure .45* -
3. Irritated .44* .27* -
4. Lonely .49* .40* .30* - 
5. Anxious .45* .54* .32* .46* - 
6. Guilty .33* .34* .31* .30* .48* - 
Within-subject variance  
1. Down -
2. Insecure .33* -
3. Irritated .40* .18* -
4. Lonely .35* .25* .20* - 
5. Anxious .31* .37* .22* .28* - 
6. Guilty .27* .20* .21* .18* .29* - 
Note. All *p< .001. 
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S3 Multilevel stepwise regression analyses
Table A 
Multilevel stepwise forward and backward regression analyses of individual ESM items for number 
of trials 
Number of trials 
B SE p 95% CI
Forward (overall) < . 001* 
• Cheerful .10 .03 < . 001* .05, .16 
• Location -.003 .06 .96 -.13, .12 
• Distraction -.19 .02 < . 001* -.23, -.15 
• Time$ .35 .03 < . 001* .28, .41 
• Hour .13 .05 .01 .03, .23 
• Hour2 -.004 .002 .02 -.007 -.0006
• Age2 -.0008 .0001 < . 001* -.001 -.0006 
Backward (overall) < . 001*  
• Cheerful .13 .03 < .001* .07, .19 
• Irritated .07 .03 .01* .02, .12 
• Age2 -.0008 .0001 < .001* -.001, -.0006 
• Time$ .35 .03 < .001* .29, .42 
• Hour .12 .05 .02* .02, .22 
• Hour2 -.004 .002 .03* -.009, -.0004 
Note. CI = Confidence Interval. Age2 = quadratic function of age. Time$ = log-transformed replication score. Hour = hours 
within a day. Hour2 = quadratic function of hour. *p< .05. 
Table B 
Multilevel stepwise forward and backward regression analyses of individual ESM items for 
percentage of correct trials
Percentage of correct trials 
B SE p 95% CI
Forward (overall) <.001* 
• Cheerful .33 .17 .06 -.007, .66 
• Relaxed .21 .16 .20 -.11, .52 
• Insecure -.36 .18 .05 -.72, .002 
• Irritated -.27 .15 .07 -.57, .02 
• Distracted -.43 .11 <.001* -.63, -.22 
Backward (overall) <.001* 
• Cheerful .36 .17 .03* .04, .69 
• Relaxed .31 .16 .05 .003, .62 
• Anxious -.69 .26 .01* -1.19, -.19 
• Location .75 .35 .04* .05, 1.44 
• Distracted -.53 .11 <.001* -.74, -.32 
Note. CI = Confidence Interval. *p < .05. 
Cognition in everyday life 
163 
chapters   24 02/12/2019   19:57
9
Digital assessment of working memory 
and processing speed in everyday life: 
feasibility, validation and lessons-
learned
N. Daniëls / S. Bartels, S. Verhagen, R. van Knippenberg, M. de Vugt, P. Delespaul
Pending revisions, Internet Interventions.
chapters   25 02/12/2019   19:57
Chapter 9 
166 
Abstract
Background: Experience-sampling tools are used in research and clinical practice to study 
and support individuals in everyday life. One key aspect of human functioning is cognition. 
To address this element in momentary assessments, an existing experience-sampling 
smartphone app was upgraded. The objectives of this study were to test the feasibility and 
validity through contextualization of two momentary cognition tasks.  
Method: The momentary Visuospatial Working Memory Task (mVSWMT) and the momentary 
Digit Symbol Substitution Task (mDSST) were developed as add-on to an experience-
sampling app. Healthy adults (n=49) between 19 and 73 years of age performed the tasks 
within an experience sampling method (ESM) questionnaire eight times a day, over six 
consecutive days. Feasibility was assessed through the completion rate and participant 
experience. Validity was assessed through the contextualization of cognitive performance 
within a broad range of intrapersonal and situational factors in everyday life.  
Results: Participants experienced the tasks as pleasant, felt motivated, and the ESM 
completion rate was high (71%). Social context, age, and distraction had an influence on 
cognitive performance in everyday life. The mDSST speed outcome seems the most sensitive 
outcome measure to capture between- and within-person variance. The mVSWMT was too 
difficult (37% of recalls correct), and needs further adjustments (i.e., more trials per moment). 
Conclusion: Short momentary cognition tasks for repeated assessment are feasible and hold 
promise for future studies. Recommendations for prospective development include 
expanding the approach into other cognitive domains and clinical populations. The 
involvement of a multidisciplinary team and flexible tailoring of the set-up to the individual’s 
needs and abilities to maintain motivation and prevent frustration are furthermore 
recommended. Finally, a balance between the enjoyment and competitiveness of the tasks 
and seriousness of the ESM items should be preserved. 
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Introduction 
Memory functions, processing speed, and other cognitive abilities are usually assessed in 
clinical or laboratory settings rather than natural environments. This approach may affect 
the ecological validity of neuropsychological test results1. An empirically validated daily diary 
method, known as the Experience Sampling Method (ESM) or Ecological Momentary 
Assessment (EMA), allows to collect real-world information2-4. Digital ESM technologies using 
smartphone apps (e.g., PsyMate™ or Smart-T) prompt participants repeatedly over the day 
to reflect on their own behavior, affect, and contextual factors5,6. Over the last decade, 
interest has increased to not only depict affect and activities with experience sampling, but 
also to include the area of cognitive functioning. It is relevant to bridge the lab-life gap and 
observe cognition closely in everyday life7. For ecologically valid cognitive assessments, digital 
diary methods delivered via smartphone apps offer unique opportunities. 
The status of cognitive assessments in everyday life 
Cognitive assessments in everyday life through technology are relatively new. A recent review 
by Moore, Swendsen, Depp 8 has identified 12 studies that use self-administered digital 
cognitive assessments. A brief literature search on PubMed identified 13 additional studies 
(see Figure 1 for a visualized summary). 
Various cognitive domains are considered for the assessments in everyday life. Often, more 
than one task is used and multiple domains are evaluated. Working memory and 
attention/reaction time are most prevalent, which may be explained by the fact that these 
domains are generally relevant for various patient populations as they are affected in 
neurological conditions9,10 as well as mental illnesses11,12. Participants’ age ranged from 
adolescents to older adults. While some studies focused on healthy individuals, others 
included patient populations. Normative data remains unavailable and, therefore, the 
validation of mobile cognitive assessments in healthy individuals is still relevant. 
To describe the internal validity of the momentary tasks, the contextualization of the 
momentary performance is a key element. Therefore, previous studies took intrapersonal 
factors such as age, mood, and drug use into account. Furthermore, psychometric properties 
of the mobile cognition tasks, including between-person reliability, within-person reliability, 
and construct validity should be elaborated8.
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The Present Study 
The present study aims to evaluate the feasibility and validity through contextualization of 
two newly developed, short momentary cognition tasks implemented in the PsyMate™ 
platform with a high sampling frequency. The PsyMate™ is an ESM tool broadly used in 
research as well as in clinical settings38,39 and has the advantage of being available for both 
Android and iOS users (www.psymate.eu). Therefore, this ESM tool is an important target for 
future cognition task development. A healthy sample was recruited to perform a visuospatial 
working memory task and a processing speed task within a momentary assessment. 
Additionally, the ESM items assess a wide range of momentary intrapersonal and situational 
factors such as mood and social context. 
To determine the feasibility, completion rate and participant satisfaction were used. Validity 
was assessed through an exploration of the contextual variation of cognitive performance. 
Cognitive performance measured with the momentary cognition tasks was evaluated by 
relating cognition outcomes to each other as well as to relevant ESM-measures such as 
mood, fatigue, and current company. The results were discussed with regard to lessons-
learned and future implications. Prospectively, researchers and clinicians who are already 
familiar with the PsyMate™ app can include cognitive measures in everyday life alongside 
affect and context to understand and support various patient populations. 
Methods 
Participants 
Recruitment from the general population was performed via snowball sampling, using media 
advertisements and the personal network as seeds. Sample size was based on previous 
PsyMate™ feasibility studies and aimed for a minimum of 30 participants40,41. Fifty-one 
participants provided written informed consent. Participants were at least 18 years old, had 
a full understanding of the Dutch language, and were able to handle a smartphone device 
(Android) with a beta version of the PsyMate™ app (version 213–253). Participants who could 
not use their own smartphone device were provided with a 5th generation iPod on which the 
same version of the PsyMate™ app was installed. Individuals were excluded based on 
medication use that could influence cognitive performance and current treatment for 
cognitive or mental health complaints. The standing ethical committee of the Faculty of 
Psychology and Neuroscience, Maastricht University (ref.no.183_02_09_2017) granted 
ethical approval and the study was carried out in accordance with the Declaration of Helsinki. 
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Measurements 
Experience Sampling Method (ESM) 
The ESM was administered using the PsyMate™ Suite; a smartphone app and a cloud-based 
platform developed by Maastricht University and Maastricht UMC+ (www.psymate.eu). 
PsyMate™ is a parametrized and flexible tool for repeated assessments in everyday life. The 
application was programmed to emit an auditory and visual prompt (beep signal) eight times 
a day for six consecutive days, signaling the availability of a self-report questionnaire. These 
beep questionnaires were provided at semi-random time blocks of 112.5 minutes, between 
7.30 AM and 10.30 PM and remained available for response during 15 minutes. Beep 
questionnaires included mood (i.e., positive and negative affect), physical status (i.e., hunger, 
fatigue, and pain), and context (i.e., location, activity, and social company) items as well as the 
two cognition tasks. Positive affect (PA) included  the items ‘cheerful’, ‘energetic’, ‘relaxed’, 
‘enthusiastic’, and ‘satisfied’, while  negative affect (NA) was composed of the items ‘insecure’, 
‘down’, ‘irritated’, ‘lonely’, ‘anxious’, and ‘guilty’. In line with ESM guidelines3, a minimum of 16 
valid beep questionnaires (1/3 of total) per participant had to be completed to be included 
in the analyses. 
In addition to the beep questionnaires, participants completed a morning assessment and 
an evening assessment every day, each consisting of seven self-report items. The morning 
questionnaire focused on self-reported sleep quality. The evening questionnaire focused on 
a global appraisal of the day. The majority of the items were answered on a seven-point Likert 
scale (1=not at all, 4=moderate, 7=very). Some items contained categories (e.g. 0, 1, 2, 3, 4, 
5, or more than 5 times awake during the night). The full list of ESM items is included in 
supplementary materials Table A.1. 
PsyMate™ momentary Digit Symbol Substitution Task (mDSST) 
The PsyMate™ mDSST was inspired by the paper-pencil version of the Digit Symbol 
Substitution Task (DSST) of the Wechsler Adult Intelligence Scale (WAIS). The original WAIS 
task measures information processing speed and short-term working memory42. The 
PsyMate™ version aims to measure information processing speed. The development team 
included psychiatric and neuropsychological healthcare professionals as well as ESM 
researchers. This team defined the following requirements for the mDSST: participants 
should be able to perform the mobile cognition task several times a day, the task needs to 
be short, sensitive to cognitive variation, and demonstrates no or a small learning effect. 
At the end of the regular ESM beep questionnaire, an instruction screen appeared with a 
start button to be pressed when ready. At the top of the task screen, the numbers 1 to 9 
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with a corresponding symbol (similar to the WAIS DSST) were displayed for encoding. In the 
middle of the screen, different numbers were displayed one-by-one for each trial. At the 
bottom of the screen, participants had to select the symbol that corresponds to the number 
presented in the middle of the screen (see Figure 2). Within a 30-seconds timeframe, 
participants had to accurately complete as many trials as possible. Ten unique encoding 
combinations with corresponding answer keys were used at random. Two mDSST outcome 
measures were computed: the number of trials (speed) and the percentage of correct trials 
(accuracy). 
Figure 2 
PsyMate™ momentary Digit Symbol Substitution Task. 
PsyMate™ momentary Visuospatial Working Memory Task (mVSWMT) 
The concept of the PsyMate™ mVSWMT is based on the popular card game ‘Memory’, also 
known as ‘Concentration’ or ‘Match Match’, where players turn cards to find matching pairs. 
‘Memory’ has been used to study concentration and memory functions in various age 
groups43,44. The mVSWMT fulfils the momentary task requirements (performable several 
times a day; short; sensitive to cognitive variation; no/small learning effect) and the same 
team was consulted during task development. The mVSWMT aims to measure concentration 
and visuospatial working memory (i.e., encoding, maintaining, and retrieving visual 
information). 
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The participants were instructed that they would see nine icons to remember. After the 
participant pressed the start button, icons were presented in a three-by-three grid for eight 
seconds (encoding phase; see left part of Figure 3 a). Next, participants answered two 
interference questions on a seven-point Likert scale: ‘I think I remembered it all’, and 
‘Generally, I feel well at the moment’. During the recall phase (see right part of Figure 3 a), 
participants were presented with a three-by-three grid of blanc squares with one icon from 
the original nine above. An instruction stated to select the square of the original location of 
the presented icon. The selected square revealed the icons underneath to provide feedback. 
There was only one trial per beep moment. The grids were filled at random from a selection 
of 122 unique icons (see Figure 3 b) and a random icon cue was selected from the grid. The 
outcome measure was correct/incorrect (correct =1) during recall. The icons presented in 
the mVSWMT were chosen as they represent well-known objects of everyday life and are 
easily recognizable. 
a)
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b) 
Figure 3 
a) PsyMate™ momentary Visuospatial Working Memory Task (mVSWMT) encoding and recall phase.
b) Summary of icons presented in the PsyMate™ mVSWMT.
Debriefing questionnaire 
Participants received a debriefing questionnaire that focused on their general experiences 
during the ESM week (e.g., ‘Was this a normal week?’, ‘Did the PsyMate™ use influence your 
daily activities?’), the usability of the PsyMate™ (e.g., ‘Were the PsyMate™ instructions clear?’, 
‘Was using the PsyMate™ stressful?’), and their experiences with the PsyMate™ mDSST and 
mVSWMT (e.g., ‘To what extent was the task pleasant to perform?’, ‘Did you experience any 
technical difficulties?’). Both seven-point Likert scale questions and open-ended questions 
were used. 
Procedure 
Following informed consent, a one-hour briefing session took place at Maastricht University 
or at the participant’s home. Sociodemographic information was gathered (e.g., gender, age, 
living situation, education level, current occupation, and ethnicity) and additional information 
was asked on current medication use, earlier treatment for mental illnesses, and cognitive 
complaints. After these general assessments, either the PsyMate™ was installed on the 
participant’s smartphone device or the participant received an iPod with the latest PsyMate™ 
version installed. After checking the device settings for battery saving options and allowing 
push notifications, participants were instructed on how to use the PsyMate™ and the 
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cognition tasks. Test trials were completed to become acquainted with the ESM procedure. 
Participants started with their six-day ESM period on the following day. During the second 
day, participants were called to check whether the application was working properly and to 
clarify potential questions. After the ESM period, a one-hour debriefing session took place 
during which participants completed the debriefing questionnaire and provided specific 
feedback with regard to the two cognition tasks. 
Statistical analyses 
Participant characteristics, feasibility, and acceptability of both cognition tasks were assessed 
by means of descriptive statistics (frequencies). The completion rate was calculated by 
comparing the mean percentage of valid beep moments to the total number of beep 
moments. The data collected with the PsyMate™ have a multilevel structure; beeps (level 1) 
were nested within participants (level 2). Multilevel regression analyses were used to assess 
cognitive variation over time and to check for learning effects. Replication score was used as 
a proxy measure of time and consists of a sequence of beeps within subjects, ranging from 
1 (first beep) up to 48 (last beep).  Learning effects were examined by using hours to assess 
a within-day time effect and study day (day 1 to 6) to assess a between-day time effect. 
Correct/Incorrect (mVSWMT), the number of trials within the 30-seconds time interval 
(speed), and the percentage of correct trials (accuracy) (mDSST) were used as dependent 
variables and a log transformation of replication (time), hour and its quadratic function, and 
a log transformation of study day as independent variables. To assess contextualization, 
dummy variables were created for location (at home vs. somewhere else) and company 
(alone vs. with others). Activity-related stress was conceptualized as an average of the items 
‘I would rather be doing something else’, ‘This is difficult for me’, and ‘I can do this well’ (reverse 
coded). To assess the association between PA, NA, fatigue, activity-related stress, distraction, 
worrying, focusing, location, company, and sleep quality as independent variables and the 
cognition outcomes of the mVSWMT and mDSST as dependent variables, multilevel 
regression analyses were computed. Covariates in these multilevel models were quadratic 
age, gender, and possible learning effects as measured with the time variables. In order to 
investigate age effects, subgroup multilevel regression analyses were performed, splitting 
participants into a young group (<45 years) and an old group (45 years or older). 
Furthermore, Fischer-z transformations of by-subject Pearson’s pairwise correlations were 
calculated between the cognitive outcome measures. Analyses were carried out using Stata 
version 13.045.  A two-sided significance level of .05 was used throughout. 
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Results 
Participants 
Seventy-one individuals expressed their interest in the study, of which 66 met the eligibility 
criteria. From these individuals, seven were not allowed to use mobile phones during work, 
four individuals did not have enough time, one could not participate because no device was 
available, and three individuals did not reply after receiving the information. In total, 51 
individuals consented to be included, resulting in a 66% recruitment rate. 
From the 51 participants who provided informed consent, two participants were excluded 
because of current treatment for mental health problems. This left data from 49 participants 
and 1499 beep records. Data of five participants could not be used due to technical 
problems (beta release of the software: loss of 70 records (4.67%), n=3 transmission 
problems, n=2 broken devices), leaving a final dataset with 44 participants and 1429 valid 
beep records. On average, participants completed 34 out of 48 beeps (SD=7.03, range 17-
47), resulting in a completion rate of 71%. The age of the n=44 participants ranged from 19 
to 73 years with a median of 36 years (M=40, SD=14.82). Sixty-six per cent were women. 
Highest education level was skewed, with 6% having finished low education, 18% middle 
education, and 76% high education. Most participants had a fulltime job (61%), others 
worked part time (23%), studied (7%), took care of their own household (5%), or were retired 
(4%). 
Feasibility 
Evaluation of the PsyMate™ procedure 
Participants reported that the items represented their experiences well (M=5.70, SD=1.53), 
that the PsyMate™ was easy to use (reverse coded, M=1.25, SD=.78), and that the verbal and 
written instructions were clear (respectively M=6.86, SD=.41; M=6.84, SD=.48). The PsyMate™ 
did not influence their mood (M=2.11, SD=1.53), their activities (M=1.91, SD=1.01), or their 
social contact (M=1.91, SD=1.18). However, six people indicated that the ESM procedure 
could be unpleasant or annoying during work, meetings, or conversations. The number of 
beeps, the duration of a beep, and the sound had a low impact on the burden (respectively 
M=3.2, SD=1.79; M=2.61, SD=1.86; M=2.32, SD=1.62). Three people found the length of the 
questionnaire too long. 
Evaluation of the mVSWMT 
Participants reported that the mVSWMT was pleasant to use (M=5.05, SD=1.57), but rather 
difficult (M=4.61, SD=1.79). Six participants indicated that the interference questions 
between encoding and recall made the task difficult. Participants did not get distracted 
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during the task (M=2.93, SD=1.53) and were highly motivated to perform well (M=5.84, 
SD=1.16). They indicated that they made few inaccuracies (M=1.75, SD=1.28) and would 
recommend the task to others (M=5.25, SD=1.62). They provided some suggestions for 
further improvement, namely a longer encoding phase and a timer. Participants reported 
strategies to recall the icons: reading aloud (7 times), creating a story or a mnemonic (6 
times), remembering the icons and the location of the icons (5 times), and remembering the 
first, the middle, or the last row (6 times). 
Evaluation of the mDSST 
Participants reported that the mDSST was pleasant (M=5.66, SD=1.22) and easy to use 
(reverse coded, M=1.86, SD=.90). They were not distracted during the task (M=3.00, SD=1.43) 
and highly motivated to perform well (M=5.93, SD=1.13). Participants reported that they 
made few inaccuracies (e.g., tapping symbol X instead of symbol Y) (M=3.00, SD=1.54). 
Fourteen people commented that the size of the response buttons was too small, potentially 
leading to inaccuracies. Participants would recommend the task to others (M=5.82, SD=1.11). 
They provided some suggestions for further improvement: to increase the symbol and 
number size or rotate the screen horizontally. This was especially an issue for iPod users 
since the screen was smaller. 
Contextual factors 
Participants experienced high PA (M=5.08, SD=.69, range 3.35–6.66) and low NA (M=1.49, 
SD=.55, range 1.01–3.20). Furthermore, they felt moderately fatigued (M=3.01, SD=1.19, 
range 1–5.64), were a little worried (M=2.23, SD=1.15, range 1–5.43), and experienced low 
activity-related stress (M=2.44, SD=.56, range 1.61–3.69). Overall, participants reported a high 
level of focus during an activity (M=4.78, SD=.77, range 3.11–6.45) and experienced low to 
moderate distraction during the mDSST (M=2.79, SD=.88, range 1.05–4.53). Participants were 
alone in 29% of the time and in company 71% of the time. Furthermore, they spend 56% of 
the time at home and 44% somewhere else. According to the morning questionnaire, 
participants fell asleep after 5 to 15 minutes (40%) and woke up once during the night (34%). 
Participants slept well (M=5.25, SD=.80, range 3.46–7) and felt well rested at the start of the 
day (M=4.62, SD=1.03, range 2.67–6.65). 
Cognition in relation to contextual factors 
mVSWMT 
Overall, participants were correct in 37% of the mVSWMT assessments (SD=.16, range .07–
.74). There was no association between time (replication score) and the mVSWMT outcome, 
(B=.01, SE=.01, p=.32, 95% CI =-.01, .04), showing no within-day time effect (B=-.004, SE=.003, 
Digital assessments in everyday life 
177 
p=.17, 95% CI=-.01, .002), nor between-day time effect (B=.04, SE=.03, p=.17, 95% CI=-.02, 
.09), indicating no learning-effect. 
Participants made more mistakes when experiencing high PA (B=-.03, p=.04), when in 
company (vs. being alone; B=-.10, p<.001), and when being distracted (B=-.03, p=.001). Being 
able to focus during an activity resulted in more correct answers (B=.04, p<.001). NA, fatigue, 
activity-related stress, location, worrying, and sleep quality (morning questionnaire) were not 
associated with the mVSWMT outcome. More mistakes were made with higher age (B=-
.00005, p=.002), whereas gender was not associated. For all results, see supplementary 
materials B. 
To build the final multilevel regression model, a basis of PA, NA, and its interaction effect was 
extended with variables that were associated with the cognition outcome measure. No 
interaction effect was found between PA, NA, and the mVSWMT outcome. The effect of PA 
disappeared and participants again made more mistakes when in company (B =-.09, p=.002), 
when distracted (B=-.02, p=.03), and with older age (B=-.00006, p<.001). Being able to focus 
during an activity was associated with more correct answers (B=.05, p<.001). The results of 
this analysis indicated that the seven predictors explained 6% of the overall variance (3% 
within-subject variance and 28% between-subject variance). Results of the final model for 
correct/incorrect are presented in Table 1. 
Table 1 
Final model of the mVSWMT outcome correct/Incorrect 
Correct/incorrect 
B SE p 95% CI
Model  < .000* 
PA -.06 .03 .08 -.13, .01
NA -.06 .09 .48 -.25, .12
   PA x NA .01 .02 .33 -.03, .05 
   Focus .05 .01 < .001* .03, .07 
   Company$ -.09 .03 .002* -.14, -.03
   Distraction -.02 .01 .03* -.03, -.001 
   Age2 -.00006 .00002 < .001* -.00009, -.00002 
Note. PA = positive affect. NA = negative affect. PA x NA = interaction between positive and negative affect. Company$ = 
dummy variable of being alone versus with others. Age2 = quadratic function of age. CI = Confidence Interval. *p < .05.   
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mDSST 
Due to technical problems, 82 times (5.7%) the mDSST did not follow the ESM questionnaire. 
These records were removed, leaving a sample of 42 participants with 1347 beep records. 
Participants completed on average 12 trials (SD=2.57, min=7.21, max=16.83) within the 30-
second timeframe, with on average 97% accuracy (SD=1.81, min=92.29, max=100). 
Participants completed more trials over time (beep 1 vs. beep 48; B=.32, SE=.04, p<.001, 95% 
CI=.24, .40), showed no within-day time effect (B=.01, SE=.01, p=.12, 95% CI =-.003, .03), but 
more completed trials at later study days (B=.61, SE=.08, p<.001, 95% CI=.45, .76). Accuracy 
was not associated with time (B=.08, SE=.20, p=.71, 95% CI=-.32, .47), showing no within-day 
time effect (B=.05, SE=.04, p=.25, 95% CI=-.03, .13) nor between-day time effect (B=-.02, 
SE=.36, p=.96, 95% CI=-.72, .68). 
NA, activity-related stress, location, sleep quality, and gender were not associated with either 
cognitive outcome measure. Looking at speed, participants completed less trials when in 
company (B=-.29, p=.001), when being distracted (B=-.15, p<.001), and with older age (B=-
.001, p<.001). Furthermore, participants completed more trials when worrying (B=.09, p=.02). 
PA and being able to focus were not associated with speed. Looking at accuracy, participants 
made more mistakes when being tired (B=-.34, p=.007) and with more distraction (B=-.54, 
p<.001). Participants made less mistakes when they experienced more PA (B=.45, p=.03) and 
when they could focus better (B=.36, p=.01). Company was not associated with accuracy. For 
all results, see supplementary materials C. 
Again, the basic model was extended with variables that were associated with the mDSST 
outcome measures. In the final model of speed (see Table 2), mood showed no effect, and 
time and worry effects disappeared. Participants completed fewer trials when in company 
(B=-.18, p=.04), when being distracted (B=-.15, p<.001), and with older age (B=-.002 p<.001). 
The results of this analysis indicated that the nine predictors explained 48% of the overall 
variance (8% within-subject variance and 56% between-subject variance). 
In the final model of accuracy (see Table 3), the effect of fatigue and PA disappeared and no 
other mood effects were found. Participants made more mistakes when being distracted 
(B=-.51, p<.001). The results of this analysis indicated that the six predictors explained 3% of 
the overall variance (2% within-subject variance and 20% between-subject variance). 
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Table 2 
Final model of the mDSST speed outcome 
Speed 
B SE p 95% CI
Model  < .001* 
PA .04 .11 .74 -.18, .26
NA .01 .30 .97 -.57, .59
PA x NA -.02 .06 .81 -.14, .11 
Worry .06 .04 .14 -.02, .14
Company$ -.18 .09 .04* -.34, -.01
Distraction -.15 .02 < .001* -.20, -.10
Age2 -.002 .0002 < .001* -.002, -.001
Time$ .17 .10 .08 -.02, .37
Study day$ .34 .18 .06 -.02, .70
Note. PA = positive affect. NA = negative affect. PA x NA = interaction between positive and negative affect. Company$ = 
dummy variable of being alone versus with others. Age2  = quadratic function of age. Time$ = log-transformed replication 
score. Study day$  = log-transformed day of study score. CI = Confidence Interval. *p < .05.   
Table 3 
Final model of the mDSST accuracy outcome 
Accuracy
B SE p 95% CI
Model  < .001* 
PA -.22 .50 .67 -1.19, .76
NA -1.15 1.28 .37 -3.66, 1.36
PA x NA .25 .28 .37 -.30, .81
Fatigue -.22 .14 .13 -.50, .06
Focus .14 .15 .34 -.15, .44
Distraction -.51 .11 < .001* -.72, -.30
Note. PA = positive affect. NA = negative affect. PA x NA = interaction between positive and negative affect. CI = 
Confidence Interval. *p < .05.   
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Young vs. older age and cognition 
In order to gain more insight into age effects, exploratory subgroup analyses were performed 
for both cognition tasks. Splitting age groups for the mVSWMT data resulted in n=26 (59%) 
in the young group (<45 years) and n=18 (41%) in the older age group (45 years or older). In 
both groups, being able to focus resulted in more correct answers (young age: B=.05, p<.001; 
older age: B=.04, p=.01). However, in the older group, participants made more mistakes when 
being in company (B=-.13, p=.001) and with increasing age (B=-.00007, p=.047). 
With the mDSST data, data from two participants were excluded due to technical problems 
(see section 3.4.2), leaving n=26 in the young group (62%) and n=16 in the older age group 
(38%). Results for speed remained largely the same in both groups, showing a main effect of 
distraction with higher distraction resulting in more mistakes. A similar result was found in 
both groups for accuracy, where higher distraction resulted in fewer trials. The difference 
was that the younger group completed more trials over time (B=.30, p=.047). The older group 
did not show a time effect on number of beeps (log-transformed replication score), but 
completed more trials over study days (B=.47, p=.02) and when PA was higher (B=.33, p=.04). 
In addition, fewer trials were completed when being in company (B=-.22, p=.02), and with 
increasing age (B=-.001, p<.001) within the older group but not the younger group. Results 
of the subgroup analyses are presented in supplementary materials D. 
Correlations between mVSWMT and mDSST 
Fisher-z transformations of by subject pairwise correlations were used between the 
mVSWMT outcome correct/incorrect, and the mDSST outcomes speed and accuracy. Over 
subject averages, there were no significant correlations between correct/incorrect and speed 
(z=1.36, p=.09), nor accuracy (z=-0.35, p=.64). 
Discussion 
Feasibility of the momentary cognition tasks 
This study confirms the feasibility of two newly developed momentary cognition tasks within 
the PsyMate™ app in healthy individuals. The completion rate was high (71%) and is in line 
with other ESM studies with and without cognition tasks46,47. Furthermore, participants 
overall experienced the cognition tasks as pleasant and were motivated to perform well. 
Although entertaining, the mVSWMT was experienced as difficult. In only 37% of the 
mVSWMT assessments the icon location was remembered correctly, with a range from 7% 
to 74% between participants. Differences may reflect the use of strategies, such as thinking 
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of an ‘icon-story’ or trying to group the icons per row. In other momentary visuospatial 
working memory studies, participants identified the correct location(s) in 90% of their 
responses26,27,29. In these studies, neutral circles in a grid were presented while meaningful 
icons were used in the mVSWMT (see Figure 3 b). Remembering the location combined with 
the meaning of the icon requires a higher cognitive demand. The choice for the here-used 
icons was made to test a greater working memory capacity48,49. Furthermore, the meaningful 
icons were expected to motivate the participant, which was confirmed by the positive 
feedback (see section 3.2.2). Participants responded randomly on the interference items to 
perform better on the mVSWMT. Prospectively a different interference29 should be 
considered. For example, a fixed timer could be applied to standardize the interference 
between encoding and recall. 
In contrast, participants experienced the mDSST as easy, which resulted in a ceiling effect for 
accuracy (97% correct). This high accuracy is in line with another digital processing speed 
task named the Colour-Shape Test, where participants answered correctly in 97% of the 
attempts15. In the paper-pencil DSST version, participants also make little mistakes reflected 
by a high accuracy, while the speed outcome proves more sensitive to cognitive variations42. 
The mDSST speed performance varied between and within subjects, which indicates this 
outcome to be suitable in detecting momentary cognitive fluctuations.  
These feasibility results confirm that both tasks are appropriate, but need fine-tuning. For 
instance, the font size could be increased or the screen rotated to further improve the 
mDSST. Nevertheless, some limitation need to be acknowledged. In the mVSWMT analyses, 
the position of the icons could not be taken into account due to technical limitations. 
Descriptive background analysis revealed that a slight primacy and recency effect appeared, 
as participants remembered the first or last icons slightly more often. The discrepancy 
between identified location and actual location may be an interesting aspect of a momentary 
working memory task in the future. Additionally, the sample was healthy and highly educated 
resulting in limited generalizability of the feasibility results. Next steps may include testing 
the adjusted mDSST and mVSWMT in a more diverse healthy and clinical populations. 
Validity of momentary cognition tasks through contextualization 
The validity was demonstrated by relating cognitive performance with intrapersonal factors 
(e.g., mood, fatigue, stress, sleep-related outcomes) and contextual factors (e.g., being in 
company of others) to evaluate and understand momentary cognitive performance. 
Surprisingly, mood and fatigue had no effect on cognitive performance. One explanation 
could be that the participants were healthy, well rested, and overall in a positive mood (see 
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section 3.3). Timmers, Maeghs, Vestjens, Bonnemayer, Hamers, Blokland 32 also found no 
indication for an effect of fatigue on cognition (i.e., short-term memory) in healthy young 
adults. Previous findings on the relation between mood and cognition in daily life are 
inconclusive. While one study found no association between changes in mood and cognitive 
functioning35, another study reported that higher positive mood resulted in less interference 
during an emotional Stroop task36. Stronger associations may appear in clinical 
populations18,25. 
Individual performance on the mVSWMT and mDSST was diminished when distracted and in 
social company. Logically and confirmed by experiments, distraction has a negative influence 
on cognitive performance50. The negative influence of being in company was also previously 
reported: von Stumm 35 argues that being alone may help to focus one’s attention and thus 
improve cognitive performance. In contrast, it cannot be assumed that social context truly 
lowers a person’s cognitive ability. This result may rather be related to variations in situational 
demands35. In the present study, participants were in company in 71% of the time. Hence, 
future studies may take the potentially mediating factors of company and distraction into 
account when analyzing momentary cognitive fluctuations. 
Age sensitivity was found for both tasks with associations between age and visuospatial 
working memory and processing speed in everyday life. As expected51, younger adults 
performed better. It is important to disentangle the cognitive decline in performance from 
an assessment bias. Compared to younger adults, older adults tend to experience 
technologies as less easy to use52. Additionally, older adults may have impaired hearing or 
vision, potentially affecting the usability and thus outcomes of technology-based 
assessments. Previous studies, however, confirmed the feasibility, reliability, and validity of 
digital assessments in the elderly13,15,28. All participants became better over time, but the 
learning curve was steeper for younger adults than for older adults. Learning effects were 
reported in previous mobile cognition tasks and may not affect sensitivity negatively28. 
Descriptive background analysis revealed that learning stabilized after 10 to 15 beeps and a 
steady state is reached within the first days of the study. 
The non-significant correlation between the two momentary tasks suggests that different 
cognitive domains are measured, namely processing speed (mDSST) and visuospatial 
working memory (mVSWMT). This finding is in line with previous research that also found no 
correlation between momentary working memory and processing speed, possibly due to the 
unreliability of one task35. Strategy use was different between the two momentary tasks in 
this study. The lack of correlation could be due to a different approach in both tasks, 
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hindering a comparison of cognitive performance per se. It is expected that the current tasks 
will correlate after adjustment are made and when tested in a clinical sample with cognitive 
complaints. If no correlation shows, it might be that strategy use is moderating cognitive 
performance.  
The present validation study did not focus on correlations with traditional 
neuropsychological tests. However, an in-house (unpublished) trial with 50 healthy 
participants showed that outcomes of a two-minute mDSST and paper-pencil DSST 
correlated (partial r=.50, p<.001). Participants reported that the digital version was slightly 
more difficult, as learning the digit-symbol combinations was challenging and the next 
number could not be anticipated. This preliminary finding provides initial evidence that the 
30-second mDSST measures processing speed, but needs extension to confirm construct 
validity. 
Overall, these validity findings can be seen as a proof of concept for the contextualization of 
momentary cognitive performance. Future research is needed to disentangle the complex 
interaction between mood, context, and cognition further. In addition, limitations include not 
taking the education level and the relation with traditional neuropsychological tests into 
account as part of the validation. Furthermore, the developed tasks are still artificial7, in the 
sense that individuals normally do not perform these tasks, but actually search for their keys 
or process information to plan their days. 
Next steps are the final adjustments of the app and testing both tasks in populations with 
different cognitive profiles. Clinical populations may include people with schizophrenia, 
major depression, or brain damage. Furthermore, situations that influence the cognitive 
performance such as tiredness, alcohol use, or medication intake may provide relevant 
insight into the validity of the tasks. Cognitive assessments in everyday life, in combination 
with momentary sampling of mood and context, may prospectively give individuals more 
insight into their functioning and thus support self-management and planning. This study is 
an important step in the anticipated personalization of holistic mobile health6. 
Suggestions for future development and use of momentary cognition tasks 
Reflecting on the overall development and use of the mDSST and mVSWMT, a number of 
lessons were learned and can be implemented in future studies (see Table 4). Most 
momentary cognition tasks are inspired by traditional neuropsychological tests. A direct 
translation can be problematic due to the variability of everyday life that needs repeated 
assessments in complex environments. Smartphone assessments can offer new possibilities 
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for task development and use. Furthermore, input from a multi-disciplinary team involving 
neuropsychological healthcare professionals and ESM experts should guide the 
development. Other stakeholders, including clinicians and patients, should be consulted 
during development and evaluation. The participant’s self-report and observations of the 
technology use53 can provide insights into their perspective and experience when measuring 
momentary cognition within an ESM paradigm. 
Gamification is a strategy to increase motivation. An example of gamification to measure 
cognition is the Sea Hero Quest smartphone app (www.seaheroquest.com). Participants 
orient themselves in a virtual sea world and get rewards when performing well. This quest 
may be a valid method to asses navigation skills in a fun way54, however, it may be less suited 
for clinical practice were repeated assessments of cognitive performance are interwoven 
with assessments of mood and context. It is important to strike a balance between a 
thoughtful completion of the ESM items and the competitiveness and enjoyment of a 
cognitive performance task. 
Testing the cognition task in a healthy sample is a useful way to test feasibility and validity26,32. 
Adjustments can be made before introducing the task to a more vulnerable clinical 
population. A benefit of ESM is that individuals can be their own controls and performance 
can be compared within one dataset8,55.  
Another aspect to consider is the beep frequency. While a high intensity may reveal more 
fluctuations, beep length and time investment need to be considered. The beep length 
should not exceed a couple of minutes to prevent interference with everyday life. Potentially, 
tasks can alternate at random across assessments to minimize fatigue effects. In general, 
participant’s experience should be explored and if necessary, guide task adjustments when 
feelings of over- or under stimulation appear. Further, task difficulty may be tailored to the 
individual’s ability. Ideally, momentary assessment promotes a flow in everyday life. Tasks 
should remain challenging when users reach a level of experienced achievement that relates 
to the individual’s overall cognitive ability (e.g., being correct in 70% of the cases). The right 
difficulty level can prevent a loss of motivation and simultaneously preclude frustration or 
even resentment56,57. Prospectively, studies may consider automatically adjusting the level 
based on an individual’s performance. 
When implementing momentary cognition tasks, the sampling duration needs to be tailored 
to the research or clinical question. Examples include single case assessments running over 
months or years, where continued experience sampling can illustrate useful insight into the 
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course of a disease58,59. In the assessment process at memory clinics, weeklong momentary 
cognition tasks can supplement traditional neuropsychological test batteries and provide 
information on cognitive fluctuations in everyday life13. Side effects of new medications may 
furthermore be detected when using momentary cognition tasks parallel to the dose 
adjustments of drugs17. Finally, in rehabilitation centers, e.g., after brain damage, momentary 
cognition tasks may determine the effectiveness of the treatment when applied before and 
after a program. Insight into momentary cognitive fluctuations in context can be used to 
provide individuals with feedback and guidance to deal with cognitive complaints in daily life. 
Table 4 
Suggestions for future task development and use 
Suggestions for momentary cognition tasks 
Task development Task use 
 Involve a multi-disciplinary team
 Orientate concepts on traditional
neuropsychological tests
 Balance enjoyment/gamification with
context information (experiences and
physical context)
 Ideal outcomes need to show clinically
relevant within- and between-subject
variance, be age-sensitive, and show no
ceiling-effect
 Use comparison data to determine
between-subject variance; within-subject
data serves as its own control
 Tailor beep frequency and sampling
duration to the research/clinical question
 Balance length and number of tasks, and
additional momentary items
 Limit assessment time (e.g., 2 minutes)
 Adjust difficulty levels to individual
abilities to prevent frustration and
maintain motivation
 Consider momentary context during
interpretation (e.g. distraction)
 Consider learning-effects (particularly in
early trials)
Conclusions 
Momentary cognition tasks aim to depict fluctuation of cognitive performance in everyday 
life and hold promise for future research and clinical use. Prospectively, the task application 
needs to be extended, for example into different cognitive domains or patient populations. 
Furthermore, the interaction with other intrapersonal factors requires further 
disentanglement. Next steps can be guided by the suggestions resulting from this study such 
as involving a multi-disciplinary team, tailoring the set-up to the individual, and balancing the 
level of enjoyment and seriousness. 
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Supplementary materials 
Table A.1 
Experience sampling protocol: Beep questionnaire  
Item 7-point Likert scale or categorical options 
1 I feel cheerful 1 = not at all 4 = moderate 7 = very much 
2 I feel energetic 1 = not at all 4 = moderate 7 = very much 
3 I feel insecure 1 = not at all 4 = moderate 7 = very much 
4 I feel relaxed 1 = not at all 4 = moderate 7 = very much 
5 I feel down 1 = not at all 4 = moderate 7 = very much 
6 I feel irritated 1 = not at all 4 = moderate 7 = very much 
7 I feel satisfied 1 = not at all 4 = moderate 7 = very much 
8 I feel lonely 1 = not at all 4 = moderate 7 = very much 
9 I feel enthusiastic 1 = not at all 4 = moderate 7 = very much 
10 I feel anxious 1 = not at all 4 = moderate 7 = very much 
11 I feel guilty 1 = not at all 4 = moderate 7 = very much 
12 I’m worrying about things 1 = not at all 4 = moderate 7 = very much 
13 mVSWMT instruction screen 
mVSWMT part 1: encoding 
14 I think I remembered it all 1 = not at all 4 = moderate 7 = very much 
15 I generally feel well at the moment 1 = not at all 4 = moderate 7 = very much 
16 mVSWMT instruction screen 
mVSWMT part 2: recall 
17 What am I doing (right before the beep) 
work, school/ housekeeping/ self-care/ relaxing/ 
sport, movement/ eating, drinking/ traveling, on 
the road/ having a conversation/something 
else/nothing 
18 I can do this well 1 = not at all 4 = moderate 7 = very much 
19 This is difficult for me 1 = not at all 4 = moderate 7 = very much 
20 I would rather be doing something else 1 = not at all 4 = moderate 7 = very much 
21 I am focused 1 = not at all 4 = moderate 7 = very much 
22 Where am I (just before the beep) 
at home/at someone else’s home/work, school/ 
public space/ on the road/ somewhere else 
23 Who am I with (just before the beep) 
partner/ family/ housemates/ friends/ 
colleagues/ acquaintances/ strangers, others/ 
nobody 
24a Company: I like this company 1 = not at all 4 = moderate 7 = very much 
25a Company: I would rather be alone  1 = not at all 4 = moderate 7 = very much 
24b Alone: I like being alone 1 = not at all 4 = moderate 7 = very much 
25b Alone: I would rather be in company 1 = not at all 4 = moderate 7 = very much 
26 I don’t feel well 1 = not at all 4 = moderate 7 = very much 
27 I am tired 1 = not at all 4 = moderate 7 = very much 
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28 Since the last beep I have used 
alcohol/ medication/ coffee, caffeine/ smoking, 
nicotine/ cannabis/ other drugs/ nothing 
29 mDSST instruction screen 
mDSST  30-seconds timeframe 
30 I got distracted during the task 1 = not at all 4 = moderate 7 = very much 
31 This beep disturbed me 1 = not at all 4 = moderate 7 = very much 
31 Thanks! 
Table A.2 
Experience sampling protocol: Morning questionnaire 
Item 7-point Likert scale or categorical options 
1 I generally felt well today 1 = not at all 4 = moderate 7 = very much 
2 I generally felt tired today 1 = not at all 4 = moderate 7 = very much 
3 I generally felt tense today 1 = not at all 4 = moderate 7 = very much 
4 I generally worried a lot today 1 = not at all 4 = moderate 7 = very much 
5 I generally could concentrate well today 1 = not at all 4 = moderate 7 = very much 
6 I generally felt forgetful today 1 = not at all 4 = moderate 7 = very much 
7 Goodnight! 1 = not at all 4 = moderate 7 = very much 
Table A.3 
Experience sampling protocol: Evening questionnaire 
Item 7-point Likert scale or categorical options 
1 How long did it take before I fell asleep 
last night? 
0-5 minutes/ 5-15 minutes/ 15-30 minutes/  
30-45 minutes/ 45 minutes-1 hour/ 1-2 hours/ 
2-4 hours/ >4 hours 
2 How often did I wake up last night? 0/1/2/3/4/5/>5 
3 How long did I lie awake this morning 
before getting up? 
0-5 minutes/ 5-15 minutes/ 15-30 minutes/  
30-45 minutes/ 45 minutes-1 hour/ 1-2 hours/ 
2-4 hours/ >4 hours 
4 I slept well 1 = not at all 4 = moderate 7 = very much 
5 I feel well rested 1 = not at all 4 = moderate 7 = very much 
6 I am looking forward to this day 1 = not at all 4 = moderate 7 = very much 
7 Thanks! 1 = not at all 4 = moderate 7 = very much 
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Table B 
Individual multilevel regression analyses of mood, context, and sleep quality on the mVSWMT 
outcome correct/incorrect 
Correct/Incorrect
B SE p 95% CI
Positive affect  -.03 .02 .04*  -.06, -.001 
Negative affect -.0003 .03 .99 -.05, .05 
Worry .002 .01 .89 -.02, .02
Fatigue -.01 .01 .54 -.02, .01
Focus .04 .01 <.001* .02, .06
Activity-related stress -.01 .01 .49 -.03, .02 
Company$ -.10 .03 <.001* -.16, -.05
Location$ -.02 .03 .38 -.07, .03
Distraction -.03 .01 .001* -.04, -.01
Time until sleep .01 .01 .23 -.01, .04
Number of wake-ups -.005 .01 .67 -.03, .02 
Slept well .01 .01 .47 -.01, .03
Well rested .005 .01 .65 -.02, .03 
Age2 -.00005 .00002 .002* -.00009, -.00002 
Gender -.04 .05 .47 -.14, .06
Note. Company$ = dummy variable of being alone versus with others. Location$ = dummy variable of being at home 
versus somewhere else. Age2  = quadratic function of age. CI = Confidence Interval. *p < .05.   
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Table C 
Individual multilevel regression analyses of mood, context and sleep quality on the mDSST 
outcomes speed and accuracy 
Speed Accuracy
B SE p 95% CI B SE p 95% CI 
PA -.01 .05 .90 -.11, .10 .45 .21 .03* .03,  .87 
NA -.05 .10 .61 -.24, .14 -.39 .34 .25 -1.04, .27 
Worry .09 .04 .02* .01, .17 -.20 .15 .17 -.50, .09 
Fatigue -.02 .03 .46 -.09, .04 -.34 .12 .007* -.58, -.09 
Focus .02 .03 .50 -.04, .08 .36 .14 .008* .09, .63 
Act-stress$ .05 .04 .18 -.03, .13 -.14 .18 .44 -.48, .21 
Company$ -.29 .09 .001* -.46, -.12 -.003 .39 .99 -.77, .76 
Location$ -.09 .08 .26 -.25, .07 .34 .36 .34 -.36, 1.05 
Distraction -.15 .02 <.001* -.20, -.10 -.54 .41 <.001* -.74, -.33 
Time-sleep$ -.04 .04 .32 -.11, .04 -.07 .17 .67 -.40, .25 
Wake-ups$ -.01 .04 .82 -.08, .07 -.08 .16 .63 -.40, .24 
Slept well -.01 .04 .84 -.08, .07 -.16 .17 .35 -.49, .17 
Well rested .01 .04 .86 -.07, .08 .08 .16 .62 -.24, .40 
Age2 -.001 .0002 <.001* -.002, -.001 .0002 .0002 .47 -.0003, .0006 
Gender .47 .85 .58 -1.19, 2.14 .71 .58 .23 -.44, 1.85 
Note. PA = positive affect. NA = negative affect. Act-stress$ = activity-related stress. Company$ = dummy variable of being 
alone versus with others. Location$ = dummy variable of being at home versus somewhere else. Time-sleep$ = time 
until sleep. Wake-ups$ = number of wake-ups at night. Age2 = quadratic function of age. CI = Confidence Interval. *p < 
.05.  
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Table D.1 
Subgroup analyses on age for the mVSWMT outcome correct/incorrect 
< 45 years of age 45 years or older  
B SE p 95% CI B SE p 95% CI 
Model < .001*  < .001* 
PA -.08 .05 .08 -.18, .009 -.01 .06 .88 -.14, .12 
NA -.10 .11 .36 -.32, .12 .11 .22 .62 -.32, .54 
PA x NA .02 .03 .56 -.04, .07 -.03 .04 .55 -.11, .06 
Focus .05 .01 < .001* .02, .08 .04 .02 .01* .008, .07 
Company$ -.05 .04 .21 -.13, .03 -.13 .04 .001* -.21, -.05 
Distraction -.02 .01 .11 -.04, .004 -.01 .01 .22 -.04, .009 
Age2 -.00005 .00009 .55 -.0002, .0001 -.00007 .00004 .047* -.0001, -1.13e-06 
Note. PA = positive affect. NA = negative affect. PA x NA = interaction between positive and negative affect. Company$ = 
dummy variable of being alone versus with others. Age2 = quadratic function of age. CI = Confidence Interval. *p < .05.   
Table D.2 
Subgroup analyses on age for the mDSST speed outcome 
< 45 years of age 45 years or older  
B SE p 95% CI B SE p 95% CI 
Model <.001*  <.001* 
PA -.05 .17 .77 -.37, .28 .33 .16 .04* .02, .63 
NA -.27 .39 .49 -1.04, .49 1.01 .53 .06 -.02, 2.05 
PA x NA .03 .09 .74 -.14, .20 -.17 .11 .10 -.38, .04 
Worry .10 .06 .10 -.02, .21 -.01 .05 .78 -.12, .09 
Company$ -.17 .13 .20 -.43, .09 -.22 .09 .02* -.40, -.03 
Distraction -.19 .04 <.001* -.26, -.13 -.08 .03 .004* -.13, -.02 
Age2 -.0007 .001 .57 -.003, .002 -.001 .0003 <.001* -.002, -.0008 
Time$ .30 .15 .047* .004, .59 .009 .11 .94 -.21, .23 
Study day$ .24 .28 .40 -.31, .78 .47 .21 .02 .07, .88 
Note. PA = positive affect, NA = negative affect. PA x NA = interaction between positive and negative affect. Location = 
dummy variable of being at home versus somewhere else. Company$ = dummy variable of being alone versus with 
others. Age2 = quadratic function of age, Time$ = log-transformed replication score. Study day$  = log-transformed day 
of study score. CI = Confidence Interval. *p < .05.  
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Table D.3 
Subgroup analyses on age for the mDSST accuracy outcome 
< 45 years of age 45 years or older  
B SE p 95% CI B SE p 95% CI 
Model .004*  .003* 
PA -.86 .68 .21 -.2.18, .47 .88 .91 .34 -.91, 2.67 
NA -1.92 1.57 .22 -5.004, 1.15 1.11 3.11 .72 -4.98, 7.20 
PA x NA .37 .36 .30 -.34, 1.08 -.15 .61 .80 -1.36, 1.05 
Fatigue -.34 .20 .10 -.74, .06 -.08 .20 .70 -.47, .31 
Focus .25 .21 .23 -.15, .65 -.02 .22 .93 -.45, .41 
Distraction -.44 .15 .003* -.73, -.15 -.57 .16 <.001* -.88, -.27 
Note. PA = positive affect. NA = negative affect. PA x NA = interaction between positive and negative affect. CI = 
Confidence Interval. *p < .05.   
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General discussion
Variability is an important factor to understand what is going on in someone’s life. People 
continuously navigate in changing environments and are subject to a multitude of 
impressions over short amounts of time. Not only the outside world changes. Internal 
dynamics, involving mood and cognition, are equally relevant. The experience sampling 
method (ESM) is a powerful assessment tool that can help to grasp the individual variability 
of internal mental states and external context factors. It has a long tradition in academia and 
in scientific research1,2. The central aim of this thesis is to explore the use of ESM in clinical 
practice and expand its scope to mental health services. This discussion focusses on the 
main findings and their implications, the lessons-learned and the future steps towards new 
horizons of good clinical practice.  
Individual landscapes 
PsyMate™ is an online ESM platform including an app, a data cloud-based data solution, and 
a reporting tool (https://www.psymate.eu). It allows persons to collect data and access their 
data online, using a secure website. Reviewing their own data allows people to make sense 
of mental state variability, a process that becomes meaningful when more ESM assessments 
are collected. Feeling cheerful most likely varies somewhat during a day. The reporting 
module presents the mental state at each moment, as a dot on a line. Sometimes, patterns 
start to appear. Activities, places, and current company may also vary across time. Feedback 
on these patterns (depicted as pie charts and called time budgets) can increase insight. For 
instance, it is possible to see in what activities a person engages in most. Clinically, combining 
mental state variability with context (time, place, activity, and people) is most relevant. 
Imagine that someone wonders if their effort to go outside also results in higher positive 
mood. The scores on feeling cheerful can then be paired with the time budget of location. 
Bar charts indicate the level of cheerfulness when being outside, and compare these with 
other situations. An illustration of reporting module is presented in chapter 5. A high average 
score of cheerfulness when being outdoors can yield the clinically relevant hypothesis that 
this is a preferred context. Such hypotheses can be explored during therapy, for instance by 
instructing the subject to spend more time outdoors. Iteratively, this process can improve 
global well-being. 
The above-mentioned description of the PsyMate™ reporting page illustrates how a personal 
landscape can be explored. A well-designed user interface is crucial to facilitate the 
exploration process and allow users to make sense of the data3. There are different ways to 
present the data and researchers continually collect feedback from the field. With contracted 
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designers, the reporting tool is periodically updated. The actual tool allows exploring different 
mood states. To contrast simple situations is a powerful method for creating awareness and 
insight, as demonstrated in the papers presented in part I of the thesis. The best illustration 
is the personal story presented in chapter 5, were the PsyMate™ is used for two years during 
the recovery of depression. These clinical explorations have let me to realize how important 
ESM can be for clinical practice. While collecting repeated assessments can be intrusive and 
burdensome, much is acceptable and motivation increases when the data is meaningful.  
ESM feedback as hypothesis generating 
Being able to see one’s own mood patterns in relation to one’s environment, without having 
to reconstruct these patterns from the mind is a great advantage. However, there is a risk 
that patients and clinicians misinterpret the data. As researchers and developers of these 
tools, we are responsible for the way we present data and confusion should be avoided. 
Patients might not be aware that differences lack significance and consequently over-
interpret the data. The question rises if enough data is available to warrant conclusions with 
enough power. Patterns in sets of only ten assessments are more uncertain than patterns 
in fifty assessments. Often, even more observations are needed to reliably assess computed 
indicators of health and the actual number needed is related to the living circumstances of 
subjects. In chapter 6 (part II), Monte Carlo simulations were used to find out how much 
assessments are needed to calculate a stable reward-related quality of life statistic. The study 
demonstrates that often more assessments are needed (> 100) than are available in a 
standard high frequency sampling week (< 60). Differences were found between persons. 
Individuals who spend more time at home and alone need fewer assessments than persons 
with more varying situational patterns. This statistical exploration reminds us that it is difficult 
and challenging to explore daily life. When patients (but also clinicians) explore and interpret 
the patient’s ESM results, additional coaching is necessary.  
It is important to realize that information is only partial information, especially in (predicting) 
human behavior. People live in a dynamic world and are in constant interaction with their 
environment. There are many unknowns when anticipating future mental states. This does 
not mean that data collection is useless and efforts towards a global, holistic understanding 
of the ecological reality in which individuals operate are fruitless. However, some caution is 
justified. Users should be conscious of the correlational nature of the data. Observed 
patterns are probabilistic, making deterministic interpretations tempting. Users should judge 
results in an open-minded manner and consider them as hypotheses ripe for testing. This 
hermeneutic exploration is a repeating, iterative process. In research, this exploration is best 
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done using a multimethod strategy, sometimes including experimental manipulation4. In 
clinical practice, a good hypothesis is often sufficient to act because the impact can be 
evaluated and adjustments made during treatment. ESM feedback can be viewed as a 
hypothesis-generating assessment instrument. It invites the individual to explore emerging 
patterns and provides clues for improving the personal health2,5. Clinical practice is enriched, 
because clinicians and patients gain a better understanding of what is going on. This 
contrasts with the classic static approach of diagnostics that tries to understand why 
complaints emerge5. This classical approach however, does not result in real etiological 
knowledge. The attempt is categorical at best and clinically rather futile (see the introduction). 
Meaningfulness of ESM feedback 
In an effort to enrich the clinical meaningfulness of ESM data, I have visited the Center for 
Self-Report Science at the University of Southern California in Los Angeles. This research 
group chaired by Arthur Stone – a pioneer in ESM research, develops expertise to improve 
accurate and reliable self-reports. They perform valuable work in the field of public health, 
exploring alternative ways of calculating outcome measures (for example in pain research) 
to increase their clinical value6-8. We worked together on a longitudinal single case ESM 
dataset, collected in a naturalistic way as part of a recovery process from depression (see 
chapter 5). The goal during the work visit was to better understand the approaches used in 
Los Angeles to process data. We focused on how to recognize patterns from data and to 
assess whether these patterns were clinically meaningful. Possibly, the PsyMate™ reporting 
page (used to view ESM data) could be enriched with new algorithms that help visualizing 
state changes during treatment.  
The case data contained 868 unique assessments, collected over 209 days. Over that period, 
different interventions occurred: repeated medication switches, psychotherapy, and self-
guided treatment such as daily exercises and vitamin use. When ESM is used for a long time, 
multiple patterns emerge in the data. Showing and understanding patterns of increased 
positive mood in different situations was relatively straightforward. It was much harder to 
pinpoint when a different state, episode, or recovery phase starts. The changes do not always 
relate to interventions and effects shift in time. State differences are ambiguous and relate 
to treatment-independent events in someone’s life9. Observed differences might be 
triggered by changed circumstances or accumulated stress and are not the consequence of 
treatment choices per se. These complexities make it a challenge to preprocess the data in 
an online reporting module, to facilitate clinical decision-making.  
General discussion 
201 
In this case study, medication switched four times at recorded moments. This allows the 
mapping of medication windows over the data to assess mood changes or context changes 
(outcome). We chose to focus on positive and negative mood and calculated the mean and 
standard deviation over time intervals. We explored whether different ways to characterize 
the data provided other clinical meaningful information for the assessment of medication 
effects. Additionally, a synchronicity score between positive and negative mood (based on 
correlations) and a measure of mixed-emotions (using the lowest mood value) was 
calculated. Epochs of one week yielded sufficient observations for a reliable momentary 
assessment and assessments of change in the 200+ day monitoring period.  
The results of this exercise showed high weekly variability among all indices and differences 
emerged between medication types. Furthermore, each of the indices provided unique 
information. However, the results were not very transparent and interpretation of its clinical 
meaning remained challenging. In such a long period of data collection, chaos emerges and 
formulating a clear message that is understandable for the average person is difficult. It 
might be that conclusions would be easier if the data stabilized in the end (as was not the 
case here). However, in clinical practice a true stable state is rare9. Maybe the above-
mentioned indices are the wrong outcome measures for good clinical communication. A 
focus on contextual changes might yield better insights. For now, the strength of ESM 
feedback lies in the exploration of shorter periods, with a linear evolution. Episodic patterns 
remain challenging.  
Daily cognitive assessments 
Cognition, mood, perceptions and behavior are central elements in psychology. Traditional 
ESM assessment focusses on behavior and mood10,11. A narrow focus on mood within 
psychopathology can lead to bias12. ESM has been widely used for mood assessments in 
relation to behavior, but is less used to assess cognitions or perceptions (except for 
hallucinations in psychosis research). Assessment of cognition, a relevant domain in mental 
health, remains unexplored (or underexplored). This thesis intends to broaden the clinical 
usefulness of ESM by adding cognition measures. Multi-domain assessments fit well into the 
new health definition and the new healthcare movement (chapter 1). 
Cognition is a relevant health domain that deserves attention in daily assessments. In mental 
healthcare, cognitive functioning plays a central role, in part because cognitive skills can vary 
over time13,14. Psychopathological complaints often co-occur with or lead to compromises in 
cognitive performance15. In psychosis-spectrum disorders or mood disorders, lowered 
cognitive functioning is even regarded as a core symptom16,17. In addition, cognitive 
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complaints often remain after symptomatic remission18. These lingering cognitive complaints 
can challenge recovery.  
Traditionally, cognition is measured with large test-batteries, at specific moments in time and 
in controlled and standardized settings19. These assessments provide valuable information 
on state performance across cognitive domains, but fail to provide insight into cognitive 
fluctuations. In clinical practice, it is helpful to know when someone struggles to perform a 
task or when performance is actually going well. Insight in these dynamics with attention to 
the role of mood and environments can be helpful for patients, allowing them to adjust their 
daily life accordingly. Part III focused on enriching ESM data with momentary cognitive 
assessments and evaluating its benefit for future use in clinical practice.  
Several short mobile cognitive tasks were conceptualized, developed, and tested for 
repeated assessments in the flow of daily life. Feasibility and initial validity were critically 
evaluated and the objective cognitive measurements seem promising in this regard. 
However, we are still in the initial stage of development and implementation. Correlational 
outcomes are found between mood, context and cognitive performance20. For example, 
people seem less able to perform well when in company or when tired. Knowledge on the 
causality of the correlations is still lacking. What do we measure when we find these 
outcomes? Is being tired actually leading to a decrease in cognitive performance or are 
people just less inclined to engage in the cognitive assessment? Choice of strategy was an 
important determinant in a momentary visuospatial memory task (chapter 9). This could 
potentially confound a conclusion on cognitive performance. Generalization needs to be 
determined and further research is needed to disentangle the different elements underlying 
outcomes.  
The presented studies do not directly examine concurrent validity with traditional 
neuropsychological assessments. This step is important in order to understand the cognitive 
domains better. For daily cognitive assessments, do we need a cognitive measure for each 
cognitive domain or is it enough to have a general measure that can inform on cognitive 
performance fluctuations? Alternatively, maybe it is enough to have one good task that taps 
into neurocognitive functioning and one that taps into social cognitive skills, as is presented 
in chapter 7. There seems to be merit in these developments, but more research is needed 
before ESM is ready to be extended with objective cognition measures in clinical practice. It 
is highly recommended, however, to add subjective cognition items to an ESM questionnaire. 
Assessing fluctuations in concentration or memory already provide valuable insight for 
patients and are of clinical use21.  
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Where do we stand with ESM in clinical practice? 
ESM in its current form is particularly useful to monitor different health-related domains in 
daily life5. Assessments are possible on mobile phones and can be person tailored2. 
Moreover, the research in this thesis helped to promote ESM as an mHealth tool for regular 
clinical practice. Further development remains necessary. The representation of the data to 
patients and clinicians in the reporting tool should be simplified and more transparent. 
However, ESM gets momentum and more people are getting interested in using experience 
sampling and mHealth technology for health purposes. Time is ripe for change.  
Commercial companies are noticing these developments22,23. They develop ‘fancy’ apps with 
many interesting features. Consumers are getting used to intuitive and attractive interfaces 
and expect a degree of user-friendliness in their tools. The focus of an academic center is 
not to develop market-ready apps, but to explore the aspects and working mechanisms of 
mHealth instrument experimentally. It is difficult to keep up with the fast changing design 
fashions of the market. This puts researchers under pressure. The development of a modern 
looking app requires large funds and multidisciplinary collaborations with app developers 
and design bureaus. Moreover, hardware and software of consumer devices (e.g., Android) 
continually change, challenging developers to keep the ESM app operational. Meanwhile, the 
field formulates new specs and innovative clinical applications are the most demanding23. 
Moreover, the European privacy laws (GDPR) redefine the role and responsibilities of eHealth 
service providers24. On the one hand, research is needed to strengthen the experience-
sampling methodology for clinical practice. On the other hand, investments are needed to 
increase the data security, the user-friendliness, and intuitiveness of ESM as a mobile tool. 
Alternatives to mobile sampling such as passive tracking or smartwatch use might be 
necessary in the future.   
In Maastricht, the department of Psychiatry and Neuropsychology accepted the challenge to 
implement this promising technology in routine clinical practice. This requires that patients 
and clinicians can access the technology, preferably by making it freely available to the public. 
Initial steps in this direction are being made and colleagues are working on the 
implementation of ESM at the general practitioners office and as a self-help tool25. 
Healthcare professionals are enthusiastic about the possibilities that ESM offers and are 
open to try the method in practice. Patients in turn become more empowered and actively 
engage in the process26. A lesson-learned is that implementation in clinical practice requires 
involvement from different stakeholders. It is important to involve users from the start and 
include patients, close-relatives, clinicians, healthcare providers, and healthcare managers25. 
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Example of a clinical service innovation 
In Dialectical Behavior Therapy (DBT) for borderline personality disorder, daily diaries are 
used to track suicidal ideations and dysfunctional behavior27. Reports are reviewed at the 
start of each therapy session. Clinicians experienced some problems with these diaries: end 
of day reports suffer from memory biases and lack contextualized information. Patients often 
struggle to reconstruct the circumstances of dysfunctional behavior from memory. Reporting 
is often forgotten and diaries are sometimes completed in the parking lot before a therapy 
session. ESM can be useful to support in situ data collection and supplement the information 
of the diaries with context descriptions of problematic moments, but also input on resilience 
(moments of optimal experience). A more dynamic picture can emerge. Due to the repeated 
momentary assessments, memory load is reduced, herewith facilitating data collection28. 
In this context, an ESM-DBT protocol was developed for use during individual therapy 
sessions at a mental health facility in the Netherlands (Mondriaan Mental Health Trust). The 
team members were a supervisor in cognitive behavioral therapy (also in training as a clinical 
psychologist) acting as project leader, DBT therapists and an ESM expert. The first step was 
to motivate the mental health facility and the DBT team to become involved. The process was 
a mutual exchange. ESM experts needed to learn about the DBT treatment and assess the 
needs, and DBT therapist had to explore the possibilities of ESM. Initial ideas for the 
development of a customized PsyMate™ supported DBT app were theory driven and 
contained straightforward implementations of existing assessment instruments. However, a 
direct translation to within-day assessments proved difficult. Therapeutic theory came in 
conflict with ESM momentary assessments needs, which have to be intuitive, short, and 
require minimal effort1. At that time, the PsyMate™ app was mainly developed for classic ESM 
research protocols and adjustments were needed to get the app technology and DBT 
framework ready for integration in clinical use. The collaborative development process took 
a year and resulted in modular applications for three different phases in the DBT treatment. 
One patient and her clinician started to use the app, providing valuable information on 
feasibility and its usefulness in clinical practice.  
In the first module, ESM was used as a functional analyses tool that replaced the daily diaries. 
Patients download the app on their own smartphone and receive a questionnaire at eight 
random moments a day. To reduce reactivity and burden, three out of the eight within-day 
assessment moments assessed suicidal ideations and dysfunctional behavior. After a week, 
the patient and therapist examined the data together by using the online report platform. 
This data exploration formed the start of the treatment session. The second module was 
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initiated during the treatment phase aimed at skill acquisition. It includes elements of 
mindfulness and uses focusing exercises on internal processes (kernoplettendheid in Dutch). 
Later, the module was extended to include an exercise on attentiveness to help patients 
integrate the therapy skill into their daily life. An algorithm was used that helped patients to 
direct their attention to exercises that are appropriate considering their current state of 
mind. After three weeks, the last ESM module was activated. This module did not include 
exercises but provided momentary in-app feedback based on mood states. An algorithm was 
created that used the answer score on negative affect and combined this with the responses 
on the tendency towards dysfunctional behavior (e.g., impulsivity or self-harm). At the end of 
each questionnaire, a remark was made on their current mood states, followed by advice on 
actions that could be taken to lower negative tension or to stay in a healthy mode.    
Several lessons were learned from this bottom-up development and implementation 
attempt. Implementation takes time and only works if there is support from the board of the 
institute. They should free clinicians from regular (production) duties and allow them to invest 
time during co-development. Starting from the theoretical background of DBT and within the 
limitations of technology resulted in a very interesting but rather complicated PsyMate™ 
mediated mHealth protocol. Trying to incorporate a multitude of elements leads to a 
multitude of problems. For instance, we found that the security regulations on internet traffic 
within the clinical setting hindered accessing the online reporting page. It took a long time 
before the data could pass correctly through the firewall, frustrating the clinical adoption 
time. In the end, the protocol was simplified to fit the current technology limitations and to 
make the procedure more intuitive for clinicians. Furthermore, institutional politics led to 
repeated drastic changes in the DBT team and to stagnation of the project. The therapist 
who co-developed the protocol switched jobs, leaving an insufficient work force for the ESM 
implementation of the DBT modules.   
With these barriers in mind, it is worth mentioning that both the patient and therapist were 
enthusiastic. Exploring the data opened up the conversation to a more positive approach of 
the patient’s weekly struggles in her daily life. Moments when suicidal ideations were low 
provided clues for resilience. The repeated assessments helped to reflect on the changes in 
emotional state in daily life, herewith increasing awareness. Repeated exercises and 
momentary feedback helped to strengthen the application of learned skills outside the 
therapy session. The patient asked if she could still use the app when her treatment ended, 
a promising sign for future implementation.  
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New horizons 
There are still new horizons for ESM in clinical practice. The rich sampling data leaves room 
for further exploration to increase its merit. The in-app feedback that was used in the 
implementation example seems promising and provides an elegant way to strengthen the 
therapeutic effect. Promising is that in the future it will become easier to personalize the 
experience sampling methodology. Daily life assessments do not require the same nuances 
as traditional cross-sectional assessments need. While engaging in ESM research and guiding 
people in their clinical use of the method I became convinced that a basic, limited set of ESM 
items is universally relevant across disorders. Sometimes an item does not vary within an 
individual. To lower the burden of ESM assessments, these nonresponsive items could be 
disabled. Machine learning techniques might be useful to detect non-responsive items and 
disable them to customize the questionnaires. For instance, the item I feel irritated may be 
relevant for one person, but not for another person. Such an item could be disabled. 
Personalization also means a close fit to someone’s perception of health. One solution is to 
add several personal items to a standard ESM questionnaire. This allows the monitoring of 
additional aspects that are relevant for the individual, but not part of the standard ESM 
questionnaire. The need for these personal aspects is an important point raised by clinicians 
and patients in the implementation project at the general practitioner office25. 
Personalization also includes the adjustment of sampling frequency. It is important to 
customize sampling schemes to fit the waking hours of an individual. However, we also 
learned that giving subjects too many options is frustrating and an inefficient way to collect 
data.  
A good balance is essential between freedom of choice to increase motivation and limitations 
due to scientific knowledge of experts. People will intuitively ask for less frequent 
assessments, but experience learned that a continuous monitoring helps to increase flow 
and ultimately lowers the cognitive burden of repeated assessments. Explaining the 
background or concept of ESM is still required. A good mHealth tool for public use needs to 
be self-explaining and intuitive22. New horizons will include the development of mHealth 
tools that can be used without the briefing of an ESM expert. Gamification elements can aid 
in the motivation for continued ESM use29. Furthermore, there is a promising future in the 
use of passive monitoring to complement the active ESM elements30. Using GPS to map 
environmental aspects or activity trackers to map activation can provide additional 
information with low effort from participants31.  
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The future horizon looks bright. Increasingly, we are moving forward and with every mile, we 
come closer to a better mental health for the majority of people. Research is an important 
facilitator that should go hand in hand with practical implications and societal 
implementations.   
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Summary 
Individual landscapes 
The work presented in this thesis aims at exploring and expanding the possibilities of the 
Experience Sampling Method (ESM) for use in clinical practice. Chapter 1 describes the 
current positive view on mental health care that includes a broad range of recovery domains 
and goes beyond symptom reduction. ESM as an mHealth tool can enhance care by making 
the individual’s everyday life, where problems occur, accessible for assessment and 
treatment. After this introduction, the thesis has three separate parts. Part I describes the 
clinical relevance of ESM with a focus on the individual patient. Part II describes 
methodological considerations that are relevant to determine data reliability for innovative 
parameters developed for use in clinical care. Part III explores the benefits of complementing 
ESM with momentary cognition tests. 
Clinical relevance  
In Chapter 2, a general overview of ESM is provided, including advantages and disadvantages 
of the method for use in clinical trial research. ESM is a valuable tool to assess the 
effectiveness of an intervention as it provides fine-grained information on relevant outcomes 
in everyday life. Researchers are advised on how to design, analyze and administer the 
method. Applications include monitoring and intervening for group comparison and for 
single-case clinical trials. Chapter 3 uses research findings to illustrate the benefit of ESM as 
a regular mobile tool for individual support. ESM as an mHealth tool can support self-
monitoring, self-insight and personalized health care in routine clinical practice, if the data 
are readily accessible for users. The method helps to highlight vulnerability as well as 
resilience and provides insight into implicit patterns between mood, behavior and context. 
In treatment, ESM facilitates shared decision-making and empowerment. Blended care, with 
ESM complementing treatment as usual, may reduce costs because ESM can be used 
outside the context of professional care. Chapter 4 assesses the reliability of ESM as a 
momentary Routine Outcome Monitoring (mROM) instrument in the general hospital. ESM 
as an mROM tool is reliable and has the advantage of informing individuals on their daily 
adaptive functioning. The method shows adequate psychometric properties, concurrent 
validity and sensitivity to change over time on relevant recovery outcomes (i.e., positive affect, 
negative affect, quality of sleep, positive social interactions, activity-related stress, feeling 
tired, and feeling unwell). Chapter 5 concludes with a personal experience story. A user 
explains how ESM supported her recovery from depression. Monitoring had a different 
meaning during consecutive recovery phases, first by providing insight in determinants of 
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vulnerability and later by confirming patterns of general recovery. This long case study shows 
that prolonged monitoring (> 2 years) is possible and meaningful. 
Methodological work 
ESM researchers often develop innovative parameters and data presentation scheme’s to 
implement in regular clinical decision-making. Chapter 6 explores the clinical utility of such 
an ESM summary statistic. Subjective momentary well-being is important for good mental 
health. Intuitively, quality of life improves by increasing the involvement in rewarding 
experiences (situations that feel good). Quality of life does not increase linearly (more is 
better), but can be optimized by balancing challenges in daily life. A reward-related quality of 
life statistic was operationalized by combining situational frequencies (relevant activities, 
locations and company) with concurrent positive affect. It generates a score (representing 
good to bad reward efficiency) for each ESM observation. Reliability of the statistic was tested 
with resampling methods, using various context definitions under different sampling 
circumstances, for real or virtual patients with low-, average- or high contextual variation. 
Overall, reliability was achieved after 100 or more observations were collected. Extra 
observations may be needed in different individual situations. Small sample sizes were only 
feasible in patients with limited contextual variation. Future studies should consider 
resampling procedures to assess the behavior of summary statistics under different 
sampling situations and across populations. This exploration is relevant for clinical practice, 
where often few observations are available.  
Cognition in daily life 
Cognitive problems are common in mental disorders and often linger even when other 
symptoms diminish. These lingering effects influence everyday life adaptation. We need our 
cognitive skills to function properly. Traditionally, cognition tests are administered at specific 
moments and in controlled environments. These assessments provide insight in state 
abilities, but lack information on cognitive variation in real-world environments. To 
compensate for this lack, brief cognition tasks are designed specifically for ESM. Chapter 7 
describes the initial feasibility of two cognition tasks in a sample of 10 patients with bipolar 
disorder. A symbol task measuring processing speed had good completion rates (82%), 
whereas a quiz task measuring liberal acceptance bias resulted in fewer completions (52%). 
The most sensitive cognition parameter on the symbol task – warranting further research – 
was processing speed (reaction time). In Chapter 8, the same task was adapted for 
smartphones and tested in a general population sample (N=40). The protocol included eight 
ESM questionnaires (beeps) with the symbol task, repeated for six days. Cognition outcomes 
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were the number of trials completed within a 30-seconds time interval (speed) and the 
percentage of correct trials (accuracy). The task was perceived as easy, pleasant and do-able. 
These subjective feelings were reflected in a high task accuracy (97%). Cognition varied over 
time and was related to mood, specifically feeling cheerful, irritated and anxious. Context 
mattered, with distraction and location influencing speed. Moreover, speed showed a 
learning effect (faster towards the end of the six-day period) and an age effect (slower with 
older age). The present study thus suggests that implementation of a short digital cognition 
task for repeated measurement in daily life is feasible. In Chapter 9, the same protocol was 
used in a new general population sample (N=49). An additional cognition task assessing 
visuospatial working memory was developed and added to the protocol. Results show 
positive experiences with both cognition tasks, with a sufficient completion rate (71%). Social 
context, age and feeling distracted influence cognitive performance in everyday life. The most 
sensitive outcome measure for cognition was speed on the symbol task. The memory task 
yielded few correct responses (being too difficult), resulting in little variation in scores. Thus, 
it requires further adjustments. More research is needed to establish validity and the 
usefulness of ESM-based brief objective cognition measures for patients in clinical practice.  
New Horizons 
Chapter 10 discusses the main findings, the lessons learned, and future implications. 
Assessing variability is key in understanding what is happening with relevant recovery 
domains on a daily basis. Resilience is related to the efficacy of daily life adaptation strategies. 
Standard instruments often lack insight into contextual variability and ESM can fill this gap. 
Due to innovations in computer technology, the method can be applied clinically at low cost. 
The method can transfer thus from a research instrument to a useful clinical instrument and 
be disseminated in mental health care. Patients monitor their individual landscapes of mood, 
behavior and environment and learn from it. The risk of misinterpreting the data remains. 
Therefore, users need to realize that information is partial. Researchers need to assess the 
behavior of ESM parameters and invest in new ways to guide data interpretation. The power 
of individual data lies in hypotheses generation and the opportunity to test them in daily life. 
In the future, ESM feedback possibilities will likely expand (e.g., by using artificial intelligence). 
In essence, however, its simplicity is its strength. The first steps towards a widespread clinical 
implementation are taken. Now, the path needs to be continued. Research is a good 
facilitator for this, next to hands-on experience in the field. Let us continue the path towards 
a bright new horizon for ESM in clinical practice.  
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Samenvatting 
Individuele landschappen 
Dit proefschrift richt zich op het verkennen en uitbreiden van de Experience Sampling 
Method (ESM), een op wetenschap gebaseerde dagboekmethode, voor de geestelijke 
gezondheidszorg (GGZ). Hoofdstuk 1 beschrijft de GGZ op dit moment, waar aandacht is 
voor positieve gezondheid en herstel. ESM als app biedt de mogelijkheid om behandeling 
naar het dagelijks leven te brengen op een manier die toegankelijk is en bekrachtigend werkt. 
Na deze introductie volgen drie delen. Deel I beschrijft de zorgrelevantie van ESM voor 
individuele patiënten. Deel II beschrijft de methodologische overwegingen die relevant zijn 
bij het beoordelen van databetrouwbaarheid. Deel III verkent de meerwaarde van het 
objectief meten van cognitie met ESM. 
Klinische relevantie  
Hoofdstuk 2 geeft een algemeen overzicht, waarbij de voor- en nadelen van ESM als 
meetinstrument voor onderzoek naar de effectiviteit van behandelingen worden 
beschreven. ESM is hiervoor geschikt, omdat het informatie verzamelt over uitkomsten in 
het dagelijks leven. Onderzoekers krijgen advies over hoe ze een ESM-studie kunnen 
opzetten, analyseren en toepassen. Dit kan bijvoorbeeld door ESM te gebruiken als 
monitoringsinstrument of als behandelinterventie, maar de methode is ook geschikt voor 
het uitvoeren van individuele behandelstudies. Hoofdstuk 3 illustreert met het gebruik van 
verschillende onderzoeksresultaten hoe ESM werkt als reguliere app binnen de zorg. De 
voordelen voor individuele ondersteuning worden besproken. Naast een persoonlijke 
aanpak, kan de app zelfmonitoring bevorderen en zelfinzicht bieden, als de data toegankelijk 
zijn voor patiënten. Deze data kunnen helpen om weerbaarheid te ontdekken en verborgen 
patronen tussen stemming, gedrag en omgeving zichtbaar te maken. Daarnaast faciliteert 
ESM een gedeelde besluitvorming binnen een behandeling en zet het patiënten in hun 
kracht. Zorg waarbij traditionele hulpverlening wordt aangevuld met ESM als digitaal 
hulpmiddel kan behandeluitkomsten verbeteren en kosten besparen. Hoofdstuk 4 
presenteert een betrouwbaarheidsstudie in het ziekenhuis, waarbij ESM is getest als vast 
meetinstrument voor behandelingen in het ziekenhuis. De uitkomsten lieten zien dat de 
methode betrouwbaar is, met voldoende psychometrische kwaliteiten. ESM meet wat het 
hoort te meten en is in staat om subtiele veranderingen over tijd op te pikken die relevant 
zijn voor herstel (den aan positief affect, negatief affect, slaapkwaliteit, activiteit-gerelateerde 
stress, moeheid en niet goed voelen). De methode verlegt de focus naar het moment en 
informeert personen over hun dagelijks aanpassingsvermogen. Hoofdstuk 5 beschrijft in een 
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ervaringsverhaal hoe ESM kan bijdragen aan het herstel van depressie. Het ervaringsverhaal 
laat zien dat langdurig monitoren (> 2 jaar) mogelijk en betekenisvol is. ESM biedt houvast 
gedurende verschillende herstelfases, waarbij de betekenis verandert over tijd. Dit kan 
variëren van een doel op de dag tot een algemeen overzicht van herstel.  
Methodologisch werk 
Hoofdstuk 6 verkent de bruikbaarheid van ESM-data voor het bijhouden van herstel. 
Subjectief welzijn is belangrijk voor een goede mentale gezondheid. Intuïtief gezien verbetert 
de kwaliteit van leven door meer tijd te spenderen aan belonende ervaringen (situaties die 
goed voelen). Een scenario waarbij alle ervaringen positief zijn is niet realistisch. Het doel is 
om een goede balans te vinden tussen fijne ervaringen en vervelende momenten. Om dit te 
meten, hebben we een op beloning gebaseerde welzijnsmaat geoperationaliseerd. Deze 
maat combineert hoe vaak situaties voorkomen (bestaande uit activiteiten, locaties en 
gezelschap) met de mate van bijbehorende positieve gevoelens. Per ESM-moment ontstaat 
er een positieve score (iemand is efficiënt bezig en spendeert de meeste tijd in situaties die 
goed voelen) of een negatieve score (iemand is minder efficiënt bezig). De betrouwbaarheid 
van deze maat is getest met resampling-procedures waarbij verschillende definities van 
situaties, onder verschillende steekproefomstandigheden zijn getest, zowel voor echte als 
virtuele patiënten met lage-, gemiddelde-, of hoge variatie in dagelijkse situaties. Gemiddeld 
100 momenten waren nodig voor een betrouwbare meting, met verschillende aantallen 
tussen personen. Kleinere aantallen (bijv. 40 momenten) waren alleen haalbaar voor iemand 
met weinig situationele variatie op een dag (bijv. iemand die veel thuis is). Resampling mag 
vaker gebruikt worden om het gedrag van uitkomstmaten te onderzoeken. Deze verkenning 
is relevant voor de praktijk, omdat minder ESM-momenten vaak de norm zijn.  
Cognitie in het dagelijks leven  
Cognitieve problemen (aandacht, geheugen en concentratieklachten) komen veel voor 
binnen de GGZ. Klachten blijven vaak lang aanwezig, ook wanneer andere symptomen 
(bijvoorbeeld stemmingsklachten) afnemen. Cognitieve vaardigheden zijn nodig om goed te 
functioneren en beïnvloeden ons dagelijks leven. Om iemands stabiele capaciteiten te 
meten, worden traditionele cognitie testen afgenomen in gecontroleerde omgevingen en op 
specifieke momenten. Wat hierbij mist is informatie over hoe cognitie varieert over tijd en 
hoe het cognitief functioneren samenhangt met andere factoren. Om hier inzicht in te krijgen 
hebben we korte cognitieve taken ontwikkeld, speciaal voor ESM. Hoofdstuk 7 beschrijft een 
eerste haalbaarheidsstudie waarbij twee cognitietaken zijn getest bij 10 patiënten met een 
stemmingsstoornis, een symbooltaak en een quiztaak. De symbooltaak (voor 
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verwerkingssnelheid) werd goed ingevuld door deelnemers (82% van de taken), terwijl de 
quiztaak (voor een verhoogde aannamebias) minder goed werd ingevuld (52%). Het meest 
gevoelig voor verandering bleek de snelheid op de symbooltaak, deze rechtvaardigt verder 
onderzoek. In Hoofdstuk 8 is de symbooltaak als app getest bij 40 gezonde personen. 
Deelnemers ontvingen gedurende zes dagen elke dag acht ESM-vragenlijsten met de 
symbooltaak. De uitkomstmaten voor cognitie waren snelheid en accuraatheid op de taak. 
De taak werd ervaren als gemakkelijk, plezierig en haalbaar en deelnemers waren in 97% van 
de gevallen correct (hoge accuraatheid). Resultaten laten zien dat cognitie varieert over tijd 
en samenhangt met stemming (opgewektheid, irritatie en angst). De context bleek belangrijk, 
waarbij afleiding en locatie invloed hadden op de snelheid. Ouderen waren gemiddeld 
langzamer dan jongeren en mensen werden sneller naarmate de testweek vorderde 
(leereffect). In hoofdstuk 9 is hetzelfde protocol uitgevoerd, maar nu bij 49 gezonde 
personen en een extra geheugentaak (voor het meten van visueel ruimtelijk werkgeheugen). 
De ervaringen waren positief en de vragenlijsten zijn voldoende ingevuld (71%). Sociale 
omgeving, leeftijd en afleiding hadden invloed op cognitieve prestaties. Snelheid bij de 
symbooltaak blijkt een sensitieve uitkomstmaat voor cognitie, terwijl de geheugentaak te 
moeilijk is en aanpassingen vergt. Vervolgonderzoek is nodig om de validiteit vast te stellen 
en te onderzoeken of de taken geschikt en waardevol zijn binnen de zorg. 
Nieuwe horizon 
Hoofdstuk 10 gaat in op de hoofdbevindingen, de geleerde lessen en de toekomst van ESM 
in de praktijk. Inzicht in variatie op relevante herstelgebieden is essentieel om te begrijpen 
wat er dagelijks gebeurd. ESM als zorginstrument kan dit bieden. Patiënten monitoren hun 
individuele landschappen van stemming, gedrag en omgeving en leren ervan. 
Voorzichtigheid is hierbij geboden, omdat het risico bestaat dat er verkeerde conclusies 
worden getrokken. Gebruikers moeten zich realiseren dat de verzamelde informatie slechts 
deelinformatie is. Het is aan onderzoekers om het gedrag van parameters te evalueren en 
te investeren in een betrouwbare dataweergave. De kracht ligt bij het formuleren van 
hypothesen en de kans om deze in het dagelijks leven te toetsen. ESM-feedback zal zich in 
de toekomst uitbreiden, maar voor nu werkt eenvoud het beste. De eerste stappen richting 
de zorg zijn gemaakt, nu moet het pad verder gevolgd worden. Onderzoek faciliteert dit, 
naast praktijkervaring in het veld. Laten we blijven bewegen naar een heldere nieuwe horizon 
voor ESM binnen de GGZ. 
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Knowledge valorization 
The general aim of this thesis was to explore and expand the utility of the experience 
sampling method for use in mental health care. This means moving away from a singular 
research focus towards creating an additional value for the public domain.  
Societal relevance 
Psychological problems are common and societal costs to deal with these problems are high. 
Research shows that every year, a quarter of the Dutch population is in need of mental health 
support1. This is a problem, because only 7.3 percent of the Dutch population actually receive 
professional mental healthcare2. The finances for expanding the mental health sector are 
lacking. So not everyone will receive accurate treatment1. A continuous effort is required to 
improve the effectiveness of available care, reduce the costs involved, and prioritize care 
better. What could help is to provide tools that allow people to work on their mental health 
without the presence of a professional.  
In light of these efforts, a transition is ongoing within the mental health care system in the 
Netherlands. The focus shifts from illness to positive health3. This is important, because a 
strong focus on illness, both in somatic care as well as mental health care, has iatrogenic 
effects and keeps patients ill. For sustainable well-being and the prevention of suffering, it is 
crucial to build resilience and increase autonomy1. The professional health care field has 
neglected these aspects in the past, but is now adopting a more holistic care approach. This 
includes paying attention to someone’s social network, his or her environment, work 
situation and general health. Resilience, in this respect, is very much a concept of everyday 
life. However, the professional field still misses the tools to assess these aspects.  
The experience sampling method (ESM) facilitates monitoring in a holistic way; it can assess 
vulnerability as well as resilience, and fits within the positive health concept. Since it works 
on smartphones, it is accessible during the day and to the majority of people. By providing 
an evidence-based mobile application in the App store or Google Play store and by making 
sure the collected data are secure and freely accessible to users, a costs-effective alternative 
is available to complement treatment. The added benefit is that patients become 
empowered, because ESM allows them to gather information and actively test personal 
hypotheses outside treatment hours. Building resilience should be possible without using 
professional resources. People who are unwell and want to explore what helps them to feel 
better are also able to use ESM. Thereby providing the chance to help people early on and 
prevent suffering.  
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Innovation 
The PsyMate™ as an ESM tool was used throughout this thesis. One of the benefits of this 
app is that it is accessible in different languages and freely available to the public. The studies 
in this thesis contributed to the development of this app. The knowledge gained by the 
naturalistic single-case trials have helped design a basic set of ESM questions that are 
universal across complaints and relevant during recovery. Up to five additional personal 
questions can be added to the free questionnaire, allowing the monitoring of specific wishes 
during recovery (e.g., I feel suspicious). Currently, efforts are made to provide intuitive 
guidelines, so that people are not dependent on an elaborate information session before 
they use the method. The app and the web-based reporting module (to view ESM results) 
could benefit from information screens that explain the method. The positive results 
presented in this thesis warrant a continuous investment in ESM for clinical practice. This 
means working towards increased user-friendliness (e.g., making the app available for people 
who have difficulty reading), improving the reliability of ESM feedback, and investigating the 
validity of ESM-based cognition tasks. Furthermore, insight is needed into the facilitators and 
barriers while implementing ESM in clinical practice. Colleagues at the department of 
Psychiatry and Neuropsychology in Maastricht are currently working on the above-
mentioned projects.   
Target audience 
The finding described in this thesis are relevant for people suffering from mental health 
complaints, health care providers, researchers, health insurance companies and policy 
makers.  
Everyone, at some point in their life, experiences mental health or somatic complaints. It 
could help to explore when and why complaints occur. Often, symptomatic variability is 
influenced by context. Knowing when pain occurs, or equally so, when someone is able to 
relax and become unburdened, is valuable in treatment and care. Knowing what happens is 
the first step towards exploring alternatives towards feeling better. ESM can provide insight 
into mood and context for people with somatic complaints, psychological complaints, or for 
anyone who is interested to increase their general well-being. The audience includes youth, 
elderly people, and people who suffer from severe health problems or mental illness. In the 
future, ESM will likely be suited to provide insight into daily cognitive functioning. This is 
especially relevant for people suffering from neurological conditions, such as dementia or 
mild cognitive impairment.  
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Health care professionals benefit from viewing ESM data together with their patient. It can 
help move away from assumptions based on group findings and center the therapy session 
on the individual situation. Patients sometimes struggle to express themselves. Looking at 
their momentary mood ratings over the past week, might open up the conversation and 
provide insight for both parties. Therapy then becomes a collaborative practice were both 
parties can equally engage. Current practices often require the use of end-of-the-day diary 
methods that suffer from memory bias. ESM could replace them and provide additional fine-
grained information on situational processes. A well-balanced ESM questionnaire focuses on 
several relevant health aspects, helping clinicians to focus beyond symptomatic recovery. 
Important is that the user is also the owner of the data. They can choose to share the data 
with their care provider, not the other way around.  
Our findings could be of interest to insurance companies and policy makers, given that ESM 
as an mHealth tool has proven merits in routine clinical practice. Next to being a useful and 
more accurate assessment instrument during treatment, ESM is also a relevant prevention 
strategy. Supporting people to increase their resilience is a useful strategy to prevent mental 
suffering in the future.  
Implementation 
To disseminate our findings among health care professionals, we give presentations and 
workshops on how to use ESM as a clinical tool and work with ESM feedback. Currently, a 
workshop is provided for psychological assistants at the general practitioners office. They are 
enrolled in a pilot were ESM is adjusted for and implemented in their current care practice. 
The clinical value of the method for both clinicians as well as patients is evaluated and 
adjustments are made accordingly. Most presentations are held at health care institutes in 
the South of the Netherlands, but efforts are made to reach interested parties across the 
country too. In a recent presentation at the Psychose café in Roermond, patients with a 
psychosis background, family members, and interested people were informed on how to use 
the PsyMate™ during recovery. These outreaching activities are very informative and help to 
guide research towards designing a practical, valuable and useful tool for the public. Future 
projects should continue along these lines and make sure the method is implemented in 
health care and freely available to the public. Ultimately, the clinician becomes an additional 
coach in the recovery process where the patient remains fundamentally in charge.  
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agendavoering. Bedankt onder meer aan Ine, Jolanda, Trees, Dafne, Inge en Dominique, maar 
ook aan Ron en Jo voor alle digitale ondersteuning. Met methodologische of statistische 
vragen kon ik altijd goed terecht bij Marjan, Wolfgang of Richel. Bedankt voor jullie geduld en 
advies. Catherine, jouw begeleiding tijdens mijn stage heeft mij het vertrouwen gegeven voor 
het uitvoeren van onderzoek en uiteindelijk het PhD traject. Maarten, fijn dat ik jouw 
reisschema’s mocht uitwerken ;) Bedankt voor alle sparmomenten, ik kijk uit naar onze 
samenwerking! Nienke, bedankt om mij te betrekken bij het toffe DaLiBi project. Frenk, 
bedankt voor de inspiratie en congres-gezelligheid. To the English-speaking colleagues, 
thanks for making the office such a nice environment and for all the fun conversations. Sinan, 
thanks for the additional ESM inspiration, I enjoyed working on the machine learning paper! 
De voormalige PhD’s: Annelie, Yori, Hennie, Thomas, Silvia, Zuzana, Esther, Claudia, Steven, 
Iris, Stijn, Jindra: het was superfijn om met jullie te kunnen sparren en ontspannen onder het 
genot van pizza, Weerwolven-spelletjes en vers gemaakte cappuccino’s! PhD’ers van nu: Kim, 
Maarten, Laila, Lotta, Mary Rose, Naomi, Christian, Sophie, Boris, Ozan, Stella, Samantha, 
Nikita, Maud, Emma, Anne, Coline, Suzanne, and Evita: thanks for making the department 
such a nice place! I enjoy chatting with you, discussing about our research and going for a 
walk to stretch our legs! 
Naast mijn eigen onderzoek, heb ik mogen werken aan een aantal andere projecten 
waaronder de Geestkrant (of Hoofdzaken) redactie. Het blijft leuk om met jullie te mogen 
brainstormen over welke interessante onderzoeken we kunnen uitlichten. Ook mocht ik 
werken als PhD representative; zonder dit had ik een aantal mensen van de andere divisies 
niet leren kennen! Mede (ex)PhD-reps, het was echt leuk om met jullie PhD evenementen te 
organiseren. Het is altijd fijn om met collega’s van buitenaf te kunnen kletsen en sparren. 
Bedankt allemaal :) Lotte en Niels, jullie proefschriftadvies was erg welkom! Christine, de 
koffiemomentjes hebben goed gedaan. Sara, it was such a pleasure to work with you on 
developing the cognition tasks! I am happy we have met and hope for more opportunities to 
work together (or hang out) in the future. Gerelateerd aan cognitie: Rudolf en Bert, hartelijk 
dank voor het delen van jullie visie en bereidheid om mee te denken. Klara, bedankt voor alle 
DGT-inspiratie, een supertof project! 
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To the ESM-expert group: Thanks so much for all the ESM enthusiasm, inspiration and advice 
in these last years! The work in this thesis has benefited from your expertise and I am happy 
that I can remain a member for a while longer. 
In het afgelopen jaar heb ik mogen starten als psycholoog bij de Nieuwe GGZ in Hoensbroek. 
Lieve Mondriaan collega’s, het is superleuk om met jullie samen te werken. Binnen het team 
kan ik groeien en de opgedane ervaringen zijn daarnaast een fijne inspiratie voor toekomstig 
onderzoek. Een combinatie van beide werkvelden voelt als een verrijking! 
I got the chance to travel to Los Angeles and work with some great researchers at the Center 
for Self-Report Science at USC. Dear Arthur, thank you for making this visit possible. You and 
your team have challenged me to take a different perspective and inspired me to be critical 
when examining EMA data. Stefan, it was such fun to discuss statistical possibilities to model 
changes! Bob, thanks for connecting research and magic and providing me with new 
perspectives :) Marta and Filip, I am so happy that I met you both! Taking me to the beach 
right after my arrival made all the difference in the world. Your enthusiasm to explore is 
contagious and without your guidance, I would have missed such cool things! 
In de afgelopen periode heb ik meerdere malen bij mijn netwerk aangeklopt voor hulp met 
het testen van de PsyMate. Soms wel tot twee keer toe omdat iets niet meteen wilde werken. 
Maar de resultaten zijn wel terug te vinden in dit proefschrift. Nogmaals enorm bedankt voor 
alle bereidheid en jullie deelname! Hiernaast wil ik ook alle stagiaires bedanken die zich 
hebben ingezet voor het PsyMate onderzoek! 
Jaimie, Christoffel, Michelle, jullie wil ik in het bijzonder bedanken. Ik heb zo enorm veel 
geleerd van het samen zoeken naar een betekenisvolle en passende monitoring, het leren 
van de rapportagepagina en de verzamelde gegevens. Mijn respect voor jullie is groot en het 
was een eer om de weg naar herstel met jullie te mogen ontdekken. 
Enorm veel liefde en dank voor mijn kamergenootjes, met wie ik stressvolle momenten, 
onduidelijkheden maar ook successen heb mogen delen en wie mij enorm veel energie en 
plezier in werk hebben gegeven. Suzanne, nog nooit heb ik zo’n enthousiast persoon 
ontmoet als jij. Een PhD is fantastisch, toch?! Onze kletsmomenten bleven wel beperkt tot 
koffiepauzes (je hebt mijn koffie-verslaving mede op gang geholpen), want er werd natuurlijk 
hard gewerkt. Al werden die hyper-focus momenten wel af en toe onderbroken door wat 
rek- en strekoefeningen op kantoor, want we mogen niet vastroesten ;). Naomi, wat was het 
tof dat er nog een PhD student begon, met ESM ging werken en ook nog eens bij mij op 
kantoor terecht kwam. Enthousiast nam jij het gezamenlijk afwas-ritueel van Suzanne en mij 
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over en konden we goed sparren over allerlei ESM en niet ESM-gerelateerde onderwerpen. 
Erg bedankt voor jouw opvang tijdens stressmomenten. Fijn dat we elkaar leren om af en toe 
aan paarden te denken en ons perfectionisme los te laten. Anne, ook jou wil ik bedanken als 
kamergenote, voor de fijne gesprekken en de toffe versiering op kantoor (waar hoop is, is 
perspectief en doe eens even niet normaal!). Ik heb veel respect voor alles wat je doet om de 
wereld net wat vriendelijker te maken en al dat stigma rondom psychische klachten te 
doorbreken. 
Vrienden zijn ook hier onmisbaar. Zonder alle gezellige, niet werk gerelateerde 
feestmomenten was de balans flink zoek geweest! De spellenavonden (of treasure hunts), 
etentjes, bakmomentjes, filmavondjes, festivals, theatershows, schaats- en pretparkfestijnen, 
carnavalsfeestjes en diepgaande gesprekken (al dan niet onder het genot van bier) worden 
erg gewaardeerd! Laten we snel wat nieuws plannen, nu is er tijd . 
Alexandra, een betere schoonmama kan ik mij niet wensen. Bedankt voor alle steun en 
bereidheid om te helpen. Een gezellige wandeling of lunch, het poetsen van ons huisje, mee-
testen (plus alle collega’s zover krijgen), of door gewoon trots te zijn. Marthè, ik weet zeker 
dat jij ook trots bent en op afstand het proces hebt gevolgd. Rebecca, al een lange tijd zusjes, 
maar binnenkort officieel (oeh yeah!). Bedankt voor al je steun en gezelligheid. Snel weer wat 
concertjes plannen! Luc, ook jij hebt me goed gesteund. Samen verliezen met Knowledge is 
Power is toch veel gezelliger. Tegen die tweeling kunnen wij natuurlijk niet op! 
Pap, Mam, Dennis, Michelle. Zonder jullie steun had ik dit helemaal niet gekund! Altijd trots, 
ook als het tegenzit. Pap, ik heb toch een aantal karaktertrekken overgenomen geloof ik (iets 
met werkmieren en mestkevers). Mam, weet je nog toen we beide slechts nieuws kregen? 
Moet je zien waar we nu staan! Jullie hebben me de kansen gegeven, waarvoor ik heel 
dankbaar ben. Dennis, als ik professor word, dan word jij luitenant! Bedankt voor je 
onvoorwaardelijke vertrouwen. Michelle, het is supergezellig met jou in de familie erbij. 
Bedankt voor alle hulp met dit proefschrift!  
Het mooiste plaatje hier is toch wel het familiewapen (thanks pap), nu officieel in print. 
D’r letste is d’r betste. Joshua, my neutron star collision. Jij bent degene die alle dalen en 
pieken heeft meegemaakt, van A tot Z! Ook voor jou is het een hele reis geweest. Toen ik 
twijfelde of ik wel zo lang weg kon gaan, was jij diegene die zei dat ik het moest doen. Jouw 
steun is onvoorwaardelijk. Ik kan niet wachten om ons avontuur voort te zetten en deze 
zomer te trouwen! 
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